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ABSTRACT
Cells analogous to vertebrate endocrine cells have been described 
in the gut epithelium of the ascidian Stvela clava. As well as some 
histochemical similarities, ultrastructural correlations have been 
demonstrated, particularly the presence of electron dense granules, 
clustered around and mainly below the nucleus, thinning out towards the 
apex. Like the endocrine cells of the vertebrate gut, the cells are 
often pyramidal, with a narrow apex which is occasionally observed to 
extend to the lumen of the gut.
In addition, strong secretin immunofluorescence was observed in 
the endocrine-like (E-L) cells of the mucous cap of the gastric 
ridges. Because of these observations, acid extracts of Styela gut 
were assayed for secretin in the rat and in the turkey. The Styela 
extracts as prepared were inactive but it is possible that this 
reflected faults in the extraction technique.
.Development of a perfused Styela gut preparation, however, 
produced evidence to support the hypothesis that a CCK-like peptide is 
released into the circulation, presumably from the E-L cap cells, 
although CCK-like immunoreactivity is not demonstrable in these cells.
The observation that in addition to CCK, bombesin and physalaemin 
also induce enzyme release suggests that the pre-pancreatic zymogen 
cells contain a rich complement of receptors, corresponding to all the 
classes of PI stimulating receptors which have been found on vertebrate 
acinar cells. There is therefore the implication that these hormones 
or analogues may be present in Styela. As secretin was found not to act 
as a secretagogue in this system, the significance of its production is 
unclear. By analogy with vertebrate systems it may exert some control 
over the secretion of mucus by the cap cells.
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INTRODUCTION
This chapter reports the finding of endocrine-like (E-L) cells in 
the gut of the ascidian Styela clava (Herdman, 1891) and their 
relationship to vertebrate gut endocrine cells. In order to do this it 
is first necessary to explain the nature of enterochroraaffin cells, and 
the APUD theory of Pearse (1968a), that relates them to the other 
vertebrate endocrine cells.
The Enterochromaffin cell
The earliest description of cells which are now recognised as 
gastrointestinal endocrine cells was made by Heidenhain (1870), who 
reported that cells in the gastric mucosa of the dog and rabbit stained 
brown when fixed in bichromate solutions.
Cells similar to those of Heidenhain's were subsequently described 
independently by a number of authors. Many believed them to be their 
own discovery, and this has in consequence given rise to confusion 
concerning their nomenclature.
Nussbaum (1879) demonstrated granular cells in the stomach and 
pylorus after osmium fixation, and from his figures, these appear to be 
the same as Heidenhain's cells. Toldt (1880) also mentions granulated 
cells in an extensive paper on the development of gastric glands.
The first report of these granular cells in the intestinal 
epithelium was by Nicolas (1891) who fixed lizard intestine in 
Flemming's fluid, and after staining with safranine, saw occasional 
bottle-shaped cells, filled with small red granules. They were 
rediscovered by Kultschitzky (1897) in the canine intestine, noting 
that degranulation took place during fasting, an observation which was 
confirmed by Moller (1899).
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In a brief paper, Ciaccio (1906) reported granulated cells in the 
canine crypts of Lieberkuhn, which stained with eosin, thionine blue, 
toluidine blue and iron haematoxylin. Ciaccio then published a far 
more detailed account of his cells (Ciaccio, 1907) attributing their 
discovery to Paneth in 1888 and mentioning the work of Nicolas, Moller 
and Kultschitsky. In this paper, Ciaccio described triangular or 
conical cells in dog and guinea pig intestine. He noted that they 
contained granules which could be stained yellow with potassium
bichromate and because of this chromaffinity he considered they were
similar to the cells of the adrenal medulla and suggested that they be
called 'enterochromaffin cells'.
In a short paper, Kaufmann-Wolf (1911) noted the cells, and 
because of their characteristic appearance called them 'basalge kornte 
zellen', or basal granulated cells, and these were also noted by Kull
(1913). Eklof (1914) in a monograph on the intestinal epithelium, made 
the unfortunate observation that he considered the granules to be 
fixation artefacts caused by coagulation of albuminoids into spheres.
Masson (1914) also described the enterochroraaffin cells in human 
intestinal tumour tissue. He found that these cells could be stained
with ammoniacal silver nitrate, using Bouin fixed tissue.
On the basis of these observations, Masson suggested that these 
cells should no longer be called enterochromaffin, as they could be 
confused with the adrenal chromaffin cells. Instead he suggested the 
epithet 'argentaffin'. Furthermore he made the inspired suggestion that 
these cells were endocrine and might constitute a diffuse 
gastrointestinal gland of endodermal origin, which was homologous with 
the pancreatic islets of Langerhans.
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This considerably predates Feyter's (1938) concept of the diffuse 
epithelial endocrine organ, and perhaps Masson should be considered as 
the originator of the concept, albeit in a more simple form.
The argentaffin description was slow to gain acceptance. Kull 
(1925) described the cells as chromaffin, and Cordier (1926) as 
chromo-argentaffin. However the argentaffinity of these cells, ie their 
ability to reduce ammoniacal silver salts, was to become an important 
criterion for their identification.
Hamperl (1932) noted that some of the enterochromaffin cells were 
not argentaffin, but they were able to accumulate cytoplasmic silver 
deposits in the presence of reducing agents. These cells he described 
as argyrophilic. The two types of cells have also been called 
enterochromaffin (ie argentaffin) and enterochromaffin-like (ie 
argyrophil) (Pearse, 1974).
In 1938, Feyter suggested that the argentaffin and argyrophil 
cells of the gut might be considered as a 'diffuse epithelial endocrine 
organ'. The individual cells were considered to produce hormones that 
acted in a paracrine fashion on neighbouring cells and this theory laid 
the foundations for the development of the gastro-entero-pancreatic 
endocrine system and its unification by the APUD theory.
The APUD theory
Subsequent to work on the calcitonin producing parafollicular 
C-cells of the thyroid, Pearse (1966) called attention to a number of 
cells, including the enterochromaffin cell, which shared common 
cytochemical properties. This germ of an idea grew into the APUD 
theory (Pearse, 1968a), in which three sets of characteristics were 
used to define an APUD cell; ultrastructural, cytochemical and
16
TABLE 1 - Ultrastructural characteristics
1. Low levels of rough endoplasmic reticulum
2. High levels of smooth endoplasmic reticulum, as vesicles
3. . High content of free ribosomes
4. Electron-dense, fixation-labile mitochondria
5. Prominent microtubules and centrosomes
6. Tendency to produce fine protein microfibrils 
(especially when neoplastic)
7. Membrane-bound secretion vesicles, with osmiophilic contents,
best preserved.by gluteraldehyde; varying density; average
size 100-200 nm
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embryological (tables 1,2,3).
The ultrastructural characteristics (Table I) are fairly general, 
and are exhibited by most peptide secreting cells. The level of rough 
endoplasmic reticulum (RER), however, is dependent on whether the cell 
is actively synthesising its secretory product, in which case levels 
will be high, or storing it, in which case levels will be low. Pearse 
(1971) puts forward the proposal that the normal state of APUD cells is 
the storage phase as an explanation for the low levels of RER. But if 
an APUD cell is observed in a secretory phase, the RER levels can be 
elevated (Gould, 1978).
The high levels of smooth endoplasmic reticulum (SER) are 
certainly not an exclusive feature of APUD cells, as the limiting 
membranes of all secretory granules are presumably derived from 
endoplasmic reticulum. In this sense, any cell actively secreting 
granules, such as the acinar cells of the exocrine pancreas, could be 
considered to have high levels of SER.
The fourth and fifth characteristics are extremely vague, and this 
makes it difficult to regard them as clear cut APUD characteristics.
In the case of the sixth characteristic, its relevance is limited by 
the fact that neoplastic cells are rarely observed except in medical 
school pathology departments.
The final characteristic is certainly a constant feature of APUD 
cells, though not unique to them. Because of the general nature of 
these ultrastructural features, it is clear that APUD cells cannot be 
identified with any certainty by electron microscopy alone, although it 
is a useful adjunct to other methods. The main use of the electron 
microscope in this field has been the classification of different types 
of cells on the basis of the size and shape of their secretion granules
table 2 - Cytochemical characteristics
A) 1. Fluorogenic amine content (catecholamine, 5-HT etc)
or ability to secondarily take it up
P)
U) 2. Amine precursor uptake (5-HTP, DOPA)
D) 3. Amino acid decarboxylase content
4. High side chain carboxyl or carboxyamide groups,
sufficient for demonstration by masked metachromasia
5. High non-specific esterase and/or cholinesterase
6. High -GPD
7. Specific immunofluorescence
5-HT = 5-hydroxytryptamine; 5-HTP = 5-hydroxytryptophan ;
DOPA = dihydroxyphenylalanine; -GPD = -glycerphosphate dehydrogenase 
(after Pearse, 1969)-
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(Solcia et al, 1978a). However even this appears to require care, as 
granule appearance is easily altered by a number of fixation parameters 
(Mortensen and Morris, 1977),
The most constant cytochemical characteristics (Table 2) are 2,3,4 
and 5, although if the first characteristic is present, then 2 and 3 
may not be. The terra APUD is an acronym derived from the initial 
letters of the first three characteristics. Amine and Precursor Uptake 
and Decarboxylation. APUD cells either contain a biogenic amine (ie 
5-HT, domamine, epinephrine or norepinephrine) or are able to take it 
up. Also they are able to take up an amine precursor (ie 5-HTP or 
DOPA) and decarboxylate it (ie to 5-HT or dopamine).
The methods used for detecting amine content are based on 
fluorescence microscopy of formaldehyde fixed tissue. Enterochromaffin 
cells have been identified in this manner, using formalin fixed frozen 
tissue, since 1932 (Eros, 1932; Hamperl, 1932) but now formaldehyde 
vapour fixed, freeze-dried tissue is used after the method of Falck 
(Falck, 1962; Falck et al, 1962).
Gaseous formaldehyde reacts with biogenic monoamines such as 5-HT 
to produce compounds which fluoresce strongly in ultraviolet light. 
Amine precursor uptake can be demonstrated conveniently by intravenous 
injection of the L isomer of DOPA or 5-HTP. If tritiated DOPA or 5-HTP 
is used, then the resultant H/-5-HT or *H/-dopamine can be visualised 
by autoradiography (Pearse and Ocurapaugh, 1966). If 'cold' amine 
precursors are employed, then the resulting amines can be visualised by 
the formaldehyde method of Falck.
Pearse had originally suggested that the process of peptide 
production may be linked to the uptake of 5-HTP and its subsequent 
decarboxylation to 5-HT (Pearse, 1966). It is now apparent that this
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is the case, and all APUD cells demonstrate these amine handling
properties. However other, non-endocrine protein producing cells have 
been shown to share these APUD properties of amine metabolism; notably 
cells from the exocrine pancreas (Aim, 1969; Aim et al, 1969) the chief 
cells (Hâkanson et al, 1970) and Paneth cells of the stomach (Ahonen, 
1973).
Some endocrine cells have been shown to stain with basic dyes such 
as pseudoisocyanin and toluidine blue (Epple, 1967; Solcia and 
Sampietro, 1965a; 1965b; 1965c). These basic dyes become attached to 
side-chain carboxyl groups of proteins (Solcia and Sampietro, 1965c) 
but are somewhat blocked in fixed tissue.
These side chains can be unmasked by acid hydrolysis (Solcia et
al, 1968). Moreover, this technique converts side chain carboxyamido 
groups (glutamine and asparagine) to carboxyl groups (glutamic and 
aspartic acid). This characteristic is usually shown as 'masked 
metachromasia', with toluidine blue at pH 5.0 (Solcia et al, 1968) or 
the acridine dye, coriphosphine 0 (Bussolati et al, 1969).
The high levels of non-specific esterases and/or cholinesterases 
are a less specific, feature of APUD cells. There is a considerable 
species variation, and high activity is often found in non-APUD cells 
(Hoyt et al, 1973; Pearse and Welbourn, 1973). A number of other 
techniques have also been employed to demonstrate APUD cells.
The lead haematoxylin method of Solcia (Solcia et al, 1969a) is 
also an effective staining technique for APUD cells. Like the 
basophilic and metachromatic stains i t is thought to act on carboxyl
groups, and is similarly made more effective by pre-treatment with 
HCl. However lead haematoxylin is more effective than the other two 
methods when the stains are considered without the HCl pre-treatment.
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It would therefore appear that lead haematoxylin also shows some 
affinity for the carboxyamido groups that are unmasked by the acid 
hydrolysis. This method has also been adapted for use with semi-thin 
sections cut from resin embedded tissues (Gorgas and Bock, 1975).
Other useful stains, particularly for the gut endocrine cells are 
silver stains, which have been developed from the method of Masson
(1914). These can be divided into two groups; those not requiring
addition of a reducing agent, but relying on the cells containing 
endogenous agents able to reduce the silver ions in an ammoniacal 
silver salt solution (cf. Pearse, 1960), and those to which an
exogenous reducing agent is added to cause the same precipitation of 
metallic silver to selectively impregnate the granules (Grimelius, 
1968). In the first case the cells are regarded as argentaffin (or
argentophil), and in the second case as argyrophil. The reducing agent 
present in the argentaffin cells is, in APUD cells, a biogenic amine 
such as 5-HT. This intrinsic reducing agent is not necessary when
staining argyrophil cells, thus argyrophil cells are not necessarily 
argentaffin, but argentaffin cells are usually argyrophil.
Many APUD cells are stained by the argyrophilic Grimelius silver 
stain (Bussolati and Pearse, 1970; Grimelius, 1968; Solcia et al,
1969b; 1970), and it has even been adapted for staining resin sections 
for ultrastructural observation (Grimelius and Strand, 1974; Vassallo 
et al, 1971).
The final cytochemical characteristic of APUD cells, as given by 
Pearse, is the specific immunocytochemical localisation of the peptide 
that they produce. These have been determined for most of the 
postulated APUD cells, and are shown in table 4. The specific 
demonstration of the peptide product is perhaps the most important test
22
TABLE 3
1. Although the cells have diverse origins, they have evolved
similar biochemical mechanisms for the production of similar 
peptide products.
2. Although the cells have diverse origins, they have evolved
similar biochemical mechanisms in response to similar specific 
secretory stimuli (aminergic or cholinergic).
3. They have a common embryologie ancestor, and have retained
a common set of ancestral functions.
(after Pearse, 1969)
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TABLE 4 - THE DIFFUSE NEUKOENDOCRINE SYSTEM 
CENTRAL DIVISION
Cell type Peptide product Amine product(s
1’ i neal Arginine vasotocin, 
lutropin releasing 
hormone
Me 1 a ton in 
5-HT
Hypothalamic 
magnocellular
Arginine vasopressin, ) 
arginine vasotocin ) 
) 
) 
)
5-IIT
Dopamine
Norepinephrine
Hypothalamic 
parvoce11ufar
Releasing factors, ) 
release inhibiting ) 
factors )
Pi tuitary 
pars distal is
Pituitary 
pars intermedia
FSII, LH, TSH 
STII, PRL, ACTH 
MSII, -I.PII 
Endorphin
Gastrin, calcitonin 
ACTH, MSI!
I.PII
Endorphin, calcitonin
b-HT
Dopamine 
Norepinephr inc
II i st amine 
1yramine
PERIPHERAL DIVISION
Cell type Peptide product Amine product(s)
Pancreas B,A
D, D^
Insulin, glucagon 
Somatostatin, VIP.PP
b-lIT
Dopamine
Stom-ich (;, 
AL.
Ect
D
Gastrin, E.XEEPH, ACTH 
G1 ucagon 
Substance P
Somatostat in
5-HT
Hi staminé
Intestine ECj
EC a(M) 
L,S, 
1,D(P) 
D.R,
N.
H
Substance P 
Motilin
Glicentin, Secretin 
C C K , Bombesin 
Somatostatin, GIP 
Neurotensin 
VIP
5-HT
Melatonin
Lung K Bombesin
Parathyroid Chief Parathyrin
Adrenomedullary K,NE Epinepbrein, 
norepinephr ine
Sympathetic Ganglion 
SIF
VIP Norepinephr i n c  
Dopami n e ,
Noref i riepbr i ne
Carot id body Type 1 ENREPll Dupami n e ,
Nor. p inephr i ne
Melanoblast/cyte Promt.' I an in
Thy ro id/
u 1timobranchial C
Urogenital EC 
tract U
Calcitonin, 
somatostat in
5-HT
A b b r e v i a t i o n s ;  I'D = p a n c r e a t i c  p o l y p e p t i d e ;  IX = e n t e r o i  h r o r a a f t i n j  
ECI. = e n t e r o c l i r o w i l  f i n - l i k e ;  ENKI.I'U = Met - o r  L e u - e n k e p h a  1 i n  ;
STF = small intensely fluorescent, Clicentin formerly enteroglucayon; 
5-lir - 5-bvdro:;yiryptamine
(after Rear se and Takor Takor, l‘J/9)
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of all, as only then can the endocrine nature of the product be 
experimentally determined.
Embryology
Since Pearse (1969) considered it unlikely that the similarities, 
in the ultrastructure and cytochemistry of the diverse cell types in 
the APUD series, were coincidental, he advanced three hypotheses which 
might explain their common features (Table 3).
The first two hypotheses would be difficult to test experimentally 
but the third has received considerable attention since it was 
proposed. Debate and experimentation has centred around the question - 
'which is the common embryological precursor cell?'
When Pearse (1968a) first proposed the APUD series he was of the 
opinion that all the cells had an endodermal origin, as all the cells 
then being considered were in the gut, or in glands or tissues derived 
from the primitive digestive tube. By the following year however 
(Pearse, 1969) his view had changed and without reference to the 
earlier view he stated that the only possible APUD ancestor was the 
(ectodermal) neural crest cell. Experiments over the next few years, 
principally by Pearse and the Le Douarin group (Le Douarin and Le 
Lievre, 1971; Le Douarin et al, 1972; Pearse and Polak, 1971; Pearse et 
al, 1973) caused a slight revision to the neural crest hypothesis. 
Pearse and Takor Takor (1976) broadened the concept of a neural crest 
origin of all APUD cells, to include the neural crest, neural ridges, 
neural tube and specialised placodal ectoderm, all of which are 
neuroectodermal.
Although a considerable body of evidence has been produced by 
Pearse to favour this theory (Pearse and Polak, 1971a; 1971b; 1971c;
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Pearse et al, 1973a; Pearse and Takor Takor, 1976; Takor Takor and 
Pearse, 1975), the results of experiments performed by other workers 
have not always been in agreement.
It is almost certain that the adrenal chromaffin cells are neural 
crest derivatives (Hamilton et al, 1972; Le Douarin and Teillet, 1971; 
Polak et al, 1971; Weston, 1970) as is also the case for the 
melanoblasts (Teillet and Le Douarin, 1979). The calcitonin producing 
C cells and the carotid body type 1 cells have also been shown to be 
derived from neural crest, at least in birds, by a series of allograft 
experiments, using chick/quail chimerae, by the Le Douarin group (Le 
Douarin and Le Lievre, 1971; Le Douarin et al, 1972). Cytochemical 
studies by Pearse and Polak (1971a) and Pearse et al, (1973b) have 
confirmed this finding. The evidence for a neuroectodermal origin for 
other APUD cells is less certain, and more contentious. To evaluate 
all the experimental evidence concerning the embyrological derivation 
of all these cell types lies outside the scope of this thesis, but the 
origin of the gut endocrine cells will be considered as being more 
relevant.
The evidence against the enterochromaffin cells of the gut having
a neural crest origin is quite conclusive (Andrew et al, 1983). Andrew
(1963; 1974; 1975) conducted a series of experiments in which she
removed the presumptive gut from 10-somite chicks, ie before the
presumed arrival of neural crest cells. However, when these 
presumptive gut cells were cultured, enterochromaffin cells still 
occurred in the intestine. Le Douarin and Teillec (1973) using 
chick/quail chimerae have also provided evidence suggesting that the 
gut enterochromaffin cells are not of neural crest origin. Pearse and 
Takor Takor (1976) suggested that these results were invalid, as they 
rely on the assumption that the neural crest has been removed before
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its cells have migrated. Their studies suggest that this takes place 
in birds at the 6-somite stage, which is long before the extirpation 
experiments of Andrew (1963; 1974; 1975) and the allograft experiments 
of Le Douarin (Le Douarin and Teillet, 1971; 1973) were carried out.
Laraers et al (1981) have worked on embryos of the cyprinid fish 
Barbus conchonius which had been injected with labelled neural crest 
cells. They subsequently found no neural crest derivatives in the gut 
epi thelium.
'Andrew (Andrew et al, 1980; 1982) has subsequently carried out
further experiments using techniques similar to those of Le Douarin, 
where endoderm and mesoderm from chick and quail were combined, neural 
crest cells being excluded. These explants, after culture, were tested 
by electron microscopy and immunocytochemistry and a broad range of 
endocrine cells were found to have developed. They conclude that 'the
majority, if not all, gut endocrine cell types arise from endoderm, and
not mesoderm or ectoderm'. On the evidence available, this conclusion
seems likely to be the correct one.
The protochordate enterochromaffin cell
In 1970, Winbladh Biuw and Hulting (1971) noted that some of the 
mammalian gut hormones had been found in lower vertebrates and
invertebrates. Because of the links of the protochordates with the
ancestral chordates (Barrington, 1965), they studied the gut of the 
lancelet, Branchiostoma lanceolatum, in the hope of finding cells
homologous with the vertebrate enterochromaffin cells, or the
pancreatic endocrine cells. Finely granulated, apparently secretory, 
cells which had staining reactions similar to the insulin producing 
cells of the vertebrate endocrine pancreas were found.
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Following this initial description, Kataoka and Fujita (1974) 
noted that on the basis of granule morphology there were in fact at 
least two types of endocrine cells in the lancelet, and they drew 
attention to the ultrastructural similarities between these and the 
vertebrate, basal granulated enterochromaffin cells.
These results were quickly confirmed by Van Noorden and Pearse 
(1976). They located the two granulated cells of Kataoka and Fujita, 
and also found two other cell types with a similar endocrine-like 
ultrestructurai appearance. They further demonstrated that these cells 
showed staining reactions similar to cells of the vertebrate 
gastro-entero-pancreatic endocrine system. Using antisera raised 
against vertebrate gut hormones they showed cells which appeared to be 
producing glucacon-, gastrin- and insulin-like peptides.
At the same time, similar reports were also being made concerning 
E-L cells in another group of protochordates, the Ascidiacea; Lison
(1933) had described enterochromaffin cells in the stomach of Ciona
intestinalis, and Gerzeli (1963; 1964) had found similar cells in a
wide range of ascidians. Ultrastructural confirmation was now provided 
by Burighel and Milanesi (1975). These later authors noted cells in 
the gastric epithelium of the ascidian Botryllus schlosseri which were 
ultrastructurally similar to endocrine cells of the vertebrate gut. 
Fritsch (1976) noted argyrophil and argentaffin cells in the gut of 
Ciona, and the following year, Fritsch and Sprang (1977) studied their 
ultrastructure and considered it to be typical of mammalian gut 
endocrine cells.
Thorndyke (1977) also reported cells within the mucous cap region
of the gastric ridges of Styela clava which were ultras trueturally
endocrine-like. The present study was initiated as a direct consequence
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of this observation.
SECTION I - HISTOCHEMISTRY
MATERIALS AND METHODS
Adult specimens of Styela clava were collected in the Portsmouth 
area from pontoons sited about one kilometre offshore. These were then 
transported to London by van in aerated sea water. Animals used for 
histological work were processed immediately. Although some animals 
were maintained in a circulating sea water aquarium at 10“ to 14“C, 
these were not used for histological examination.
The animals were rapidly dissected and portions of oesophagus, 
stomach and intestine were treated in one of a number of ways.
Some tissues were fixed for 24 hrs in Bouin’s fluid that had been 
prepared using picric acid saturated sea water. Other tissues were 
fixed overnight with 6% glutaraldehyde (glutaric dialdehyde) in 
phosphate buffer at pH 7.0 (appendix 1). This material was dehydrated 
in graded ethanols, cleared in xylene and embedded in 56“C mp paraffin 
wax.
For the demonstration of biogenic monoamines after the method of 
Falck et al (1962), small pieces of tissue were quenched in melting 
Arcton (mp -148“C) which had been pre-cooled in liquid nitrogen. These 
were then freeze dried using an Edwards EPTD2 tissue drier. Following 
subsequent fixation over paraformaldehyde (ie in formaldehyde vapour) 
for 3 hrs at 60“C the tissue was embedded in 56“C mp paraffin wax in a 
vacuum oven.
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Sections were cut at 6 to 8 ^ on a Jung rotary microtome. These 
were subsequently stained by one of the following methods; argyrophilia 
(Grimelius, 1968), argentaffinity (Solcia et al, 1969b), masked 
metachromasia (Solcia et al, 1968), lead haematoxylin (Solcia et al, 
1969a) or aldehyde fuchsin (Bussolati and Bassa, 1974). Full details 
of these staining methods are given in appendix 1.
RESULTS
Oesophagus
The staining reactions of the oesophageal endocrine-like cells in 
Styela are somewhat capricious. The reason for this is not clear, but 
as the stains are only weakly taken up when staining does occur it is 
probably caused by a weak affinity between the cells and the stains 
employed.
Aldehyde fuchsin was the most successful and reproducible stain. 
Here, small granulated cells were observed lying on the basement 
membrane (Fig 1:1b). The dense population of oesophageal mucous cells 
was also stained, but as only the apical region, adjacent to the gut 
lumen, was stained, they did not interfere with the observation of 
cells on the basal lamina. Grimelius' method for argyrophilia also 
gave positive results showing cells containing distinct granules (Fig 
1:1c). When staining was successful, considerably fewer cells were 
stained than by aldehyde fuchsin, but they would be seen to occupy a 
similar position in the epithelium, on the basal lamina.
No staining was observed using techniques for argentaffinity, 
masked metachroraasia or lead haematoxylin.
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Fig 1.1 Light photomicrographs showing oesophageal epithelium of
Styela clava. a) Insulin-immunoreactive cell (arrow) follow­
ing immunofluorescence staining with antiserum to insulin 
,, (1:10), X 1750. b) Aldehyde fuchsin stained cell (arrow)
resting on the basement membrane, x 650. c) Argyrophilic 
cell (arrow) showing distinct granules clustered around 
the unstained nucleus, x 1500, BM= basement membrane;
L = lumen; M = apex of mucous cell.
Fig 1:1 31
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Fig 1:2 a-c: Light photomicrographs of the cap region from the
gastric epithelium of Styela clava. a) Immunofluorescence 
of cells after treatment with dilute anti-secretin serum,
A (1:5000), X 200 . b) Formaldehyde induced fluorescence,
X 500 . c) Lead haematoxylin, x 5Q0 • L = lumen;
BM = basement membrane.
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Stomach
The gastric epithelium of Styela clava consists of 20 to 30 
longitudinal folds, together with a single, flat strip or raphe of 
cells. At the apex of each ridge is a distinct 'cap' of ciliated 
mucous cells. Within these caps are a number of elongated cells, 
extending from the basement membrane to the luminal edge, which stain 
weakly with lead haematoxylin (Fig 1:2a), and exhibit formaldehyde 
induced fluorescence (FIF) (Fig 1:2b). However these cells did not 
stain with methods for argyrophilia, argentaffinity, masked 
metachromasia or aldehyde fuchsin.
Intestine
No cells were stained in the intestinal epithelium using methods 
for argyrophilia, argentaffinity, masked metachromasia, lead 
haematoxylin or aldehyde fuchsin. The intestinal epithelium was not 
examined using methods to demonstrate FIF.
SECTION 2 - ELECTRON MICROSCOPY 
MATERIALS AND METHODS
Before observing cell structures, it is necessary to preserve them 
with the introduction of minimal artefacts. Conventional fixation 
normally involves the immobilisation of the structural proteins by 
cross-linking them, normally with an aldehyde such as formaldehyde or 
glutaraldehyde. Glutaraldehyde is particularly good and is normally 
considered to be the fixative of choice for electron microscopy. Its 
main disadvantage is that its action is slow and its penetrative power 
is low. It is only possible to fix very small pieces of tissue (1 mm* )
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and fixation takes at least 2 hr (at 4“C). This primary fixation is 
normally followed by a period of post-fixation with 1% osmium 
tetroxide, which cross-links between tissue proteins and unsaturated 
lipids and also helps reduce lipid loss during dehydration (Nielson and 
Griffith, 1979).
The choice of fixative is however only one variable. To obtain 
optimal fixation and to enable comparisons to be made of 
ultrastructural appearance between tissues fixed on different 
occasions, it is essential to rigorously maintain all the other 
variables (choice of buffer, pH, duration, temperature and 
osmolarity).
One of the most important of these is osmolarity. For 
glutaraldehyde fixation the vehicle must be close to, or slightly 
below, the osmolarity of the extracellular fluid (Bone and Ryan, 
197 2). In the case of an osmoconf ormer such as Styela this is 
isosmotic with seawater (c. 1030 mOsm/kg). This was achieved by adding 
filtered artificial seawater to the basic 3% cacodylate buffered 
glutaraldehyde.
Small pieces of gut (approx 1 mm^  ) from animals freshly collected 
from Portsmouth, were rapidly excised into cold (4“C) 3% glutaraldehyde 
(glutaric dialdehyde), in O.IM sodium cacodylate buffer (pH 7.2) in sea 
water. Further details of this 'marine fixative' are given in appendix 
1.
Tissues were fixed for 2 hrs in sodium cacodylate buffer and 
post-fixed for 1 hr in cold (4°C) 1% osmium tetroxide prepared in
cacodylate buffer (pH 7.2). Following fixation, the tissue was washed 
in buffer overnight and transferred by graded ethanols and propylene 
oxide (1,2-epoxypropane) to TAAB laboratories epoxy resin. These
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preparations were then polymerised for 48 hrs at 60“C (for full 
schedule, see appendix 1).
Thin sections were cut, using glass knives, on a Cambridge Huxley 
II ultramicrotome. Tissue orientation was facilitated by taking thick 
(0.5y) sections which were mounted onto glass slides by gentle heating, 
and stained with 1% toluidine blue in borax (appendix 1). Thin 
sections showing silver or pale gold interference colours were then 
picked up on uncoated copper or nickel grids. These were then stained 
in a freshly filtered saturated solution of uranyl acetate in 30% 
ethanol for 20 mins and then after rinsing with distilled water, were 
counterstained for 5 to 10 mins in alkaline lead citrate (appendix 1). 
After washing in 0.02 M sodium hydroxide and distilled water, the grids 
were allowed to dry and were then examined on a Corinth 275 or Zeiss 
109 electron microscope.
RESULTS
Granulated cells, ultrastructurally similar in appearance to 
vertebrate gastrointestinal endocrine cells, were found at all levels 
of the post-pharangeal digestive epithelium of Styela, although the 
overwhelming majority were found in the gastric epithelium.
Oesophagus
The oesophageal E-L cells were distributed evenly, but sparsely 
amongst the mucous cells which form the oesophageal mucosa (Fig 1:4- 
1:6). They occurred on the basal lamina and although they occasionally 
appeared slightly elongated (Fig 1:4), they were not observed to extend 
to the gut lumen and were therefore presumed to be of the closed
type (Fig 1:3).
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'ig 1 ;3 Endocrine cells of open (left) and closed (right) type, 
observed in the gastric and oesophageal epithelium 
respectively. Open cells reach the lumen via an apical 
process equipped with microvilli, whereas closed cells 
do not reach the lumen. Secretory products are presumed 
to be released bv exocvLosis.
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Fig 1:4 A medium power electron photomicrograph showing a typical 
granulated oesophageal E-L cell (arrow), extending a short 
distance from the basement membrane and flanked by oesopha­
geal mucous cells, 
bm = basement membrane (x 8000)
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Fig 1:4 A medium power electron photomicrograph showing a typical 
granulated oesophageal E-L cell (arrow), extending a short 
distance from the basement membrane and flanked by oesopha­
geal mucous cells, 
bm = basement membrane (x 8000)
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Fig 1:5 a) A low power and b) a medium power electron photomicro­
graph, showing the same oesophageal E-L cell (arrow), 
including a section of the nucleus. This cell, typically, 
is not observed to extend to the oesophageal lumen. The 
majority of the regularly shaped, electron-dense granules 
can be observed to have a very narrow, or non-existent halo, 
to vary little in size, and to be concentrated in the sub- 
nuclear region. Mitochondria are present throughout the 
cytoplasm. There is evidence of the exocytotic release of 
these granules at the basal lamina (fig b, arrows).
L = lumen; m = mitochondria; n = nucleus (a, x 5000; 
b, X 13250)
Fig 1.5 40
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Fig 1:6 a) A low power and b) a medium power electron photomicro 
' graph showing an oesophageal E-L cell (arrow) extending a
short distance from the basement membrane. The other 
(mucous) cells can clearly be seen. They are tall and 
narrow with an apical mass of mucus. The large nuclei 
fill most of the width of the cells and are sited in the 
basal region. The nucleus of the E-L cell is, as is common, 
not included in this section.
bm = basement membrane; mu = mucus ; n = nucleus 
(a, X 6000; b, x 13000)
Fig 1.6 42
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Fig 1:7 A high power electron micrograph of part of an oesophageal 
E-L cell. The smooth, regular, electron-dense granules can 
be seen to be scattered evenly throughout the cytoplasm. 
Some granules (arrow) can be seen to have a very slight 
electron-lucent halo. Two prominent mitochondria can be 
seen in the centre of the figure. Also prominent are large 
amounts of smooth endoplasmic reticulum as vesicles, 
m = mitochondria; s = SER (x 30,000)
Fig 1.7 44
nt
%
p
45
The granules were regular in shape with a narrow or non-existent 
halo. They varied only a little in size (100 to 175 nra, av 130 nm 
diameter) and gave every appearance of being an homogenous population.
In sections where the nucleus was included (Fig 1:5) very few 
supra-nuclear granules were observed, the majority being grouped 
between the nucleus and the basement membrane.
Rough endoplasmic reticulum was not observed, but smooth vesicular 
endoplasmic reticulum was often prominent (Fig 1:7). Golgi membranes 
were only occasionally seen but mitochondria were present in all 
sections.
Stomach
The gastric E-L cells also extended from a position
on the basal lamina but unlike the oesophageal population, they were 
frequently observed to extend to the luminal edge (Fig 1:8). They were 
observed to lie only in the mucous 'cap' region of the gastric ridges. 
No E-L cell of any description was observed in the side walls. The 
overall shape of these E-L 'cap' cells was columnar, but slightly 
tapered so that the apex was narrower than the base.
The juxtaluminal part of a gastric E-L cell was readily 
distinguishable from the apices of the flanking mucous cells, which 
contained numerous mitochondria and obviously secretory granules. In 
the E-L cells there were few or no apical granules nor mitochondria, 
and therefore no indication of luminal secretion. The cells reach the 
lumen in a frequently constricted region which was tipped with a tuft 
of microvilli (Fig 1:9).
The rounded nucleus lay in the lower mid-zone of the cell. The 
secretory granules were clustered below and around the nucleus and
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Fig 1:8 a) A low power and b) a high power electron photomicrograph 
of the mucous 'cap' region of one of the gastric ridges.
a) This plate shows the major constituent cells of the 
mucous cap. These mucous cells are tall, with large 
basally sited nuclei. The lumenal membrane bears a number 
of cilia and microvilli. E-L cells (arrows) of similar 
proportions, appear scattered throughout the 'caps^ .
b) An enlargement of of the basal part of the central 
E-L cell from (a), showing the typical irregular appear­
ance of the electron-dense granules, and their 
surrounding electron lucent halos.
bm = basement membrane; g = granule; m = mitochondria; 
n = nucleus. (a, x 2700; b, x 30,000)
Fig 1.8
47
m
m m4#
f  *.
48
Fig 1:9 Medium power electron photomicrographs showing the apical 
regions of two E-L cells from the gastric mucous 'cap' 
region. In the E-L cells there are no mucous droplets, 
such as are packed into the apical regions of the surroun­
ding mucous cells. The apices of the mucous cells contain 
large numbers of mitochondria, which are absent from the 
E-L cells. The apices of these E-L cells frequently 
protrude slightly into the gut lumen, and are tipped with 
a tuft of cilia and microvilli. A prominent ciliary 
rootlet can be seen in plate a. Almost no endocrine 
granules can be seen in this region of the cell, 
c = cilia; EL = E-L cell; g = endocrine granule;
L = gastric lumen; md = mucous droplet; r = ciliary 
rootlet; v = microvilli. (a, x 14,250; b, x 17,500)
Fig 1.9 49
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Fig 1:10 High power electron photomicrographs, showing the basal 
regions of two E-L cells from the gastric mucous 'cap' 
region, showing the range of size and shape in the 
endocrine-like granules found in these cells, a) These 
granules demonstrate an uncharacteristically narrow halo, 
and regular appearance. The number of granules observed 
lying on the basement membrane and the number of inden­
tations in that membrane (arrow), are suggestive of 
basal granule release, b) The granules contained in 
the two cells observed in this plate are of a more normal 
appearance. They frequently have an irregular profile 
with a distinct electron-lucent halo which separates the 
electron dense core from the limiting membrane. 
Mitochondria are frequently numerous in the basal region, 
bm = basement membrane; g = granules; m = mitochondria; 
n = nucleus. (a, x 50,000; b, x 30,000)
Fig 1:10 51
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Fig 1:11 High power electron photomicrograph showing part of the
supranuclear region from an E-L 'cap’ cell. Granules often 
appear fused (arrows) as well as simply e longated.
(x 50,000)
Fig 1:11 53
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thinned out considerably towards the apex. Granules were often 
intimately associated with the basal membrane and occasionally 
characteristic omega profiles were observed (Fig 1:10), indicating 
basal release into the rete of blood capillary spaces which ramify 
below the epithelium.
The individual granules (Fig 1:8, 1:10) varied somewhat in
appearance but had a frequently irregular profile with a normally 
distinct electron lucent halo separating the electron dense core from 
the limiting membrane. Granules occasionally appeared elongated or 
even fused (Fig 1:11) and were small, varying in size between 50 to 155 
nra in diameter (90 nm average). Mitochondria were never particularly 
numerous and the Golgi apparatus was rarely well developed. The 
cytoplasm was filled with largely vesicular smooth endoplasmic 
reticulum, interspersed with free ribosomes.
Intestine
Preliminary surveys of the intestinal epithelium confirmed the 
histochemical observations of Section 1. Over much of the intestinal 
epithelium, E-L cells were absent.
SECTION 3 - IMMUNOCYTOCHEMISTRY 
MATERIALS AND METHODS
Small pieces of gut from animals collected from Portsmouth were 
rapidly excised into cold sea water (4 C) and fixed in sea water 
Bouin's fluid (appendix 1) for 3 hrs at the same temperature. The 
tissue was then dehydrated in a graded series of ethanols, cleared in 
xylene and embedded, using a vacuum oven, in 56 C nip paraffin wax.
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Sections were cut at 6 to 8 ^ on a Jung rotary microtome and spread and 
mounted on albumenised glass slides at 37°C. Sections were then fully 
dried in a 37“C oven for 24 to 48 hrs before use.
Slides were subsequently stained either by the indirect 
fluorescent antibody technique (Coons et al, 1955) or the unlabelled 
antibody peroxidase-anti-peroxidase (PAP) method of Sternberger et al 
(1970).
Immunofluorescence
The paraffin sections were dewaxed in xylene which was then 
removed with petroleum ether. The slides were allowed to dry and were 
then spread out in a humid chamber. A 10 ^1 drop of the appropriate 
antiserum or control solution (Table 5) was then dispensed onto each 
section. This procedure made for economic use of antisera, as if wet 
slides were used, the solutions did not stay on the sections but spread 
out over the slides.
The slides were incubated for 18 hrs at room temperature after 
which the slides were washed in phosphate buffered saline (PBS) 
(appendix 1). The slides were then replaced in the humid containers 
and treated for 1 hr with FITC conjugated swine or goat anti-rabbit 
serum (Nordic), diluted 1:30 with PBS. Following a further wash in PBS 
the sections were mounted in buffered glycerine (9 parts glycerine to 1 
part PBS) and examined with a Zeiss Universal Epi-fluorescence 
photomicroscope equipped with filters selected to give peak excitation 
at 490 nm (excitor, KP490, LP440; reflector, FT510; Barrier,
BP520-560).
Immunoperoxidase
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Although the PAP technique was more time consuming than 
conventional fluorescence methods, it was considerably more sensitive. 
This had the effect of enabling more dilute antisera to be used, thus 
reducing any non-specific interactions between plasma and tissue. It 
also helped to conserve precious antisera. A second advantage of PAP 
staining was that, unlike fluorochrome labelling, it was permanent and 
did not fade during observation. Also it could be viewed with white 
light and sections counterstained, facilitating the observation of 
surrounding structures.
The paraffin sections were dewaxed in xylene and then transferred 
to absolute alcohol. The slides were immersed in fresh 0.03% hydrogen 
peroxide in methanol for 30 mins to block endogenous peroxidase 
activity. Following a rinse in 0.9% sodium chloride and then 15 mins 
in tris-HCl buffer (pH 7.2) the slides were immersed for 30 mins in the 
same buffer containing 0.5% crystalline bovine serum albumin and then 
replaced in the original tris-HCl buffer for 15 mins. The sections 
were then placed into an humidity chamber and treated with optimally 
diluted antisera or controls and left for 24 hrs at 4°C.
The slides were next washed in three washes of tris-HCl buffer (pH 
7.2) and replaced in the humidity chamber. The sections were then 
treated at room temperature with unlabelled swine anti-rabbit IgC, 
diluted 1:20 with tris-HCl buffer. Following a wash with the buffer, 
the slides were replaced in the humidity chamber and the sections 
covered with rabbit peroxidase—anti—peroxidase complex (PAP) 1:50, at 
room temperature for 30 mins. The slides were washed through tris-HCl 
(pH 7.2) and then tris-HCl (pH 7.6).
The end product was then revealed with a freshly made solution of 
5 mg 3,3' diaminobenzidine tetrahydrochloride dissolved in 10 ml 0.2 M
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tris/HCL buffer (pH 7.6) to which 0.1 ml fresh 1% hydrogen peroxide had 
been added immediately prior to use. The depth of staining was 
controlled visually ( 10 to 20 mins). The slides could at this stage 
be counterstained with weak haematoxylin, cleared in xylene and mounted 
in DPX for permanent storage.
Antisera to a wide range of peptides were obtained from a number 
of sources, most being generously donated by Prof G Dockray (Liverpool) 
and Miss S Van Noorden and Prof J M Polak (RPGMS). These are listed in 
table 5. In addition to these gifts, an antiserum to secretin was 
prepared by the following method.
Preparation of antiserum
Antiseruinwas prepared after the method of Goodfriend et al, 1964. 
One mg porcine secretin (Sigma), 10 mg bovine serum albumin and 10 mg 
l-ethyl-3-(3-diraethylaminopropyl) carbodiimide hydrochloride were 
separately dissolved in three 200 jul aliquots of 0.1 M phosphate 
buffer, pH 7.3. These were then pooled and gently agitated at room 
temperature for 2 hrs. The reaction was then terminated by dialysis 
against 400 ml of phosphate buffered saline (PBS) pH 7.4. The 
resultant conjugate was then added to 1 ml Freund's complete adjuvant 
(Difco) and thoroughly emulsified by repeated aspiration and explosion 
from a syringe fitted with a 21 g needle. The homogenate was then 
injected subcutaneously into an adult female New Zealand white rabbit, 
evenly divided between six sites about the neck and slioi'Iders.
This procedure was repeated after six weeks and thereafter every 
three months. About 10 ml of blood was taken 10 days after each 
three—monthly booster, and stored overnight at 4 C. 'the clot which 
formed was gently removed and the plasma was stored in small ampouled 
aliquots at -20"C. For convenience this anti serum will be referred to
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as secretin A .
Serum specificity
Two approaches were employed to assess the specificity of secretin
A:
1) After determining the working dilution (by staining a series of 
sections with varying dilutions of antiserum), the diluted antiserum 
was incubated overnight with a range of concentrations of the parent 
antigen. This procedure demonstrated that incubation of the diluted 
antiserum (1:5000) with TOam^e/ml secretin abolished staining,
2) The antiserum was incubated with either glucagon, VIP or CCK (50 
/»mc'-2-s/ml) under the same conditions described above' there was no effect
on staining intensity.
Controls
Where positive immunostaining occurred, control staining was 
carried out using serum which had been exposed to the appropriate 
antigen ( 25nmoW^ml, at working dilution). This was carried out using 
antiserum diluted by the appropriate amount, alongside identical
anstiserum which was to be used at the same time. This ensured that 
any factor other than an interaction between the antibody and antigen 
would affect both samples. They were left overnight in sealed ampoules
at 4°C, and then used the following day. Control staining was also
carried out using PBS or non—immune serum in place of the active serum. 
Positive controls were carried out by staining similarly processed
mouse tissues.
TABLE 5
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Antiserum Antigen Working
dilution
Specificity Source
L48
L112
L83
L85
L89
53
278
38
460
CCK-8, 
conjugated 
to BSA
1/1000
G-4, 1/1000
conjugated
to thyroglobulin
Substance P 1/1000
(VIP) porcine 1/1000
Bombesin
Secretin
(natural)
Gastrin
(synthetic
human)
Glucagon 
(natural) 
Somatostatin 
(synthetic)
CCK9-20
Insulin
(bovine)
Secretin, 
conjugated 
to BSA
1/1000
1/2000
1/1000
1/1000
1/1000
1/1000
1/100
1/5000
G-17 and 
CCK-8 equally
Gastrin/CCK
COOH-terminal
tetrapeptide
COOH-terminus
Some VIP 
X-React ivity 
COOH Terminal
Some PP 
X-Reactivity
Mo VIP, CCK or 
glucagon 
X-react ivi ty
Prof G Dockray
Prof G Dockray
Prof G Dockray 
Prof G Dockray 
Prof G Dockray 
RPGMS 
RPGMS
RPGMS
RPGMS
RPGMS
Wellcome
Bedford
Rl’GMS = Royal Postgraduate Medical School
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RESULTS
Oesophagus
Positive immunofluorescent staining was observed, using 
anti—insulin serum diluted 1:10 and 1:100. This immunofluorescence was 
not observed after pre-exposing diluted antiserum to 100/i'«'oL/ml bovine 
insulin. Cells were observed throughout the oesophageal epithelium, in 
a basal position but extending by a slender process towards the gut 
lumen (Fig 1:1a). These were not observed with controls. These cells 
were not visualised using antisera to secretin (53), secretin (A), 
gastrin (278), glucagon (38), or somatostatin (460), even at dilutions 
considerably less than their normal working dilutions. All mouse 
control tissues were stained with the appropriate antisera.
Stomach
Sections of gastric epithelium were tested with both the 
immunofluorescence and PAP techniques, using all the antisera listed in 
table 5.
Positive results by both methods were observed with secretin (53) 
and secretin (A) (Figs 1:2a; 1:12; 1:13: 1:14). No immunoreactive
cells could be visualised using any of the other antisera, although 
their activity could be demonstrated in mouse tissues.
The secretin immunoreactive cells occurred within the mucous 
'caps' of the gastric epithelial ridges, in varying numbers. Very 
rarely a section of a cap was found that did not contain any 
immunoreactive cells, but normally caps contained between one and five, 
and occasionally even more. This immunoreactivity could be abolished by 
the pre-exposure of the diluted antiserum to 10/imJes/ml secretin and both
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Fig 1:12 Light photomicrograph of secretin-immunofluorescent cells 
(arrow) in the gastric ’cap’ region. Anti-secretin serum 
53, diluted 1:5000, x 750 • L = lumen; BM = basement 
membrane.
61
\  /
Fig 1:13 Light photomicrograph of the secretin-immunofluorescent
cells (arrow) in the gastric ’cap’ region. Anti-secretin 
serum A, diluted 1:5000, x500 • L = lumen; BM =
basement membrane.
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Fig 1:14 Light photomicrograph of secretin-immunoreactive cells
(arrow) in the gastric 'cap' region. Anti-secretin serum 
53, diluted 1:9000, PAP method, x 3 50. L = lumen;
BM = basement membrane.
Fig 1.15
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Fig 1:15 a) Immunofluorescence of Styela gastric 'cap’ after 
incubation with anti-secretin serum 53, (1:5000) 
preabsorbed overnight with 10 nM/ml secretin x 250.
b) Immunofluorescence of Styela gastric cap after 
incubation with anti-secretin serum A, (1:5000) 
preabsorbed overnight with 10 nM/ml secretin x 250.
In both a) and b) staining of E-L cells has been 
abolished, c) Immunofluorescent localisation of 
secretin in immunoreactive cell (arrow) in mouse 
duodenum, incubated with anti-secretin serum A, >; 250. 
d) PAP localisation of a secretin immunoreactive cell 
(arrow) in mouse duodenum using anti-secretin serum 53,
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secretin anCisera could be used to demonstrate immunoreactive cells in 
mouse duodenum (Fig 1:15),
The secretin-positive immunoreactive cells visualised by both 
methods showed an identical appearance and distribution. They lay on 
the basal lamina of the 'cap' epithelium and extended towards the gut 
lumen by a typically slender tapering process. The immunoreactivity 
appeared throughout the cells, but the most intense staining occurred 
basally, particularly about the prominent nucleus.
DISCUSSION
It is apparent from the results that the basal granulated cells 
in the gut of Styela bear some resemblance to the hormone producing 
cells of the vertebrate gastro-entero-pancreatlc endocrine system (for 
reviews cf Falkmer and Ostberg, 1977; Fujita and Kobayashi, 1977; 
Pearse, 1974; Solcia et al, 1978b). The general ultrastructural 
appearance of these cells in Styela is similar to that of APUD cells 
(Pearse, 1968a, 1969). Like APUD cells they contain little rough
endoplasmic reticulum, but they do contain smooth endoplasmic reticulum 
in the form of vesicles. Free ribosomes and electron dense 
mitochrondria are prominent, but most distinctive and typical are the 
membrane bound secretion vesicles.
The appearance of these secretion vesicles has been used as the 
basis of a classification of endocrine cell types at the Symposium on 
Gastrointestinal Hormones, held in Weisbaden in October 1969 
(Creutzfeldt et al, 1970). Despite being updated (Solcia et al, 1973) 
and completely revised (Solcia et al, 1978) these class!ficatory 
systems are of little direct use in determining the nature of the E-L 
cells of Styela, as they were specifically developed for use with
65
mammalian and in particular, human, gastro-entero-pancreatic endocrine 
cells.
There are, however, clear differences between the granule 
morphology of the gastric and oesophageal E-L cells of Styela. Wliereas 
the gastric granules are small (50 to 155 nm, 90 nm av), irregular in 
shape and electron density and have a distinct 'halo', the oesophageal 
granules are larger (100-175 nm, 130 nm av), more regular in shape and 
electron density, and have a narrow or non-existent 'halo'. No other 
attempt has been made to distinguish between E-L cell types in 
ascidians from ultrastructural evidence.
E-L cell types have been described from the gut of a number of 
ascidian species. One endocrine cell type has been observed in the 
gastric epithelium of Botryllus schlosseri (Burighel and Milanesi, 
1975), Halocynthia papillosa (Pestarino et al, 1982), Styela plicata 
(Pestarino, 1982a; 1982b) and Ciona intestinalis (Fritsch and Sprang, 
1977), although in this last example, there is considerable 
histological and immunofluorescence evidence that more than one type of 
E-L cell is present (Fritsch, 1976; Fritsch et al, 1978).
Welsch and Dilly (1980) have been unable to demonstrate any E-L 
cells in the heraichordate gut epithelium, but work on cyclostomes, the 
most primitive vertebrates, has demonstrated a single gut endocrine 
cell type (Ostberg et al, 1976; Van Noorden and Pearse, 1974).
Observations on the digestive epithelium of Branchiostoma (Kataoka 
and Fujita 1974 ; Van Noorden and Pearse, 1976 ; Welsch, 1975 ) have 
distinguished at least two cell types and possibly three or four, on 
the basis of their granule morphology. Thus in Branchi os toma, type 1 
cells have dense, rather irregular granules with an obvious 'halo' and 
an average size of 140 nm. Type III cells are similar but smaller
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(average diameter 60 nm) and with the granules eccentrically placed 
within their surrounding membranes. The granules of the gastric and 
intestinal E—L cells of Styela have a similar appearance to the type 1 
and type 111 cells of Branchios toma, and a size range that lies 
somewhere between the two (50 to 155 nm, 90 nm average). These cells 
will be referred to as Styela type 1 cells.
The Branchios toma type 11 cells show close similarities to the
Styela oesophageal cells, which will therefore also be referred to as 
type 11 cells. Like them, the Branchiostoma type 11 cells have a more 
rounded appearance, a narrow or non-existent halo, and an average 
diameter of 170 nm. They also, like Styela type 11 cells, stain with 
aldehyde fuchsin and immunoreact with anti-insulin serum (Van Noorden 
and Pearse, 1976).
The E-L cells described by Fritsch and Sprang (1977) in Ciona are 
similar to Styela type 1, although the granules are somewhat larger.
However when attempting to compare granule size and appearance it must
be born in mind that these factors can be markedly affected by the
method of fixation employed (Mortensen and Morris, 1977). It is 
therefore probably safe to say that in Styela where the same fixation 
routine has been followed throughout, there are two distinct 
populations of granulated cells. The comparison of these with 
superficially similar cells in Branchiostoma and Ciona is perhaps 
unwise. A clearer insight into the nature of the product of these 
cells is provided by the histochemical and immunocytochemical staining 
reactions which have been demonstrated.
The gastric type 1 cells of Styela exhibit a formaldehyde induced 
fluorescence (FIF), indicating that they contain a biogenic monoamine 
(Fig 1:2b). Similar cells have been recorded in the gactric epitlieli urn
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of Ciona (Erspamer,1946), and in the gut epithelium of a large number 
of other ascidians (Gerzeli, 1964). The mechanism by which certain 
biogenic monoamines are converted to fluorescent derivatives is well
established (Falck et al, 1962; Fuxe and Jonsson, 1973). Initially 
they react to form a weakly fluorescent intermediate, which is 
subsequently dehydrogenated and incidentally made insoluble to form an 
intensely fluorescent dihydro derivative. This method displays a 
considerable sensitivity and as little as 0.5 ng of noradrenaline can 
be detected within a single nerve terminal (Fuxe and Jonsson, 1973).
No attempt was made to quantitate the amine content, but the level of 
fluorescence obtained, compared to mouse adrenal gland, was low.
The argentaffin staining reaction is dependent on the reduction of 
silver salts by a tissue component such as a biogenic monoamine.
Therefore it is possible that the levels of amines located in the 
gastric type 1 cells are insufficient to cause this reduction. 
However, as it was not possible to stain these cells by argyrophil
methods, where an exogenous reducing agent is added it must be 
concluded that these cells are not capable of accumulating silver. 
This is slightly surprising as argyrophil and argentaffin cells have 
been noted in the gastric epithelium of Ciona (Fritsch, 1976). Perhaps 
of more significance is the observation by Pestarino (1979; 1982b) that 
there are columnar cells within the mucous caps of Styela plicata that 
stain with phosphotungstic acid-haematein (Cavellero et al, 1968;. But 
he finds that these cells do not stain with the Crimelius argyrophil 
method, and are non-argentaffin. Like the E-L cap cells of S. clava, 
those of S. plicata are not stained by aldehyde fuchsin or masked 
metachromasia. Three other supposedly endocrine cell types that 
Pestarino (1979; 1982c) located in the side walls of the gastric mucosa 
have no counterparts in cfaya and until the gastric epithelium of
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plicata has been fully observed at an ultrastructural level it will be 
difficult to interpret this finding*
Another unexpected observation is that in Styela  ^type I cells 
stain with lead haematoxylin, though not masked metachromasia. These 
stains are both believed to act on the side—chain carboxyl or 
carboxyamido groups of granule proteins (Solcia et al, 1968; Solcia et 
al, 1969a). However both of these methods are empirical and neither 
are fully understood. It is not therefore possible to determine 
whether this result has any significance. Pestarino (1982b) finds that 
neither of these stains are taken up by secretin-like immunof luorescent E-L 
cap cells in Styela plicata. This finding is in partial agreement with 
the situation in Styela clava where the lead haematoxylin staining is 
only weak and the sections need to be exposed for longer than control 
tissues.
The oesophageal type 11 cells are also unstainable wltl\ masked 
metachromasia but they do stain with aldehyde fuchsin. A number of 
vertebrate structures are stained by aldehyde fuchsin, including 
elastic tissue, ^-cells of the pancreas, pituitary ^-granules, mast 
cell granules, mucins and gastric chief cells. Ortman et al (1966) 
have shown in the frog pituitary, that the staining is caused by a 
combination of the dye with carboxyl groups. In the staining of 
pancreatic ^-cell granules, Bussolati and Bassa (1974) have suggested 
that the dye forms an association with sulphate groups caused by 
oxidation of disulphide bonds in the insulin molecule. However, 
although aldehyde fuchsin is not a specific staining method, taken in 
conjunction with the observation that these cells also display an 
insulin—like immunofluorescence, it would seem more likely that it is 
this second mechanism which is causing these type il cells to stain.
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It is not completely certain that the immunofIncrescent cells and 
the aldehyde fuchsin cells are identical, as although their appearance 
and position on the basement membrane are the same, the 
insulin—immunofIncrescent cells are observed less frequently, 
Argyrophilic cells were observed only rarely and it is possible that 
the argyrophilic cells represent a second oesophageal cell type which 
was overlooked at the ultrastructural level. The reason that the 
iraraunofIncrescent cells were observed less frequently than aldehyde 
fuchsin stained cells is possibly linked with the poor cross-reactivity 
of the cells with the antiserum. The cells which were observed may 
represent cells containing a full complement of granules, while other 
cells in a different phase of the secretory cycle, and hence partially 
degranulated, would show insufficient fluorescence to permit their 
observation. Immunofluorescence is a highly specific technique and it 
might be expected that protochordate peptides would be immunologically 
dissimilar to their mammalian counterparts. It is possible that an
anti-avian insulin, if available, would display a higher affinity for
'ascidian insulin', as such a factor extracted from the gut of Ciona
intestinalis, has been found to be antigenically closer to chicken 
insulin than mammalian insulins (Falkmer and Wilson, 1967).
These type 11 cells show many parallels with the type 11 cells in 
Branchios toma (Van Noorden and Pearse, 1976), which can also be
demonstrated by immunofluorescence using anti-human insulin. They also 
noted that positive immunofluorescence could only be obtained using 
certain antisera and only then by using higher concentrations than 
those used in vertebrate control tissues and by staining for an 
extended period of time. They also noted considerable variations 
between the individual animals and the degree of staining achieved for 
no discernable reason. Tndeerl with some batches of animals, no insulin
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immunoreactive cells could, be demonstrated (Van Noorden, personal 
communication). These insulin imraunoreactive cells, when they could be 
visualised, restained with aldehyde-fuchsin, but they noted that other 
cells, which had not shown any immunofluorescence, were also stained. 
The ultrastructural appearance of the granules is also similar, as has 
already been noted.
Similar aldehyde fuchsin positive cells have been observed in the 
upper digestive tract of Ciona intestinalis by Falkmer (1969). These 
cells have not been tested with anti-insulin sera, but insulin activity 
has been achieved using an 'immunological bioassay' in the gut of Ciona 
(Davidson et al, 1971; Falkmer, 1969; Falkmer and Wilson, 1967).
The gastric type 1 cells readily immunoreact with anti-secretin 
sera but not with any of the other antisera listed in table 5. No E-L 
cells were observed by any of the methods employed anywhere in the
gastric epithelium other than in the mucous 'caps'.
Since this work was carried out, the presence of secretin-like 
immunoreactivity has been confirmed by Pestarino and his co-workers in 
two ascidian species, Halocynthia papillosa and Styela plicata 
(Pestarino et al, 1982; Pestarino, 1982a; 1982b).
Styela plicata, like Styela clava, has a folded gastric epithelium 
topped by mucous caps which contain E—L cells which immunoreact with 
anti-porcine secretin, even after pre-incubation with VIP, GIP or
glucagon. No immunofluorescent E-L cells were observed anywhere else
in the gastric epithelium, although Pestarino does also describe 
anti—secretin immunoreactive cells in the oesophageal and intestinal 
epithelium (Pestarino, 1982b) which have not been observed in Styela 
clava.
71
The ’caps' are absent from the gastric epithelium of Ciona
intestinalis (Yonge, 1925; Thomas, 1970) and in contrast to the 
situation in Styela clava and S« plicata, E—L cells appear scattered 
throughout the columnar epithelium of the gut (Fritsch, 1976). These 
cells demonstrate somatostatin—, gastrin— and neurotensin-like 
imraunoreactivity (Fritsch et al, 1978; Reinecke et al, 1980). A 
CCK—8—like peptide has also been observed by radioimmunoassay in the 
gut of Ciona (Falkmer et al, 1981).
Secretin is phylogenetically old. It has been demonstrated in 
nerve fibres in the brain of the hoverfly larva, Eristalis aeneus, 
though not in the digestive tract (El-Salhy et al, 1980). It has also 
been localised in nerve fibres in the gut wall of a mollusc, the giant 
African land snail, Achatina fulica (Van Noorden and Falkmer, 1980; Van 
Noorden et al, 1980:). Secretin-like bioactivity has also been reported 
in extracts of the spiral caecum of the mollusc Octopus vulgaris 
(Ledrut and Ungar, 1937; Mutt, personal communication).
Van Noorden and Pearse (1974; 1976) have been unable to
demonstrate a gastrointestinal cellular site of secretin production in 
either Branchiostoma or the lamprey Lampetra fluviatilis, although 
secretin-like activity has been demonstrated in intestinal extracts of 
various species of lamprey using bioassay (Barrington and Dockray, 
1970; Nilsson, 1973). Attempts to immunostain secretin-producing cells 
in the gut of fish, amphibia and birds using mammalian anti-secretin 
have proved unsuccessful (Van Noorden and Falkmer, 1980) although 
secretin immunoreactive cells have been successfully demonstrated in 
reptilian gut by Buchan (1981).
Although the Styela 'cap' cells immunoreact with two secretin 
antisera, it is not known to which portion of the secretin molecule
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these antisera are directed; only that control mammalian tissues also 
immunoreact. It is possible that the 'cap’ cells contain an unrelated 
molecule which nevertheless shares the peptide sequence towards which 
these antisera are directed. To investigate this possibility it has 
been necessary to prepare extracts of Styela gut and test whether they 
have a secretin-like action in vertebrate systems.
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INTRODUCTION
The secretin bioassay
Any bioassay system relies on the quantification of a specific 
response to a specific challenge. In the bioassay of secretin, the 
responses which have been measured have been the production of water 
(Ivy et al, 1930) and bicarbonate ions (Hammarsten et al, 1928) by the 
exocrine pancreas.
The initial finding of secretin was in the dog (Bayliss and 
Starling, 1902a; 1902b) and many bioassay systems have subsequently
made use of this animal (Ivy et al, 1930; Greengard and Ivy, 1938; Ivy
and Janecek, 1959; Lin and Alphin, 1962; Vagne et al, 1968; Spingola
and Grossman, 1973). The particular advantages of dogs are their 
sensitivity to secretin, and the reproducibility of results in any 
given dog (Lin and Alphin, 1962). They are, however, expensive to 
purchase and maintain, and require elaborate housing and trained 
personnel.
Cats have long been used as a cheaper and more easily maintained 
alternative (Hammarsten et al, 1928; Mellanby, 1928; Wilander and 
Agren, 1932; Burn and Holton, 1948; Ivy and Janecek, 1959; Mutt and
Soderberg, 1959; Jorpes and Mutt, 1966; Konturek, 1969). They also 
have the advantage that they can be maintained, under anaesthesia, for 
two to five consecutive days by using sterile operating conditions and 
administering antibiotic therapy, and oral Placydil (ethchlorvynol) 
(Mutt and Soderberg, 1959). This considerably reduces the number of 
animals required.
However as facilities to maintain dogs and cats were not 
available, and a Home Office certificate E is required for operative
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procedures on these animals, it was decided that neither species were 
suitable in this instance.
Rabbits have been used for the assay of secretin (Dorchester and 
Haist, (1952), though they have not been used by other workers. They 
are reported to readily succumb to operational trauma (Mutt and 
Soderberg, 1959) and display a high level of spontaneous pancreatic 
secretion (Jorpes and Mutt, 1973).
A technique using turkeys (Dockray, 1972b; 1975a) has proved more 
sensitive than has a rat bioassay, to intestinal extracts of pike. Esox 
lucius (Dockray, 1974) and cod, Gadus morhua (Dockray, 1975b). This 
effect is presumably due to structural differences between fish and 
mammalian secretins. Although fish secretins have not been 
characterised, chicken secretin has about 50% sequence dissimilarity to 
porcine secretin (Fig 3:9) (Carlquist and Mutt, 1980) and this
dissimilarity might be expected to be even greater for Stye 1 a 
'secretin'. Thus from this point of view a turkey bioassay was
considered to be a desirable choice. There were however problems 
associated with accommodating numbers of birds between their purchase 
and use, and for this reason it was decided that in the first instance, 
a rat bioassay should be tested to determine its ability to recognise 
Styela 'secretin'.
The assay of secretin using rats was pioneered indepedently by 
Love (i957) and Svatos and Jelinek (1957). They have since been
commonly used (Debray et al, 1962; Lin and Alphin, 1962; Heatley, 
1968a; 1968b; Tachibana, 1971; 1973; Dockray, 1972a; Schmidt et al,
1972), probably because of the low cost of their purchase and
maintenance, and the ready availability of standardised laboratory 
strains.
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However this bioassay suffers from two disadvantages. Firstly, 
the rat appears to-be insensitive to secretin, compared with other 
species which have been used (Dockray, 1972a). Lin and Alphin (1962) 
found dogs to be forty times more sensitive to secretin than were rats, 
calculated on the basis of dose per kilogram body weight. This 
apparently major problem is not however serious, due to the 
considerably smaller body weight of the rat, which therefore responds 
over much the same range of doses as does the dog.
The second complication arises because, in the rat, as well as 
stimulating pancreatic enzyme secretion (ecbolic effect), CCK also
promotes the flow of pancreatic fluid (hydrelatic action) (Heatley, 
1968a; Dockray, 1972a). Two solutions to this problem have been
proposed by Heatley (1968a). Both secretin and CCK may be assayed 
simultaneously, and then a correction can be made for the calculated
hydrelatic action of the CCK present in the test material. 
Alternatively the CCK activity of the sample can be selectively 
destroyed using the hydrogen peroxide method of Mutt (1964).
In .the rat, pure CCK has a hydrelatic action, with a potency 
approaching one quarter of that of pure secretin (Heatley, 1968a). 
Thus a sample containing CCK but no secretin, could, if assayed without 
using one of the two above mentioned controls, be mistaken for a sample 
containing secretin.
Thus it would be imperative to use one of these variations in a 
bioassay of Styela gut extract to ensure that the hydrelatic response
was not entirely due to a CCK—like molecule, present in the gut, which 
had not been detected by immunocytochemical means.
These considerations would only apply however if a hydrelatic 
response to the extracts was obtained, and as this was far from certain
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it was decided to conduct a pilot study in the first instance. This
would be used to test: a) commercial secretin, to test that the
bioassay was working correctly; b) extracted pig duodenum, to test that
the extraction method was working correctly; c) Styela gut extract, to
test whether it contained any material which provoked a hydrelatic 
response, and d) extracts of control tissues (known not to contain 
secretin), to ensure that the hydrelatic action was not an artefact 
produced by some other unknown factor.
If a), b) and c) produced a hydrelatic effect, and d) did not it 
would then be necessary to determine to what extent the effect in c) 
was caused by CCK-like factors.
The extraction of secretin
In 1902, Bayliss and Starling reported that dilute aqueous 
hydrochloric acid extracts of the canine jejunal mucosa contained a 
substance which caused pancreatic secretion when injected into the 
bloodstream of dogs (Bayliss and Starling, 1902a, 1902b). This
substance they named ’secretin'.
They found that it was thermostable and non-volatile, insoluble in 
ethanol and ether, though soluble in aqueous ethanol; it dialysed 
through parchment, and was inactivated by dilute aqueous potassium 
permanganate, proteolytic enzymes and the salts of mercury, lead and 
iron.
Their secretin extracts were prepared by boiling the upper 
intestinal mucosa in 0.4% hydrochloric acid. This was then neutralised 
with sodium hydroxide, while still boiling, and allowed to cool. The 
mixture was then re—acidified with acetic acid and filtered. Ethanol 
was \then added to the filtrate, which caused the precipitation of many
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impurities, while the secretin remained in solution.
The purification techniques have been the subject of a number of 
excellent review papers (Still, 1931; Greengard, 1948; Grossman, 1950; 
Mutt, 1959b) and will therefore not be fully discussed here. However 
some of the more important stages in the development of the 
purification techniques will be mentioned insofar as they bear on the 
choice of a method for preparing Styela extracts.
All attempts to obtain secretin in a chemically pure form were 
unsuccessful until recently (Jorpes and Mutt, 1961) because the 
necessary separation techniques, such as column chromatography and 
counter-current distribution had not been developed. However in the 
half century which proceeded its eventual isolation a considerable 
amount of information regarding its properties was derived.
No significant advances on the original preparations of Bayliss 
and Starling (1902a; 1902b) were made until the mid 1920s, when
researchers began to change from canine to porcine material, which 
could be obtained in far greater quantities. Thus sufficient material 
could be produced to enable them to undertake more extensive 
purification than had hitherto been possible. This was coupled with an 
important development, separately introduced by Penau and Simonnet 
(1925) in France, and Weaver et al (1926) in America, which involved 
the separation of secretin from toxic, low molecular weight impurities, 
by salting it out from aqueous solutions with neutral salts.
Another important development, pioneered during this era, was the 
adsorption of secretin, which was known to be basic, onto a weak, 
insoluble acid, followed by its subsequent elution by a stronger acid. 
Thus by careful choice of these acids, materials with a lower pH than 
secretin would not be adsorbed, and materials with a higher pH would
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not subsequently be eluted. This enabled a considerable factor of 
purification to be made at an early stage in the extraction process.
The choice by Mellanby (1928) of precipitated bile acids as an 
adsorbant was perhaps unfortunate, as the variability of commerical 
bile salt preparations rendered his successful purification procedure 
unrepeatable when attempted by others (Mortimer and Ivy, 1929; Still, 
1931). This approach was therefore not further pursued until it was 
refined by Jorpes and Mutt during the 1950s.
Using a modification of the method of Friedman and Thomas (1950), 
Jorpes and Mutt (1952) originally made secretin preparations by 
extracting pig intestines with dilute aqueous hydrochloric acid from 
which, after filtering, the secretin could be salted out by the 
addition of sodium chloride.
They encountered problems however, in filtering these extracts, 
and tried to circumvent this step by extracting with acid alcohol, and 
subsequently distilling off the liquid, rather than filtering. 
Unfortunately the residues were rich in lipids and equally difficult to 
handle.
This led them to seek a water and alcohol insoluble material upon 
which to adsorb the secretin from this initial extract, so that the 
troublesome, lipid rich acid alcohol could be filtered off and 
discarded. Their subsequent experiments with ion exchange resins and 
pectic acid have been comprehensively reviewed by Mutt (1959b) but none 
of the materials which they used were entirely satisfactory.
Alginic acid, when it was tried, appeared to have considerable 
advantages. However it would only adsorb secretin from aqueous 
solutions. To reduce the original problems of working with aqueous
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Fig 2:1 Flow diagram showing the original scheme for the 
production of biologically pure secretin. After 
Jorpes and Mutt, 1^67.
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extracts they boiled the intestines for a few minutes in water, to 
destroy the proteolytic enzymes and stabilise the secretin. Subsequent 
extraction at room temperature with dilute acetic acid left most of the 
coagulated proteinaceous material and lipids undissolved in the 
intestine, which made the extracts much easier to filter, greatly 
facilitating the removal of the intestinal tissue
Alginic acid was then added to the filtrate, to adsorb the 
secretin, which was subsequently eluted with dilute hydrochloric acid. 
The secretin could then be precipitated from the eluate with sodium 
chloride (Mutt 1959a).
This concentrate of thermostable intestinal peptides (CTIP) could 
then be processed further to purify the secretin (Fig 2:1) or indeed 
any of the many other peptides which it contains (Mutt, 1976; 1978;
1980).
It was found at an early stage in the present study that the 
amount of CTIP that could be prepared from Styela stomachs was 
extremely small, compared to that produced from a comparable weight of 
pig gut. Also that the stomachs of approximately 1,000 Styela weighed 
the same as the first metre of duodenum from one pig (300 g). Thus the 
amounts that could reasonably be prepared did not allow for any further 
purification of the crude CTIP.
It was therefore decided that Styela stomach CTIP and pig duodenum 
CTIP should be used as test materials in a bioassay using rats, which 
would measure an increase in pancreatic fluid output, such as that 
known to be elicited by mammalian secretin and CCK.
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Control tissues should consist of regions of gut deficient in 
active peptides. In the mammalian gut, secretin immunoreactive cells 
are almost entirely restricted to the duodenal and jejunal mucosa 
(Larsson et al, 1977), although Chey and Escoffery (1976) have reported 
them to be also present in the antral mucosa of man, dog and rat. As 
the antral region of the stomach additionally contains a large quantity 
of gastrin (Nilsson et al, 1973), which has a CCK-like effect, and 
would therefore interfere with the rat secretin bioassay, non-antral 
tissue was chosen as porcine control material. Styela pharynx was also 
collected and extracted to check that any positive bio-activity was 
specific to the gut. These control tissues were extracted in the same 
way as the Styela stomach and porcine duodenum.
MATERIALS AND METHODS
Gut extracts
a) Source of standard: Boots secretin (the generous gift of The Boots 
Company Ltd) was used as a crude stimulant of pancreatic secretion. 
This material is extremely impure.
According to data supplied by Boots, each milligram of the batch 
used (CMC 11789Y) contained approximately 100 ng of secretin, 4 ng of 
CCK and 180 pg of gastrin. Undoubtedly many other gut hormones were 
also present. However 'Boots' secretin is a readily available 
pancreatic secretagogue, separate batches of which do not vary greatly 
in potency (Stening et al, 1968).
It was felt that it would be a sufficiently accurate standard for 
the purpose of this pilot study. If the Styela gut extracts were found 
to have any effect on pancreatic secretion then a request, for reliable
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A
boil tissue in 
0.5 M acetic acid
extract for 
5hrs at 20 C
filte r to remove tissue 
CD
add alginic acid, 
s tir 30 mins
adjust pH 
2.6 - 2.8
recover alginic acid 
and elute peptides 
will! 0.2 M HCI
Fig 2:2 The extraction method. Tissues were added to boiling 0.5 M 
acetic acid, and heated at 80 to lOO^C for 10 mins. They 
were then stirred at 20°C for 5 hrs, after which the extract 
was cooled, sieved, and finally filtered under reduced 
pressure. The pH of the filtrate was lowered to between 2.6 
and 2.8 by adding 2 M HCI. Carefully washed and fined 
alginic acid was added to the filtrate and stirred for 30 
mins. The alginic acid was recovered and eluted with a 
small volume of 0.2 M HCI. The pH was adjusted to 4.0 by 
addition of 1.0 M NaOH. This neutralised solution was 
Ihrn freeze dried.
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hormone standards from the Karolinska Institute in Stockholm could be 
justified.
b) Source of tissues: All porcine tissues used were obtained from the 
British Beef Abattoir, Watford. Complete gastrointestinal tracts,
received within 5 mins of slaughter, were packed in insulated 
containers with ice and transported to London by van. The first metre 
of the duodenum and the proximal stomach were removed separately,
emptied of their contents, flushed with cold water and minced.
Specimens of Styela clava were collected in the Portsmouth area 
and transported to London in aerated seawater. The gut and pharynx 
were excised separately and transferred to dry ice prior to
processing.
c) Processing of tissues (Fig 2:2): Extracts were prepared by a method 
based on the initial stages of the procedures described by Mutt (1959a) 
and Dockray (1975a). Tissues were added to boiling 0.5 M acetic acid 
(500 g/1), and heated at 80 to 100°C for 10 mins. Following stirring 
at room temperature for 5 hrs, the bulk of the solid material was 
removed by passing the extract through a stainless steel sieve (1 mm
mesh). The liquor was cooled and filtered under reduced pressure using
Whatman 113 paper. The pH of the filtrate was then lowered to between
2.6 and 2.8 by the addition of 2 M hydrochloric acid.
Alginic acid (Sigma, London) was hydrated in distilled water, 
fined and then washed with acetic acid (0.5 M), hydrochloric acid (0.2 
M), then more acetic acid (0.5 M). This was added to the filtrate 
(lg/50g tissue) and stirred at room temperature for 30 mins. It was 
left to allow the bulk of the alginic acid to sediment. The 
supernatant was decanted and the remaining alginic acid sediment 
recovered by filtration using Whatman GF/B paper under reduced
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pressure,
The alginic acid was eluted with a small volume of hydrochloric 
acid (0.2 M) and the pH adjusted to 4.00 by the addition of sodium 
hydroxide (1.0 M). This neutralised solution was then freeze dried 
using a Birchover Instruments freeze drier.
Operative procedure
a) Rats (Fig 2:3): Animals of either sex, weighing in excess of 250 g, 
were fasted for 24 hrs prior to use. They were anaesthetised with a 
single intraperitoneal (IP) injection of a 25% (w/v) solution of
urethane (ethyl carbamate) in 0.9% physiological saline (5 ml/kg).
They were then transferred to a darkened cage with adequate 
bedding for 1 hr. If after this period they showed any signs of 
'light’ anaesthesia, ie whisker twitch, corneal reflex or an elevated 
respiratory rate (above 100/min) an ether soaked pad was placed near 
the nose until a deep anaesthesia was achieved.
If after the insertion of a venous cannula animals again showed 
symptoms of becoming 'light' a small amount of the same urethane 
solution was injected into the cannula.
When full anaesthesia had been achieved, the abdomen and neck 
regions were clipped and the animal was secured to a perspex board 
using leg ties.
The external jugular vein was exposed and ligated distally (Fig 
2:3a). A small incision was made proximal to this ligature and a 
saline filled polyethylene cannula (Portex pp.00) inserted and tied in 
place. A saline filled syringe, fitted with a 26-gauge needle was 
inserted directly into the end of this tube and by alternate injection
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Fig 2:3 The rat bioassay for secretin: a) The anaesthetised rat
is shown clipped and secured to a perspex board using leg 
ties. The external jugular is exposed (arrow), with two 
ligatures around it. The distal ligaturé when tightened, 
prevents the venous return and the proximal one is placed 
ready to tie in the cannula following insertion, b) The 
abdominal incision is shown, with the empty stomach with­
drawn from the peritoneum. A ligature is shown being drawn 
tightly around the pyloric sphincter (arrow). c) When the 
stomach is replaced,the first duodenal loop is withdrawn 
and the bile duct (arrow) identified. This is ligated 
distally, and cannulated at its junction with the duodenum,
d) l^fhen this is complete, the intestine is replaced and the 
peritoneum is closed,normally with small steel clips, silk 
sutures are more time consuming to insert. The saline filled 
syringe can be seen attached to the venous cannula. The 
pancreatic catheter is lead from the peritoneal incision 
to a glass measuring capilliary. A small 0-50°C thermometer 
is seen to be inserted into the rectum.
Fig 2:3 87
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and withdrawal a visual check could be made of the correct insertion of 
the cannula.
This syringe, refilled with saline as necessary, was left 
connected, except when injections were made, using a similar syringe 
and needle. Following the injection of test materials a small volume 
of saline (200 ^1), exceeding the volume of the cannula (0.6 |il/cm), 
was injected to flush out the material from it.
The abdomen was opened with a midline incision from xiphisternum 
to umbilicus. The pyloric sphincter was identified and ligated to 
prevent acid passing into the duodenum and causing endogenous secretin 
release (Fig 2:3b).
In most mammals the pancreas is drained directly into the duodenum 
by one or two pancreatic ducts. However in the rat a large number of 
small ducts drain the pancreatic secretions into the bile duct, which 
for much of its length is embedded in the pancreatic tissue. The 
pancreatic juice therefore mixes with the bile before passing into the 
duodenum. However if the flow of bile is interrupted then pure 
pancreatic juice may be collected from it.
The bile duct was therefore ligated, distal to the lowest biliary 
radical but proximal to its entry into the pancreatic tissue. A 
ligature was passed around the distal end of the duct and with the aid 
of a low power dissecting microscope, a small incision was made in the 
duct at its junction with the duodenum. It was found to be important 
that this incision did not sever any of the superficial capillaries, as 
the subsequent bleeding could cause blood to be introduced into the 
duct, which occluded the flow from it. The slightly drawn end of a 
polyethylene cannula (Portex pp.00) was inserted through the incision, 
and the ligature drawn tight to secure it (Fig 2:3c).
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The cannula was led out o£ the body cavity through the midline 
incision, which was then closed with braided silk sutures, or small 
steel clips (Down Bros and Mayer and Phelps Ltd; Mitcham, Surrey). The 
body, monitored by means of a rectal themometer, was maintained between 
36° and 38°C by positioning lights above the animal (Fig 2:3d).
A length of glass capillary tubing (50 jil Drummond 'Microcap') was 
attached to the free end of the cannula and this was replaced at 5 rain 
intervals. The volume of secretion was assessed by measuring the 
length of fluid within the tube (1 mm = 0.5 jil).
b) Turkeys (Fig 2:4): Eight week old birds were obtained from a local 
turkey breeder and maintained on commercial turkey food in an 
outbuilding. The experiments described were performed on birds weighing 
2.0 to 5.0 kg.
The animals were fasted for the 24 hrs prior to being 
anaesthetised with 20% urethane in 0.9% physiological saline (7.5 ml/kg 
IP).
They were transferred to a cage with adequate bedding and examined 
periodically to determine their level of anaesthesia. If after a 
period of about 1 hr they showed signs of 'light' anaesthesia, ie 
corneal reflex, they were given a further injection of urethane (0.1 to 
0.75 ml/kg IP).
When completely anaesthetised, a wing vein was exposed and ligated 
distally (Fig 2:4a). A saline filled polyethylene cannula was then 
inserted into an incision made proximal to this point. This cannula 
was then used for subsequent injection of test material.
The feathers in the abdominal region were removed and a mid line 
ventral incision made to expose the duodenal loop and pancreas. The
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Fig 2:4 The turkey bioassay for secretin: a) The left wing is
shown, partially cleaned of feathers and wiped with a wet 
tissue to clean the skin. The wing vein (arrow) is shown 
exposed with two ligatures, the distal one to occlude the 
venous flow, prior to cannula insertion and the proximal 
ligature to tie the cannula in place, b) The duodenal 
loop and pancreas are shown exposed. One of the pancreatic 
ducts has been ligated and the cannula has been tied into 
the other (arrow). c) Finally a large vinyl catheter is 
inserted into the gizzard through an incision in the 
proximal limb of the duodenum to drain the acid secretions 
of the proventriculus.
Fig 2:4 91
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pancreatic ducts were located. One was ligated at its distal end and a 
loose ligature was passed around the other at a point immediately 
before its opening to the duodenum. A small incision was made beyond 
this point, and a polyethylene cannula (Portex pp.00) was introduced 
and the ligature tightened to secure it firmly in place (Fig 2:4b).
The cannula was led out of the body cavity through a small hole made at 
one side of the abdomen, situated so as to prevent the cannula from 
becoming kinked. A vinyl catheter was inserted into the gizzard
through an incision in the proximal limb of the duodenum (Fig 2:4c). 
This drained the acid secretions of the proventriculus, preventing them 
from entering the duodenum and causing endogenous hormone release.
The abdomen was then closed using a number of steel clips. The 
body temperature, monitored by means of a rectal thermometer, was 
maintained between 37“C and 39°C by positioning lights above the bird.
A length of glass capillary tubing (50 jil Drummond Microcap) was 
attached to the free end of the cannula and this was replaced at 5 inin 
intervals. The volume of secretion was assessed by measuring the 
length of fluid within the tube (1 mm = 0.5 |il).
Administration of test materials
All hormones and test materials were weighed up on the day of
use. They were then dissolved in normal saline containing 0.01 M
acetic acid. Injections were made in a random order into the 
cannulated vein and at least 30 mins was allowed to elapse between 
injections.
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RESULTS
AIL data obtained from rat and turkey bioassays are presented in 
tabular form in appendix 2.
The rat
The effect of five doses of 'Boots' secretin on the output from 
the cannulated rat pancreas is shown in Fig 2:5. Typically, following 
the injection of a dose of 'Boots' secretin, levels rose from basal 
(6.05 ±_ 1.33 ^ l.Smm' ) to a maximum rate of output within 5 to 10 rains.
In the case of the highest dose (500 yug/kg), this maximum output was
measured as 23.1 . Larger doses of secretin produced higher
maximum outputs, as well as increasing the period over which levels 
were sustained significantly above basal.
. Significant elevations of output were produced by all doses (p < 
0.001), except for the lowest dose of 1 jug (p > 0.1). Peak flow rates 
occurred 10 to 15 mins after injection.
Within the range of doses studied, the volume of the total
response, ie the increase in fluid output caused by the injection,
increased with dose (Fig 2:6).
Extracts prepared from porcine duodenum demonstrated an effect on 
the volume of total response parallel to that of 'Boots' secretin (Fig 
2:6). However the extract displayed only about 10% of the activity,ie 
500 ^g of extract produced a response similar to 50 yg of 'Boots' 
secretin.
Styela gut extracts produced no significant elevation in the rate 
of pancreatic secretion when administered as a dose of 0.5 or 1.0 mg (p 
> 0.1). However a dose of 5 mg produced a total réponse which might
TABLE 6
TABLE OF TEST SUBSTANCES A.NU DOSES GIVEN
RAT BIOASSAY
Material
tested
Dose/Weight
mg/kg
Number of 
determinations (n)
14
'Boots' 
secret in
0.3
0.05
0.01
0.005
0.001
Pore inc
duodenal
extract
1.6
0.8
0.4
0.2
0.1
Porcine
gastric
extract
1.0
2.0
Styela 
gut extract
1.0
2 . 0
5.0
Styela
pharynx extract
5.0
TABLE 7
TABLE OF TEST SUBSTANCES ,\ND DOSES GIVEN
TURKEY BIOASSAY
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Material
used
Dose/Weight 
mg/kg
Number of 
determinants (n)
’Boots’ 0.5 '3
secret in 1.0 3
2.0 3
Pore ine 2.0 3
duodenal
extract
5.0 3
Pore ine 
gastric 
extract
5.0 3
Styela 1.0 3
gut extract 2.0 1
Styela
pharynx
extract
2.0 3
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Fig 2:5 The effect of five doses of 'Boots' secretin on the output 
from the cannulated rat pancreas. Doses were given at 
time 0 (t, 500 pg/kg; «, 50 pg/kg; ®, 10 pg/kg;
0, 5 pg/kg; 1 Pg/kg).
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Fig 2:6 The effect of increasing doses of ’Boots’ secretin (•), 
and porcine duodenal CTIF (0) on the volume of the total
response in the rat.
o>
e n
T T T
-10 0 10 
T i m e  a f t e r
20
dose  ( m i n )
30
Fig 2:7 The effect of three doses of ’Boots' secretin on the 
output of the cannulated turkey pancreas. Doses were 
given at time 0. (t, 2.0 mg/kg: 0, 1-0 mg/kg;
©, 0.5 mg/kg).
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Fig 2:8 The effect of increasing doses of 'lioots secretin (•) 
and porcine duodenal CTIP (0) on the volume of the 
total response in the turkey.
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be considered marginally significant (0.05 < p < 0.1).
Porcine gastric extracts (1.0 and 2.0 mg) and extracts of Styela 
pharynx (2.5 rag) produced no significant elevation in pancreatic fluid 
output (p > 0.1).
The turkey
The effect of three dose levels of 'Boots' secretin on the rate oF 
Flow from the cannulated turkey pancreas are shown in Fig 2:7. The 
pattern of activity is the same as that found In the rat (Fig 2:5). 
Increased doses of secretin caused increases both in maximum output and 
duration of response. The relationship between dose and the volume of 
the total response are shown in Fig 2:8.
Porcine duodenal extracts (2.0 and 5.0 mg) both caused significant 
elevations in secretin (p < 0.01) (Fig 2.8). Porcine gastric extract 
(5.0 mg/kg) produced no response (p > 0.1).
Extracts of Styela gut (1.0 and 2.0 mg/kg) and Styela pharynx (2.0 
mg/kg) produced no significant elevation in pancreatic output (p > 
0 . 1).
DISCUSSION
Both rat and turkey bioassay systems when used to test 'Boots' 
secretin appear to have operated successfully, as a bioassay, in a dose 
related fashion. However, insufficient data was collected for any 
meaningful comparison with the results obtained by other workers who 
have employed these techniques.
These assays were performed in this instance, not for the accurate 
determination of specific levels of secretin, but in the hoje of
initially establishing whether extracts of Styela gut c o n t a i n e d  a 
factor with a secretin-like action on the vertebrate pancreas.
Clearly no such conclusive demonstration has been made. This 
result however, may not be inconsistent with the immunohistochemical 
findings reported in chapter 1.
The most likely explanations for this are that either the 
secretin-like immunoreactive material is not biologically active in the 
systems used, or that the factor has not been retained in the 
purification system. Alternatively an inhibitory factor might have been 
co-extracted, which has completely or partially masked the effect of 
the secretin.
It is possible that the secretin antisera used in this study were 
directed against a part of the secretin molecule inessential for 
bioactivity. This would allow binding to take place with peptides 
which contained this sequence, but had different amino acids elsewhere 
in the molecule which reduced or abolished secretin-like bioactivity in 
the rat and turkey.
The specificity of the antisera used was not established, except 
that it cross—reacted with porcine secretin, though not with glucagon, 
VIP or CCK. Antisera have been developed which are highly specific for 
certain known peptide sequences (Dockray et al, 1981; Rehfeld, 1978), 
but at the time that this study was made no region specific antisera 
were available for examining secretin-like peptides.
In the case of some peptide hormones, only a small portion of the 
molecule may be required for full biological activity. The C terminal 
octapeptide of cholecystokinin, CCK-8 (Mutt and Jorpes, 1968a) and the 
C-terminal tetrapeptide of gastrin, G-4 (Tracy and Gregory, 1964) show
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the same activities as those demonstrated by their parent molecules.
This however is not the case for secretin (Fig 2:9) where the 
entire peptide chain appears to be required for any substantial level 
of pancreatic stimulation. The hexacosapeptide des-histidyl-secretin 
(secretin 2-27), which lacks only one amino acid residue, has less than 
1% of the activity of secretin 1-27, in terras of its ability to 
stimulate pancreatic secretion in the cat (Mutt and Jorpes, 1967) and 
dog (Solomon et al, 1977). Another analogue in whicli the phenylalanine 
at position 6 is replaced by tyrosine shows only 10% of the activity of 
secretin (Guiducci, 1974).
The aspartic acid residue at position 3 is also crucial and an 
analogue in which the configuration of the molecule is affected by the 
incorporation of this aspartic acid residue in the ^-configuration, 
instead of the c<, results in a peptide which shows only 0.6% of the 
potency of normal synthetic secretin in its stimulation of rate of flow 
and bicarbonate secretion from the dog pancreas (Ondetti et al, 
1970a). Analogues with asparagine (Mutt and Jorpes, 1967), glutamic 
acid or glutamine (Adler et al, 1980; Wunsch et al, 1977) substituted 
at position 3 have virtually no secretin-like action. However the very 
low secretin—like effect on the mammalian pancreas of PHI (Dimaline and 
Dockray, 1980), in which both His-1 and Asp-3 are conserved 
demonstrates that residues other than 1 and 3 are also important for 
activity.
Therefore if Styela ’secretin’ were to differ from porcine 
secretin even by only one amino acid substitution at a critical 
position, then an extract containing this peptide might show no 
biological activity.
U4
There is however considerable evidence to Indicate that Styela 
secretin-like immunoreactive material does possess biological 
activity* Extracts with a secretin—like action have been prepared from 
representatives of many of the vertebrate groups, including the mammals 
(Jorpes and Mutt, 1970), birds (Dockray, 1975b), reptiles and 
amphibians (Bayliss and Starling, 1903), fish (Dockray, 1975b; Nilsson, 
1970) and cyclostomes (Nilsson, 1973).
All of these are evolutionarily more advanced than Styela and 
therefore no more than hint at the possibility that a recognisable and 
bloactive secretin-like peptide might also exist in the
protochorda tes. However the presence of a biologically active
secretin-like factor in the spiral caecum of Octopus vulgaris,
originally found by Ledrut and Ungar (19 37) and confirmed by Mutt 
(personal communication) provides evidence that secretin may be
phylogene tically older than the protochordates and is therefore 
circumstantial evidence for its presence in this group.
Recently, and subsequent to the present study, extracts of Stjdl_Ul 
gut have been produced, initially with the assistance of Prof Mutt at 
the Karolinska Institute and later in London, which are capable of 
causing the stimulation of water and bicarbonate ion production by the 
cat pancreas, as well as an increase in fluid output from the rat 
pancreas (Thorndyke and Bevis, 1983).
Although bovine secretin is structurally identical to the porcine 
variety (Carlquist et al, 1981) chicken secretin (Nilsson et al, 1980) 
shows 13 amino acid alterations (Fig 2:9), whilst still demonstrating a 
secretin—like action in cats and birds (Dimaline and Dockray, 1979).
As the structures of gut hormones have evolved in the same manner 
as other features which are subject to evolutionary pressures (Van
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Noorden and Polak, 1979) it is quite possible that a primitive species 
such as Styela clava might show as great or greater sequence 
dissimilarity from porcine than the avian peptide. Chicken secretin 
could equally well be completely atypical, as the porcine structure 
appears to be strongly conserved in mammals (Carlquist et al, 1981) and 
other secretins, including Styela could all be more like the mammalian 
peptide.
Certain alterations of the molecular structure, particularly those 
affecting the charge of the molecule, could result in the molecule not 
being retained in the purification system. A crucial aspect of the 
purification scheme which was used was the reversible adsorption of the 
basic peptide onto an insoluble acid, in this case alglnic acid, which 
acts as a cation exchanger. If the Styela secretin were not basic then 
it might not be retained by the alglnic acid at this stage in the 
purification.
Circumstantial evidence favours the hypothesis that Styela 
'secretin’ would be retained. Alginic acid has been used to purify a 
wide range of porcine peptide hormones including secretin (Mutt, 1978), 
GRP (McDonald et al, 1978), CCK-33 (Jorpes and Mutt, 1959), CCK-39 
(Mutt, 1976), CCK-58 (Tatemoto, 1984b), VIP (Said and Mutt, 1972), 
chyraodenin (Adelson et al, 1980), somatostatin-28 (Pradayrol et al, 
1978; 1980), PHI (Tatemoto and Mutt, 1981), PYY (Tatemoto, 1982) and 
galanin (Tatemoto et al, 1983).
In other vertebrate species the alginic acid step has been 
successful in the purification of human VIP (Carlquist et al, 1982), 
and PHI (Tatemoto et al, 1984a); bovine secretin (Carlquist et al,
1981) and VIP (Carlquist et al, 1979); and avian VIP, secretin and GRP 
(Dockray, 1975a; McDonald et al, 1980; Nilsson, 1974; Nilsson et al.
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1980). CCK/gastrin like factors have been extracted from rat, frog, 
salmon, pike, Chimaera monstrosa. dogfish and hagfish as well as 
secretin like factors from pike, Chimaera monstrosa and hagfish 
(Dockray, 1974; Nilsson, 1970; 1973; Vigna, 1979).
In addition to these vertebrate peptides the secretin-like factor 
in the spiral caecum of octopus has also been extracted using alginic 
acid (Mutt, pers com).- There was therefore good reason to suppose that 
Styela ’secretin' would also be adsorbed onto alginic acid and indeed 
this hypothesis has been confirmed by subsequent successful extractions 
(Thorndyke and Bevis, 1982).
There is thus strong evidence that the Styela secretin-like 
immunoreactive material is biologically active and can be retained by 
the type of alginic acid based purification scheme used in this study. 
It is suggested that the negative results described in this chapter can 
be explained only by faults in the execution of the experimental 
technique, rather than the design of the extraction, which resulted in 
the retention of insufficient activity for its detection in the 
bioassays used.
Possible causes of loss of bioactivity
a) Enzyme inactivation: Secretin, like all peptide hormones, is readily 
denatured by proteolytic enzymes. The problem of extracting 
thermolabile peptides from enzyme rich tissues such as gut and pancreas 
are commonly dealt with by extracting at low temperatures to reduce 
enzyme action. Fortunately secretin, and indeed other gut hormones, 
are thermostable, and by boiling briefly the enzymes may be 
inactivated, allowing the peptide to be extracted without losses being 
sustained due to proteolytic degradation.
10/
It was impossible to predict, except from circumstantial evidence, 
that Styela ’secretin’ would be thermostable, but the subsequent
successful extraction by this method indicates that this is indeed the 
case. Losses may occur, due to proteolysis before the tissue Is
boiled, or subsequently should the period of boiling be insufficient
and proteolytic enzymes therefore remain intact. Losses may also be
incurred by prolonged boiling if the thermostability is not absolute.
When preparing Styela extracts, guts were rapidly excised onto 
blocks of dry ice, which ensured extremely rapid freezing of the 
tissue. Tissue was accumulated in this manner prior to its transfer to 
boiling acetic acid. The possibility of proteolytic degradation at 
this stage seems unlikely.
The porcine tissue was collected by van from an abattoir 90 mins 
drive from the laboratory. Tissues were received within 5 mlns of 
slaughter. No facilities were available for flushing out the gut or 
dissecting out the required tissue. The entire gastro-intestinal tract 
was therefore transported to the laboratory where these procedures took 
place.
The guts were placed into polythene sacks and packed, with an 
ice/dry ice mixture, into an insulated container. Although the gut was 
cool when removed at the laboratory, this cooling may well have been a 
slow process due to the large bulk of warm tissue and It is possible 
that losses of secretin, due to proteolysis, took place at this stage.
b) Interface inactivation: The formation of foams and films should be 
reduced as far as possible as peptides tend to denature at interfaces. 
Considerable frothing however was allowed to take place during the 
preparation of these extracts due to their difficult nature. 
Extraction with boiling acid causes lipids and fats to be dissolved up.
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thus making filtration extremely slow. Reduced pressures were 
therefore used to speed up this procedure.
Under these circumstances foaming occurred and as filtrations 
could take an hour or more, considerable losses could have occurred. 
It has subsequently been ascertained that filtration can be speeded up 
by boiling tissue in water, rather than acid, and then extracting with 
cold acid. These extracts, when chilled to 0“C and particularly 
following the addition of 2% Hy-flo, become comparatively easy to
filter. The tendency of the filtrate to foam can be reduced
considerably by the addition of a few drops of octan-l-ol.
c) Alginic acid: This material is produced from a variety of species of 
marine algae in various countries and by a number of methods. The
final product is a linear polymer of high, but variable molecular
weight consisting of ^-(1-4) linked units of mainly D-mannuronic acid 
(with some L-guluronic acid), in the pyranose ring form. The ratio of 
these two acid units is variable and depends upon the source.
Because of the uncertain nature of the product it is possible that 
the alginic acid used in the present study, obtained through 'Sigma', 
differs from the material which has been used exclusively by the
Karolinska group, which they obtain through Ed Mendell Co, Carmel, NY. 
If the alginic acid supplied by Sigma has a lower affinity for the
secretin than that produced by Ed Mendell Co, this would not
necessarily be important, as a larger quantity could be used as 
adsorbant. However a more important feature of alginic acid used in 
this way is that a proportion of the peptide is irreversibly bound
(Mutt, personal communication). Presumably the guluronic acid units 
adsorb secretin which is not then eluted with 0.2M HCl. These acid 
units are then blocked and so if the alginic acid had been recovered
Iü9
and subsequently reused these losses would have been considerably 
reduced.
To prevent the possible charge that an apparent Styela secretin 
was merely residual porcine material being belatedly eluted from 
pre-used alginic acid, fresh acid was used for each extraction. Losses 
undoubtedly occurred for this reason and so if the 'Sigma' alginic acid 
contained a larger percentage of guluronic acid than did that supplied 
by Ed Mendell Co, then significant losses could have occurred.
To help reduce the losses still further, it is normal practice in 
Prof Mutt's laboratory to use the minimum amount necessary to adsorb 
the peptide material. Alginic acid is added stepwise and samples of 
supernatant are repeatedly tested with an equivalent amount of 
saturated picric acid. When this addition fails to cause a precipitate 
then further addition of alginic acid would be to no avail. This 
useful tip was not known at the time and alginic acid was added in a 
'one for the pot* fashion in the mistaken belief that what adsorbs will 
elute. These factors taken together may have produced considerable 
losses of material.
CONCLUSIONS
This mainly circumstantial evidence points to the conclusion that 
the lack of demonstrable secretin—like bioactivity was not due to the 
absence of a secretin—like factor located within the gut mucosa of 
Styela. It would appear that the method used was unable to produce a 
sufficiently active extract to be detected at the doses used.
It is suggested that viewed critically, and with a degree of 
hindsight, various opportunities existed for losses to have occurred.
It is also possible that the highest dose of Styela gut extract 
used did have a real effect but lack of material prevented the use of a 
higher dose which might have confirmed this.
Finally when the experiment was repeated using substantially the 
same techniques but an improved methodology in a period later than that 
covered by this thesis, secretin-bioactive extracts were successfully 
prepared from Styela gut (Thorndyke and Bevis, 1983).
These speculations should not however, overshadow the fact that no 
evidence has been presented in this chapter which demonstrates that 
Styela clava contains a secretin-like factor. It was therefore felt 
that in order to gain such evidence it would be necessary to approach 
the problem from a direction which would not require the preparation of 
extracts.
If Styela clava was itself the bioassay then commercially 
available natural and synthetic mammalian peptides could be tested to 
determine whether Styela could recognise and respond to them.
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INTRODUCTION
In vertebrates, the hormones which are produced by cells in the 
gastrointestinal tract are broadly concerned with the regulation of the 
digestive process (Norris, 1980; Tache, 1984; Thompson and Marx, 
1984). For this reason it was supposed that the secretin-like 
immunoreactive factor in Styela would also, if it acted in an hormonal
manner, be involved in some way with the process of digestion.
Speculation as to what role it might play requires the consideration of 
the special feeding habits of ascidians.
Mechanism of feeding (Fig 3.0)
All ascidians are ciliary filter feeders and the mechanism by 
which they ingest their food has long been a subject of study 
(Goodbody, 1974; Millar, 1953; Roule, 1884). The particular problems
associated with this method of feeding have been fully reviewed 
(Morton, 1960) and will therefore only briefly be discussed here.
The detritus which is ingested by filter feeders is of a very low 
nutritive value. This means that large quantitites of this material 
must be taken into, and moved through, the gut which generally requires 
that a continuous flow must be maintained. It is also essential that 
it should have a long transit time through the gut, in order for 
complete digestion to take place. Movement of fine particles in 
suspension through the gut by cilia or peristalsis, would be
impractical. In order to ingest sufficient food and pass it through 
the gut, the transit time would be too rapid to allow for digestion and 
assimilation. The particles are therefore normally removed from the 
feeding current and compacted into a mucus cord before being passed 
slowly through the gut.
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Fig 3:0 The digestive system of the ascidian, Styela clava
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In StyeJ j , cilia lining the pharynx draw a current of water 
through the inhalent (oral) syphon, into the pharynx, and out through a 
series of slits (stigmata) into the atrium. From there it passes out 
of the exhalent (atrial) syphon. The inside of the pharynx is covered 
with a continuous layer of mucus or muco-protein, produced by the 
endostyle. It is this mucus sheet which traps particles from the water 
current and in the case of Ciona intestinalis is capable of retaining 
particles as small as 1.0 in diameter (Jorgensen and Goldberg,
1953).
By a combination of ciliary action and waves of contraction of the 
body wall muscles (Hecht, 1918), the mucus sheet is moved across the 
branchial wall until it reaches the dorsal lamina. There it rolls into 
a cord and it is pulled into the oesophagus, by the cilia located at 
its mouth.
■ As well as pulling in the mucus food rope from the pharynx, the 
oesophagus helps to consoldiate it by adding more mucus and giving it a 
spiral twist. Once in the stomach, the food cord folds upon itself, 
presumably to increase its transit time. The cord is then drawn into 
the intestine by the action of a ring of ciliated cells at Its
stomachic end (Millar, 1953). The food cord is then passed along the
intestine by general ciliary action and folded back and forth over the
typhlosole, which is an infolding of the intestine that serves to
increase its surface area.
Ultimately the faeces are formed by the breaking off of sections 
of the string, which become coated with mucus in the rectum before
being released from the anus into the atrial cavity. They are
dispersed through the atrial siphon, by the strong exhalent current.
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Knowledge of the digestive processes which occur during the 
transit of the food string through the gut is extremely rudimentary 
when compared with the information which is available concerning 
vertebrate digestion. The rather primitive early studies by Yonge 
(1925), Berrill (1929) and Van Weel (1940) have been reviewed by 
Barrington (1962) and more recent studies have been collated by 
Goodbody (1974).,
Digestive enzymes are secreted into the stomach and digestion 
appears to be largely extracellular, although there is evidence that 
some phagocytotic uptake may also occur (Burighel, 1979; Burighel and 
Milanesi, 1975; Van Weel, 1940; Thorndyke, 1977).
Extracts of gut have been shown to contain enzymes which act as 
maltase, lactase, amylase, invertase, lipase and protease (Berrill, 
1929; Yonge, 1925). However there is no evidence that normal 
physiological release of these enzymes occurs, although this appears to 
be a logical inference.
More recent studies have been able to use more sophisticated 
techniques and therefore produce more meaningful results. Koch and 
Marsh (1972) have demonstrated that a wide range of polysaccharidases 
can be extracted from the pyloric gland of Pyura stolonifera. These 
are able to degrade a variety of substrates, including starch, 
carboxymethy1 cellulose and alginates. Elyakova (1972) has confirmed 
that ascidians, including Styela clava can hydrolyse carboxymethyl 
cellulose and in the case of one species, Halocynthia aurantium, a 
chitinase is also present in pyloric gland extracts.
The pyloric gland was originally thought to have an excretory 
function (Colton, 1910) but it is perhaps more likely to serve a 
function analogous to the molluscan hepatopancreas, releasing digestive
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enzymes into the gut. The gland consists of a series of tubules 
terminating in small swellings or ampullae, which ramify over the gut 
between the internal gut epithelium and the connective tissue sheet 
which encloses it. The tubules join together and discharge from a
single duct which connects to the gut lumen by a small opening at the 
junction of the stomach and intestine. This pyloric duct is lined with 
cilia which beat towards the gut so as to discharge some substance into 
the gut lumen.
Goodbody (1974) draws attention to the fact that early workers 
(Berrill, 1929; Van Weel, 1940; Yonge, 1925) did not find evidence of 
digestive enzymes in ascidian intestinal extracts which would have 
included the pyloric gland. He therefore argues for the pyloric gland 
having a role in acid secretion, though on rather circumstantial 
grounds.
In recent years two other workers, Ermak (1975; 1977) and Gaill 
(1977; 1980) have produced convincing results which indicate an hepatic 
role rather than a pancreatic role. Ermak (1975) noted that the 
pyloric tubules occurred directly adjacent to the intestinal absorptive 
cells and he therefore suggested that this indicated a role in nutrient 
absorbtion and assimilation. He subsequently (Ermak, 1977) found that 
the gland cells contained large glycogen deposits, which can be 
digested with alpha amylase and which are depleted by a period of 
starvation. He concludes that the ultrastructural, positional and 
functional characteristics are strikingly similar to those of the 
vertebrate liver.
The presence of glycogen in the pyloric gland cells of Dendrodoa 
grossularia has been confirmed by Gaill (1980). He also reports 
preliminary experiments showing uptake of labelled metabolites.
E-L cell
mucous  c o l l  
absorptive cell
zymogen cell
capi l lary rete
Fig 3:1 Schematic representation of a transverse section of one 
of the gastric ridges of Styela clava. The cap reg ions, 
which consist of mucus cells and endocrine cells, project 
into the gastric lumen and are therefore well situaLiul to 
respond to material passing through the stomach. It is 
sug,;',ested that the,se intraluminal nutrients act as a 
stimulus, causing the release of an hormonal factor into 
the underlying capillary retc. This is presumed to 
stimulate basal receptors on the zymogen cells, situated 
amongst absorptive cells in the side walls, causing them 
to release digestive enzymes into the gastric lumen.
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particularly glucose from the digestive epithelium, into the pyloric 
gland.
If the source of digestive enzymes is not the pyloric gland, then 
the most likely alternate source is the gastric epithelium. The
gastric mucosa in Styela is thrown into 20 to 30 longitudinal folds. 
One of these ridges is a continuation of the ventral oesophageal groove 
and comprises ciliated mucous cells of the same type as the oesophageal 
mucous cells.
This raphe expands into a large bulb halfway down the length of 
the stomach and continues as the typhlosole in the intestine. The
remaining ridges (Fig 3:1) have a cap of mucous cells, contiguous with
those of the raphe, oesophagus and typhlosole, which contain scattered 
E-L cells (Bevis and Thorndyke, 1979; Pestarino, 1982),
Between the ridges are pseudostratified undifferentiated cells 
which are regions of intense cell proliferation (Ermak, 1975; Relini
Orsi, 1968; Thorndyke, 1977 ) giving rise to the cells of the side 
walls. These side wall cells are of two types. A vacuolated cell, 
characterised by a large number of apical vacuoles and a protein
secreting zymogen cell. The vacuolated cells are however more aumerous 
and undoubtedly have an absorptive function (Berrill, 1929; Burighel 
and Milanesi, 1973; Morton, 1960; Pestarino and Staffieri, 1980; Relini 
Orsi, 1968; Thomas, 1970; Thorndyke, 1977; Van Wpel, 1940) although 
Peres (1943) describing possibly corresponding cells in several species 
of Oikopleura has attributed a secretory function to them.
Experimental evidence of the correctness of the former view has
been provided in Styela clava by Thorndyke ( 1977) and in t_ry
schlosseri by Burighel (1979). They have demonstrated that, the 
absorptive cells of ^tyelj^ and Botryllus are capable of phag^^-ytosing
ferritin particles and horseradish peroxidase from the gut lumen.
The zymogen cells, with their presumed role of protein secretion 
are directly pertinent to the present study. Relini Orsi (1968) in her 
full description of the gut epithelium of Styela plicata. notes the 
presence of cells secreting protein granules containing tyrosine and 
tryptophan. She concludes that they probably synthesise digestive 
enzymes.
Thomas (1970) has described these cells in Ciona as 'gland 
cells'. From histochemical evidence he concludes that they produce a 
protein rich seromucous secretion and suggests that they are 
responsible for the production of the digestive enzymes described by 
Yonge (1925) and Van Weel (1940). Burighel and Milanesi (1973) have 
described corresponding cells from the gastric epithelium of Botryllus 
schlosseri, which they refer to as basophilic or zymogenic cells. They 
also consider them to play a fundamental role in the production of 
digestive enzymes.
Corresponding cells in Styela clava, have been described in the 
side walls of the gastric mucosa (Thorndyke, 1977). They open to both 
sides of the epithelium with a number of apical microvilli (Fig 
3:2a,b). Just below and often closely associated with the apical 
membrane, are secretory granules (Fig 3:2a). These cells also exhibit 
prominent rough endoplasmic reticula (RER) and Golgi complexes (Fig 
3:2c) which are comparable with the ultrastructural features of protein 
secreting cells (Barrowman, 1975) and in particular the vertebrate 
pancreatic acinar cell (Case, 1978; Hunger, 1973).
In vertebrates the pancreatic acinar cell produces a minimal 
output of secretory products under basal conditions but the release of 
zymogen granule contents is considerably elevated in response to food
njm
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Fig 3:2 Medium and high power electron photomicrographs, showing
zymogenic cells between the more numerous vacuolated cells
a) In the apical region the zymogenic cells can be seen 
to reach the lumen in a constricted region, packed with 
zymogenic granules, b) In the basal region, large 
quantities of rough endoplasmic reticulum are evident, 
in association with mitochondria. These are shown in 
detail in plate c.
L = lumen; n = nucleus; rr = RER; z = zymogenic cells; 
zg = zymogenic granules. (a, x 6000; b, x 8750; 
c, X 50,000)
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ingestion. This response depends on either acetylcholine (ACh) 
released at the postganglionic cholinergic nerve endings, or the 
presence of one or more of a considerable range of peptide hormones.
Since there is no evidence of any gut associated nerves in Styela 
(Pestarino, personal communication; Thorndyke, personal communication), 
and considerable evidence indicating the presence of peptide secreting 
E-L cells, it is possible that the zymogen cells might be controlled in 
a way which is analogous to the vertebrate system.
The vertebrate pancreatic acinar cell
The function of the pancreatic acinar cell is established as the 
site of synthesis and release of a wide variety of digestive enzymes 
including amylase, trypsin, chymotrypsin, lipase and ribonuclease 
(Desnuelle and Figarella, 1979; Kraehenbuhl et al, 1977). Those 
enzymes are packaged into the zymogen granules and are then secreted by 
exocytotic release of the granule contents (Case, 1978; Harper and 
Scratcherd, 1979; Palade, 1975).
Although the synthesis of these enzymes is a relatively continuous 
process, the secretion occurs episodically as a response to food 
ingestion. The enzyme secretion is under the control of hormones and 
neurotransmitters, notably CCK and ACh (Case, 1978; Webster et al, 
1977). After stimulation of receptor sites, events are Initiated 
within the cell which result in the controlled release of the zymogen 
granules from the apical portion of the cell.
Polypeptide hormones and cholinergic agonists, unlike lipid 
soluble steroid hormones, are unable to enter their target cell^ due to 
their size and ionic charge. Instead their effects are mediated 
through receptor sites located on the external cell mciriuinnes. These
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Cholinergic 
Agents
CCK Gastrin 
Caerulein
Bombesin
LItorin
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VIP PHI
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CYCLIC AMP
Fig 3:3 Guinea pig pancreatic acinar cells, showing classes of 
receptors and their mechanism of action. Membrane 
receptors are activated by various secretagogues to 
increase enzyme secretion by one of two routes. One route 
involves an increase in phosphatidylinositol (PI) turnover, 
followed by an increase in cytosolic ionised calcium: the
other involves adenylate cyclase activation, causing an 
increase in cyclic AMP. Although these two sequences are 
initially separate, they interact at an unknown point, 
following the mobilisation of calcium and the generation 
of cyclic AMP. Potentiation occurs when acinar cells 
are incubated with a combination of secretagogues which 
act by different routes. (After Gardner and Jensen, 1983a).
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receptors are able reversibly to bind the appropriate ligand, and this 
initiates the ultimate physiological response by their intermediate 
effect on some intracellular second messenger system such as
3',5'-cyclic monophosphate (c-AMP).
It has long been known that CCK and ACh operated on acinar cells 
through different receptors (Harper and MacKay, 1948), However Gardner 
and his co-workers using radiolabelled secretagogues and dispersed 
pancreatic acinar cells, have been able to define six functionally 
distinct classes of receptors which mediate the actions of a 
considerably larger number of different secretagogues on enzyme 
secretion (Gardner, 1979a; Gardner and Jensen, 1980; 1983a; 1983b) (Fig 
3:3).
These receptors are generally considered to operate via two
distinct second messenger systems. One mechanism involves the 
activation of adenylate cyclase and activation of c-AMP dependent 
protein kinase, the other mechanism involves the formation of inositol 
trisphosphate and diacylglycerol from polyphosphoinositide and the
subsequent increase of intracellular calcium ions.
a) c—AMP; The first group consists of receptors for cholera toxin 
(Gardner and Rottraan, 1979) and for the VIP/secretin/PHI/helodermin 
group of peptides (Christophe et al, 1976a; 1984; Gardner et al, 1979; 
Jensen et al, 1981b; 1983; Robberecht et al, 1976; 1984). This second 
set of receptors may be further subdivided into secretin— and VIP
preferring receptors.
The secretagogue action of Gila monster venom (Kaufman et al, 
1982) which is produced by the secretin-like peptide helodermin 
(Robberecht et al, 1984) is mediated through the secretin-preferring 
receptors. The structurally related peptide PHI, however, induces its
increased enzyme secretion by acting on the VlP-preferring receptors 
(Jensen et al, 1981a),
Occupation of the VIP-preferring receptors by VIP produces an 8- 
to 10-fold increase in intracellular c-AMP and a corresponding increase 
In enzyme secretion. Secretin also increases the c-AMP levels via the 
VIP-preferring receptors, although its effect is obscured by the larger 
increase caused by secretin acting on secretin-preferring receptors 
(Gardner et al, 1979).
Occupation of the secretin-preferring receptors causes an 80- to 
100-fold increase in c-AMP, it is not known what cellular function , if 
any, is effected by this change. Gardner has postulated that there is 
compartraentalisation of c-AMP and the increase produced by these 
receptors is not in the appropriate compartment to increase enzyme 
secretion. Alternatively he has postulated that some acinar cells 
possess secretin- but not VIP-preferring receptors and that in these 
cells an increase in c-AMP has no effect on enzyme secretion.
It should also be noted that the increased c-AMP caused by VIP and 
secretin does not increase enzyme secretion in all species. Robberecht 
et al (1977) have shown that although VIP and secretin increase c-AMP 
in fragments of mouse, dog, cat, rat and guinea pig pancreas, enzyme 
secretion is only potentiated in the guinea pig and rat pancreas.
b) Intracellular calcium: The second group of receptors involve the
increase of intracellular calcium ions. Four classes of receptor are 
known to belong to this group. The cholinergic receptors respond uo 
muscarinic cholinergic agents such as ACh and analogues (carbachol, 
bethanechol) and are specifically Inhibited by atropine (Singh and 
Webster, 1978).
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The CCK receptors are activated by CCK and its various active
fragments such as CCK-8, as well as other structurally related peptides 
such as caerulein and gastrin (Jensen et al, 1980; Sankaran et al,
1982; Schulz and Stolze, 1980). This effect can be specifically 
inhibited by butyryl derivatives of c-GMP (Peikin et al, 1979) and by 
proglumide and benzotript (Hahne et al, 1981).
The physalaemin receptors interact with the tachykinins such as 
physalaemin, kassinin, eledoisin and substance P (Bertaccini, 1980;
Jensen and Gardner, 1979).
The final class are bombesin receptors which respond to the
structurally related group of bombesin-like peptides, including 
alyte sin, ranatensin and litorin (Erspamer, 1980; Jensen et al, 1978a; 
1978b). These receptors respond in vivo to gastrin releasing peptide 
(GRP) (McDonald et al, 1979), the mammalian counterpart of these 
amphibian skin peptides. A substance P analogue, has recently been 
shown to be a bombesin receptor antagonist (Jensen et al, 1984).
Although these four classes of receptors are clearly very 
different they are all believed to bring about their actions as 
secretagogues by the same intracellular mechanisms.
The conformational changes in the receptor, brought aoout by its 
activation, cause an increased hydrolysis of certain phospholipids 
associated with the plasma membrane. The intracellular effects on 
calcium ion levels and protein kinase C, have been the recent subject 
of full reviews (Gardner and Jensen, 1983b; Nichizuka et al, 1984) and 
so will be only briefly described here.
Initially phosphatidylinositol (PI) was identified by Michell 
(1975) as having an important second messenger role, analogous to
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c-AMP, although more recently it has been suggested that 
polyphosphoinositides which differ from PI by having one (PIP or DPI) 
or two (PIP2 or TPI) additional phosphate groups on the inositol ring 
may play a more important role than PI (Marx, 1984),
PI is an acidic phospholipid, normally occurring as a minor 
membrane component on the inner leaflet of the plasma membrane. When 
the calcium ion-linked receptors are occupied, PI turnover is initiated 
by a number of different mechanisms. This turnover is not simply PI 
hydrolysis but includes increases in synthesis and degradation by a 
number of mechanisms which have been reviewed by Farese (1933),
This stimulation of PI turnover causes an increase in the ionised 
calcium concentration of the cytosol compartment of the cell. Evidence 
that the PI effect precedes the calcium mobilisation is given by the 
observation that the antibiotic and calcium ionophore A-23187 can mimic 
the action of the calcium ion-linked secretagogues, without stimulating 
PI turnover (Calderon et al, 1980).
It has been suggested that the breakdown product, inositol
1.2-cyclic phosphate is directly responsible for this calcium 
mobilisation (Marx, 1984). The other PI metabolite,
1.2-diacyIglycerol, appears to facilitate the activation by ionised 
calcium of a cyclic nucleotide—independent protein kinase (Kishimoto et 
al, 1980).
The net calcium ion fluxes are biphasic. The initial requirements 
are met from calcium ion reserves associated with the plasma membranes 
and with intracellular organelles. However prolonged stimulation 
causes a secondary calcium ion influx which is probably due to an 
increased calcium ion permeability of the membrane and/or an increase 
in calcium-ion pump activity (Schulz, 1980; Schulz and ocolze, 1980).
en
The role of c-GMP Is unclear, although pancreatic secretagogues 
which increase cellular calcium also increase c-GMP (Webster et al, 
1977; Williams, 1980). The increase in intracellular calcium appears 
to be directly reponsible for the rise in intracellular c-GMP
(Christophe, 1976b), presumably mediated by stimulation of guanylate 
cyclase production (Schultz et al, 1973). It is possible that this 
c-GMP causes activation of c-GMP dependent protein kinases (Jensen and 
Gardner, 1978), and thus has some effect on enzyme secretion. Gardner 
and Jensen (1983b) do however point out that although CCK increases 
c-GMP, calcium outflux and enzyme secretion, sodium nitroprussl.de, 
whilst causing a 70-fold increase in c-GMP, does not increase calcium 
outflux or enzyme secretion. It is therefore most unlikely that 
endogenous c-GMP has a direct effect on enzyme secretion, and most
investigators have found that exogenous c-GMP derivatives also do not 
increase enzyme secretion(Heisler and Grondin, 1975). The fact that 
some have (Gardner and Jackson, 1977; Haymovits and Scheele, 1976) may 
be explained by their ability to inhibit cyclic nucleotide 
phosphodiesterase, with a resultant increase in cellular c-AMP and 
enzyme secretion (Gardner, 1979a).
The full list of causal relationships between all these observed 
events and the ultimate zymogen granule release is far from clear. 
Although release of cellular calcium increases c-GMP, it may be the
change in calcium, not the cyclic nucleotide that is ultimately
responsible for initiating the increased enzyme secretion.
Although the two receptor-initiated pathways for enzyme secretion 
stimulation are initially separate there is some convergence, after the 
stage of cyclic nucleotide production, as potentiation of enzyme 
secretion can occur between secretagogues which act through the 
different second messenger systems (Gardner and Jackson, 1977).
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mechanism by which this potentiation occurs however is not clear.
The situation in the postulated acinar cell homologue in Styela, 
the gastric zymogen cell, may perhaps be broadly similar, from the 
point of view of receptors, and/or second messenger systems. Quite 
possibly the best way for testing this hypothesis would be to use a 
forward, or direct approach, by measuring the binding of radiolabelled 
hormones to the putative receptor sites on the epithelial cell membrane 
(Gardner, 1979b). This type of approach however requires the 
production of radiolabelled hormones with high specific levels of 
radioactivity, and appropriate detection equipment.
A second problem with this type of approach, particularly so for 
the inexperienced investigator, is the ease with which false positive 
results can be obtained. Binding can take place that is not relevant 
to the cell being studied, or to a portion of the molecule other than 
the active site, which does not cause receptor activation.
The alternative ’backward' or 'indirect' approach, where the gross 
biological effect is observed seems to have distinct advantages, from 
the point of both technical simplicity as well as ease of 
interpretation. It was therefore decided to develop a gastric 
perfusion system using Styela in order to test the effect of a range of 
peptide hormone secretagogues, with particular reference to secretin, 
in order to examine their effect on gastric enzyme secretion.
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MATERIALS AND METHODS
a) Animals: Specimens of Styela clava were collected in the Portsmouth 
area and transported to London in aerated seawater. The animals were 
cleaned in running seawater to remove the considerable quantities of 
detritus and commensals which were attached to the test and transferred 
to a circulating seawater aquarium maintained at 10°C to 14°C. Most 
animals adapted well to these conditions and the small percentage of
moribund animals were readily identified by their flaccidity and closed
siphons. Also dead animals floated to the surface and could be
removed. Death normally ensued when the narrow process which connects 
the body to the holdfast was damaged during collection. Only animals 
which were healthy, turgid and actively siphoning a week after 
collection were used in experiments.
b) Hormones and reagents: Synthetic, non-sulphated CCK-8 and secretin 
were purchased from Peninsula Laboratories Inc, California and 
technical grade CCK was purchased from Sigma (London). Sincalide
(Kinevac, synthetic sulphated CCK-8) was the gift of Squibb Europe Ltd, 
Middlesex. Synthetic bombesin, caerulein (ceruletide) and physalaemin 
were the gifts of Farmitalia Carlo Erba, Milan. Pure natural porcine 
CCK—33 was the generous gift of Prof V Mutt. Dibutyry 1-guanosine
3':5'—cyclic monophosphate (Bt2c—CMP), bovine albumin (fraction V) and 
bovine/porcine glucagon were purchased from Sigma (London).
' Synthetics artificial seawater was purchased from Waterlife 
Research Industries Ltd, Longford, Middlesex.
Perfusion technique
a) Anatomy: The result of injections of latex and Bateson s 
Anatomical Corrosion Compound' have confirmed Chat the circulatory
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system of Styela clava in the region of the gut is essentially the same 
as that found in other ascidians (Alder and Hancock, 1905; Brien, 1948; 
Herdman, 1904; Millar, 1953),
The blood vessels themselves are simply channels within the 
connective tissue. Only close to the heart are they lined with 
endothelial cells where the large vessels which connect with it are 
lined with a loose cellular reticulum. The smaller lacunae ramify and 
anastomose, making an extensive capillary re te.
The most noticeable feature of the circulatory system is the 
heart, a simple 'V shaped tube lying on the ventral and posterior edge 
of the stomach, projecting into the pericardium. The wall of the heart 
is in fact continuous, along one edge, with the pericardium and can be 
regarded as a tubular invagination of the pericardial wall. The open 
ends communicate with the large blood sinuses which lead to the 
branchial sac, viscera, body wall and test.
The cavity of the heart is undivided and has no valves. The wall 
is formed of a single layer of epithelio-muscular cells with 
cross—sttiated fibres which run around the heart. Waves of contraction 
pass along the heart, propelling the blood in the same direction. 
These peristaltic contractions are periodically reversed, thereby 
reversing the blood flow. This interesting phenomenon has recently 
been reviewed by Goodbody (1974).
The antero—ventral end of the heart (pharyngeal) gives rise to the 
ventral vessel which accompanies the endostyle and connects with the 
transverse bars of the pharynx. The other end (visceral) of the heart 
connects to a vessel which lies on the right wall of the stomach, the 
cardio-stomachic vessel (CSV). This vessel soon bifurcates to form an 
anterior and posterior CSV. The posterior branch supplies the network
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of vessels which overlie the intestine.
Both vessels divide to form a dense network of small vessels,
which ultimately supply an elaborate rete under the gastric ridges (Fig 
3:1). Thus on anatomical grounds the large cardio—stomachic vessel 
would appear to be the best site for the injection of a test substance
in order for it rapidly to reach the gastric epithelium.
Unfortunately the wall of this vessel, despite being the strongest
in the animal was not sufficiently elastic to seal around the tip of a
syringe needle (30 gauge, stainless steel) and consequently
considerable loss of blood occurred.
Trials using glass micropipettes drawn on a Narishige 
microelectrode puller proved that although extremely fine pipettes 
could be produced, they had insufficient mechanical strength to 
penetrate the wall of the CSV. When occasional insertion was
accomplished (using a Leitz micromanipulator), the tip was normally 
occluded by cellular debris and injection was not possible.
It was therefore decided that a polyethylene cannula would have to 
be tied in place with ligatures. This would have the unfortunate 
effect of stopping the circulation and thus, in order to ensure that 
material from this injection reached the gastric epithelium, a
comparatively large quantity of fluid would have to be given. From 
trials using Bateson's resin this quantity was determined as 200 j i l .  
The injection also caused displacement of the blood in the stomachic 
vessels and therefore injections were given in a tunicate Ringer 
(appendix 1) to minimise the stress which this might induce.
b) Surgical techniques (Fig 3:4): A left ventral incision was made
extending the length of the body cavity, passing through all the layers
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of vessels which overlie the intestine.
Both vessels divide to form a dense network, of small vessels, 
which ultimately supply an elaborate rete under the gastric ridges (Fig 
3:1). Thus on anatomical grounds the large cardio-stomachic vessel 
would appear to be the best site for the injection of a test substance
in order for it rapidly to reach the gastric epithelium.
Unfortunately the wall of this vessel, despite being the strongest 
in the animal was not sufficiently elastic to seal around the tip of a 
syringe needle (30 gauge, stainless steel) and consequently 
considerable loss of blood occurred.
Trials using glass micropipettes drawn on a Narishige 
microelectrode puller proved that although extremely fine pipettes 
could be produced, they had insufficient mechanical strength to 
penetrate the wall of the CSV. When occasional insertion was
accomplished (using a Leitz micromanipulator), the tip was normally 
occluded by cellular debris and injection was not possible.
It was therefore decided that a polyethylene cannula would have to 
be tied in place with ligatures. This would have the unfortunate 
effect of stopping the circulation and thus, in order to ensure that 
material from this injection reached the gastric epithelium, a
comparatively large quantity of fluid would have to be given. From 
trials using Bateson's resin this quantity was determined as 200 j i l .
The injection also caused displacement of the blood in the stomachic 
vessels and therefore injections were given in a tunicate Ringer 
(appendix 1) to minimise the stress which this might induce.
b) Surgical techniques (Fig 3:4): A left ventral incision was made
extending the length of the body cavity, passing through all the layers
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Fig 3:4 The Styela perfusion system. A specimen of Styela clava 
is shown, opened by a ventral incision, exposing the gut, 
A small polyethylene tube is shown inserted into the 
stomach through a small incision in the oesophagus. A 
larger tube is shown passing into the intestinal end.
The stomach is perfused by pumping artificial seawater, 
at 28 pl/min, into the smaller tube. After passing 
through the stomach it drains out of the large tube, 
to be collected prior to analysis. A short polyethylene 
tube is shown tied into the CSV through which test 
materials may be infused into the blood vascular system. 
The system is shown both diagramatically (a) and photo­
graphically (b). In (b) a small volume of haemoglobin 
has been injected into the CSV to make the major gastric 
vessels stand out clearly. CSV = cardio-stomachic 
vessel; ST = stomach.
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of the test and body wall, so as to expose the gut. A polyethylene 
tube (Portex 100) was inserted into the proximal end of the stomach
through a small Incision in the distal end of the oesophagus and
secured with a suture. A large tube (Portex 300) was then inserted 
through a shallow incision on the outer side of the intestinal loop, 
passing into the distal end of the stomach, and secured by a ligature 
at the proximal end of the intestine. To prevent the end of this tube 
from becoming occluded by the gastric epithelium a hole was cut in the 
side wall of the tube about 5 mm from the proximal end. The animal was 
then transferred to a small perspex dish through which was passed
aerated seawater at 12“C. Using the cannulae, and a 5 ml syringe, the 
stomach was flushed with 5 ml of filtered seawater to remove any solid 
gastric contents and then using a binocular microscope the CSV was
located and loosely ligated at both ends of the vessel. A small
incision was made between the ligatures and a short polyethylene tube
(Portex 100) which had been drawn slightly to reduce the outside
diameter at one end to 0,2 - 0.3 mm, was filled with tunicate Ringer
(internal volume <10 jul) and inserted within the circumference of the
stomachic ligature with the aid of a micromanipulator. Both ligatures 
were then tightened, the stomachic one to tie in the tube and the
cardiac one to prevent undue blood loss from the heart.
With practice this procedure took less than 10 min, occasional
failures being caused by rupture of the vein during cannula insertion
or puncture of the gastric epithelium by the cannula tip.
Experimental procedure
The preparation was maintained in a circulating seawater system at 
12°C. Artificial seawater (Synthetica) from a storage tank was passed 
through a heat exchanger in a tank of coolant maintained at 10 L, into
1 JO
the dish containing the animal. Surplus water overflowed from this 
dish, was collected and pumped back to the storage tank. This 
maintained the water which surrounded the preparation at 12“C (±. l ° c ) .
The stomach was perfused with freshly prepared artificial 
seawater, prefiltered through Wliatman GF/B paper, through the 
oesophageal cannula, using a Watson-Marlow pump (MHRK-1), at a flow 
rate of 28 ^1/min. The perfusate was collected in the wells of a 
microtitre plate, the cannula being transferred to a fresh well at 10 
min intervals.
After six samples had been collected 200 j i l of the tunicate 
Ringer, containing the test material, was infused through the CSV 
cannula over a 15 second period.
Samples were taken over a 2 hr period, the infusion being given 
after 1 hr. At the end of this period, protein and acid phosphatase 
levels in each sample were determined. At the end of each experiment, 
200 jil of filtered, aqueous, methylene blue was injected into the CSV 
cannula to confirm its accurate placement, and also that no rupture of 
the delicate vessels had been caused by the original infusion.
a) Chemical assays; Perfusate protein levels were taken as an index of 
enzyme output and were measured using 200 ^1 of the seawater perfusate 
by the method of Lowry et al (1951). This is potentially 10 to 20 
times more sensitive than simply measuring the absorbance at 280 nm, 
more specific and less likely to be influenced by turbidity.
Proteins present in the sample react, after alkaline copper 
treatment, with Folin phenol reagent, to form a compound which absorbs 
blue light with a maximum at about 750 nm. This colour may not be 
strictly proportional to concentration but as values were determined
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only within the range of a standard curve, this was not considered 
significant.
It was found however that the addition of Folin-Ciocalteu reagent 
(Sigma, London) caused the appearance of a white crystalline 
precipitate which interfered with the absorbance measurements. 
Spinning the tubes in a bench centrifuge for the 30 mins development 
period, however, caused the precipitate to be compacted and a reliable 
absorbance value of this supernatant could then be determined. This 
variation of Lowry's (1951) method gave a very reproducible standard 
curve with values slightly lower than those obtained from protein 
solutions in distilled water.
Acid phosphatase levels were determined using a colourimetric 
method with materials supplied by Boehringer Mannheim GmbH, West 
Germany.
b) Administration of test substances; The weights of individual animals 
were badly reproducible when repeatedly weighed, as a significant but 
variable quantity of seawater is retained within the pharynx. A high 
percentage of the weight of these animals comprised seawater and the 
keratinous tunic, which was often covered with common fouling 
organisms. The wet weight of these animals was therefore felt to be an 
unreliable index for calculating the dose for each animal. Animals 
were therefore chosen which appeared to be of approximately equal 
size. Dry weights of most of the animals were determined after use and 
found to lie within the range 0.51 - 1.22 g.
Test materials were dissolved immediately before use in sterile 
filtered (millipore GS, 0.22 mean pore size) tunicate Ringer (NaCl,
25.9 g/litre; KCl, 0.75 g/litre; CaC12, 1.05 g/litre; MgC12, 5.295 
g/litre; Na2S04, 1.63 g/litre; NaHC03, 0.06 g/litre; glucose, 1.0
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TABLE 8
TABLE OF TEST SUBSTANCES AND DOSES GIVEN
Test
Material
No. of determinations at each dose
0.1 pg 1,0 pg 10 pg 100 pg 200 pg
Bombesin 
Caeru J e in
CCK-8 (non-sulphated)
CCK-8 (Sincalide)
CCK-8 (Sincalide)
+ 5 mM Bt2 C-CMP
CCK-33
CCK-33
+5 mM Bt^c-GMP 
Glucagon 
Physalaemin 
Secretin
Technical grade 
CCK (Sigma)
0.1mg(4) 0.2mg(5) 0.4mg(4) 1.0mg(5)
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g/litre), prepared from figures produced by Robertson (1954).
c) Statistical analysis. Differences between means were considered to 
be significant if, using Student's t-test, p < 0.05. Values are given 
as mean +. standard deviation (a n-1) as determined using a Casio FX-501 
P programming calculator.
RESULTS
The levels of protein and acid phosphatase which were determined
for each experiment are tabulated in appendix 3.
Effect of gut perfusion
If samples were taken of the fluid normally contained by the gut, 
it was found to contain high levels of both protein and acid 
phosphatase. Even after flushing the gut through with seawater, levels 
were still detectable and experiments were initially performed to 
determine whether a basal level could be achieved. Fig 3:5 records the 
effect of perfusing with artificial seawater, a preparation in which 
the CSV had not been cannulated.
During the first 60 mins, protein levels fell from 10.1 + 1.5 
mg/dl to 2.6 ±  1.5 mg/dl. The levels then remained relatively stable 
over the subsequent 60 min period.
Acid phosphatase levels showed a similar response. Levels
recorded in the perfusate fell from 1.98 + 0.52 U/1 to 0.30 +. 0.12 U/1
over the initial 60 min period. The levels did not rise significantly 
above this value over the subsequent 60 mins.
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Fig 3:5 Effect of seawater perfusion on protein and acid
phosphatase levels in the perfusate over a 120 min period. 
Mean ± SD, n = 5. Stomachs were preflushed with 5 ml 
seawater, then perfused at 28 pl/min. During the first 
60 mins, levels of protein and acid phosphatase fell 
sharply, followed by relatively stable levels over the 
subsequent 60 rains.
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Fig 3:6 Effect of cannulation and subsequent infusion of Ringer
on levels of perfusate protein and acid phosphatase. Mean 
± SD. The response is not significantly different from 
that produced by perfusion alone.
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Fig 3:7 Effect of Sigma CCK (infused at 0 min) on protein and
add phosphatase levels in the perfusate over the subsequent 
60 min. Mean ± SD, Infusions of 0, 0.1 mg (n = 4), ® ,
0.2 mg (n = 5), a, 0.4 mg (n = 4), and 9, 1.0 mg (n = 5)
CCK all produced levels of protein and phosphatase during 
the subsequent 60 min which were significantly higher than 
control infusions (•, n = 6).
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Effect of infusion
The effect of cannulation and subsequent infusion of 200 of the 
tunicate Ringer into an animal being perfused as before is shown in Fig 
3:6. During the first 60 mins protein levels fell from 9.9 + 2.1 rag/dl 
to 2.2 1»1 mg/dl. After the Infusion of 200 ^1 of Ringer, protein
levels were not elevated and indeed continued to fall slightly, over 
the subsequent 60 mins.
Acid phosphatase levels also fell, from 1.68 _+ 0.26 U/1 to 0.28 + 
0.08 U/1 over the first 60 mins. Following the Ringer infusion they 
showed no elevation and remained fairly constant over the subsequent 60 
min period.
The effect of cannulation of the CSV and infusion of 200 jjlI of 
vehicle Ringer did not therefore appear to have any effect on the 
secretion of gastric enzymes.
Effect of CCKs and secretin on perfusate protein and acid phosphatase
Infusion of Sigma CCK at all doses between 100 jig and 1,000 jig 
produced significant elevations of both protein and acid phosphatase 
(Fig 3:7). Maximum levels of protein varied from 5.4 _+ 1.5 mg/dl, 20 
mins after infusing 100 yig, to 42.3 _+ 9.6 mg/dl, 20 mins after infusing
1.000 ^g.
Maximum acid phosphatase levels ranged from 0.53 + 0.1 j i/ ly 10 
rains after infusing 100 ug to 3.85 ±  1.92 jj/1, 20 mins after infusing
1.000 jug.
Recovery to normal basal levels occurred within 60 rains of 
infusing 100, 200 and 400 jig doses, but 1,000 jig of Sigma CCK produced 
significantly elevated levels of both protein and acid phosphatase
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Fig 3:8 Effect on gastric production of protein and acid phospha­
tase of infusion of Sigma CCK (0,1 - 1.0 mg). Response 
to each dose is estimated by calculating the total amount 
of protein and acid phosphatase produced during the 60 
min post-infusion period. Mean ± SD. (No. of animals in 
parentheses). In both instances an approximately linear 
relationship between log dose and response exists.
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Fig 3:9 Effect of a 100 jig dose of non-sulphated CCK-8 on
perfusate protein and acid phosphatase levels. Mean 
± SD, n = 5.
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Fig 3:10 Effect of three doses of sulphated CCK-8 on perfusate 
protein levels. Infusions of 10 pg (8, n = 3), 100 pg 
(i, n = 3) and 200 pg (0, n = 8) CCK-8 all produced 
significant elevations in perfusate protein levels. 
Mean ± SD.
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Fig 3:11 Comparative effects of 100 pg of sulphated (f, n = 3) 
and non—sulphated (0, n = 3) CCK-8. No significant 
difference in response was observed. Mean ± SD.
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Fig 3:12 Effect of CCK-33 on perfusate protein levels. Infusions 
of 100 pg (0, n = 5) and 10 pg (•, n = 4) both produced 
significant elevations in perfusate protein levels.
Mean ± SD.
I ;'l
throughout the entire GO min post-infusIon sampling period.
An approximately linear relationship (over the range studied) was
observed between the dose oE Sigma CCK given and the resultant total 
output of both protein and acid phosphatase (Fig 3:8). This total
output was estimated by calulating the amount of protein or acid 
phosphatase present in all the samples collected during the min
post-infusion period.
Non-sulphated CCK-8 also caused an elevation of protein and acid
_  C V
phosphatase levels (Fig 3:9). A 100 jjg ( 9 . 4 1 x ] (j '«oiejdose produced a 
maximum level of protein ( 19.8 8.7 mg/dl) and acid phosphatase f'4.9 ±
2.4 0/1) within 10 mins of its infusion.
Following infusion with sulphated CCK-8, a considerablv larger 
response was observed after a 200 j_ig (1 .75xlC ) infusion, than a 100
-  Q _Q
jig(S.76x10 "role. ^  or 10 pg (8.76x10' «us j infusion (Fig 3:10). Wher.^ns a 
- 910 pg (8.76x10 y nf us ion produced a maximum response of 7.4 ^  4.7
mg/dl after 10 mins, a 200 j.ig ( 1 . 7 5 1 C ) inf vis ion produced a max i mum
protein output of 23.9 +_ 10.4 mg/dl after 10 mins.
Similar 100 pg (S .7 6-9 .4 Ixio"!,,,) infusions of the sulphated and
non-sulphated CCK-8s evoked indistinguishable responses (Fig
—8
Whereas infusing 100 pg (9.41x10 of the non-sulphated form was
shown Co cause a maximal level of 19.8  ^  ^ rag/dl after 10 mins,
falling to 3.0 +_ 1.9 rag/dl 30 rains later, an infusion of the same
amount of sulphated CCK-8 caused a maximal level of 18.9 6.3 mg/dl
after 10 mins, falling to 2.4 +_ 0.6 rag/dl after 30 rains.
The larger molecular forra, CCK-33, proved to be considerably more 
potent, particularly when compared on a molar basis (Fig 3.12). A 100 
jigl (2.55xl0”®„„,,..) dose of CCK-33, which in molar terms is only about a
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Fig 3:13 Effect of secretin (100 ;jg) on perfusate protein and 
acid phosphatase levels. Secretin did not cause any 
significant elevation in either parameter following its 
infusion. Mean ± SD, n = 4.
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Fig 3:14 Effect of 5 mM Bt2 ^”GMP on the response produced by
infusion of 10 ug of CCK-33. Infusion of CCK-33 alone 
(•, n = 4) produced a significantly larger response 
than the infusion of 10 pg CCK plus 5 mM Bt2C-GMP 
(0, n = 3). Mean ± SD.
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Fig 3:15 Effect of 5 mM Bt2 C-GMP on the response produced by 
infusion of 100 jjg CCK-8 (sulphated). Infusion of 
sulphated CCK-8 alone (0, n = 3) produced a signifi­
cantly larger response than the infusion of 100 pg 
sulphated CCK-8 plus 5 mM Bt2 C-GMP (t, n = 4).
Mean ± SD.
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Fig 3:16 Effect of bombegin 6-14 nonapeptide on perfusate
protein levels following infusion of 0.1 pg (9, n = 2), 
1.0 pg (0, n = 3) and 10 pg (•, n = 4). All doses 
increased perfusate protein levels. Mean ± SD.
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ijuarierof the 100ug(8./6 9.41x10 ^leJcCK-S doses (Fig 3:11), produced a
far greater response than that which was observed with the octapeptLde
-- -9
forms. A dose of 1(3 (2.55x10 ) produced a maximal response of
13.9 4.0 mg/dl after 10 mins, similar to the effect of 100 (3.7bx
10 1,„ )of CCK-8
The infusion of 100 ^g (3.27x10 ) of secretin (Fig 3:13)
produced no significant elevation of either protein or acid phosphatase 
levels. The response following secretin infusion was not significantly 
different to the infusion of vehicle Ringer alone (Fig 3:6).
Effect of Bt2c-CMP on the response to CCK
The addition of 5 mM of Bt2c-GMP to each dose of peptide had a 
significant influence on the response produced by infusion of r,(3K-H and 
CCK-33 alone. Repeated infusions of 200 ul of ringer containing only 5 
mM of Bt2c-GMP produced no significant response.
-9Wliereas 10 |ig (2.55x10 ,^.= )of CCK-33 caused a maximum perfusate
protein level of 13.9 +. 4.0 mg/dl, the same dose with 5 mM Bt2c-GMP 
added produced .i maximum level of only b.i mg/dl iFig 3:1-4).
Similarly a 100 ^g (3.76x10"^^^^|dose of sulphated CCK-8 produced 
a maximum response of 18.9 b. 3 mg/dl, but if infused with 5 mM 
Bt2c-GMP this response was almost halved, the maximum level of 
perfusate protein being 11.0 2.9 mg/dl (Fig 3:15).
Effect of bombesin
Bombesin 6-14 nonapeptide was the ‘ most potent secretagogue 
tested. Doses of 0.5, 5.0 and 10 pg (9.33x10"''\  9.33x10 and 9.33%
10 -9 produced maximum levels 10 rains post—infusion, of 6.1, 14,9
4.6 and 24.4 + 8.7 mg/d 1 respectively (Fig 3:16). The time course of
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Fig 3:17 Effect of an infusion of 100 jjg of caerulein on
perfusate protein levels. Caerulein produced a small 
but significant elevation of perfusate protein lev :s. 
Mean ± SD, n = 3.
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l’ig 3; 18 LI feet of an infusion of 1.Ü0 of physalaemin on 
perfusate protein levels. Physalaemin produced a 
significant elevation of perfusate protein levels 
Mean ± SD, n =4.
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the response was superficially identical to that observed following CCK 
infusion (ie Fig 3:10) but the potency of the peptide was about an 
order of magnitude greater.
Effect of caerulein
~8
A 100 jjg (7.40x10 moles dose of caerulein produced a small but 
highly significant response (Fig 3:17). The maximum response was 
measured 10 mins post-infusion (8.1 _a_ 3.7 mg/dl) and the level was 
still significantly elevated during the subsequent 10 minute period 
(5.5 2  1.1 mg/dl).
Effect of physalaemin
Physalaemin ivas observed to have a similar potency to caerulein 
(Fig 3:18). A dose of 100 pg (7 .9 0 xl0 "/n^cs elicited a significant 
response with a maximum level being recorded 10 mins post-infusion, of 
13.3 _+ 9.0 mg/dl.
Effect of glucagon
Glucagon, like secretin (Fig 3:13), produced uo significant effect 
on perfusate protein levels. Mean perfusate levels remained 
substantially unaltered by a 100 jig ( 2.82x10 “moles infusion of g lue agon, 
the pre—perfusion protein levels being 1.6 _+ 0.6 mg/dl, and those 10 
mins post-perfusion being 1.8 0.8 mg/dl.
DISCUSSION
The results presented in this chapter indicate that a number of 
regulatory peptides stimulate the release of a proteinaceous secretion 
into the gastric lumen of Styela clava. In the experiments where it 
was measured, acid phosphatase showed a simultaneous and parallel
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elevation, which confirms that this material may be enzymatic in 
nature. Subsequent attempts to further identify the nature of the 
secretion by attempting to measure amylase and protease activity in the 
perfusate were unsuccessful and so this may indicate their absence. In 
this context it is perhaps significant that Thomas (1970) was unable to 
demonstrate the presence of either protease or lipase activity by 
histological methods in zymogen granules in the gut of Ciona. For the 
sake of simplicity this material, detectable by the Lowry method will 
be considered to be the product of the zymogenic protein secreting 
cells, as there appears to be no other histological cell type capable 
of releasing a proteinaceous secretion (see chapter 1). It is hard to 
imagine that this material should turn out not to be involved in 
extracellular digestion, but it is readily conceded that the material 
has not been adequately defined. As has been noted, extracts of the 
ascidian gut have been found to contain many enzymes and it seems 
inconceivable that in future studies the proteinaceous perfusate, 
induced by the secretagogues mentioned in this chapter, wi 11 not be 
shown to contain enzymes in addition to acid phosphatase.
Acid phosphatase was measured in initial studies because of its 
presence in both vertebrate pancreatic acinar cells (Hunger, 1973; 
Wachstein and Meisel, 1959) in the 'pancreatic' protein synthesising 
cells of the digestive caecum of Branchiostoma (Welsch, 1975 ; Welsch 
and Storch, 1969) and in the zymogen cells of Styela (Relini Orsi, 
1968) where it is located in the apical cytoplasm at the site of 
zymogen granule release. It was therefore felt that its presence might 
be taken as indicative of zymogen granule release. The assay was 
available in kit form and was thus simple to use but having established 
that it was detectable in parallel with the Lowry protein, the 
considerable cost of performing this test meant that in later
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experiments it was not determined.
From the results obtained in this study it is clear that whilst 
all the secretagogues which effect PI, intracellular calcium and c-GMP 
in the vertebrate pancreatic acinar cell, increase the levels of 
perfusate protein, glucagon and porcine secretin have no effect. Given 
that secretin-like immunofluorescence is readily identifiable in Styela 
gastric epithelium, whereas CCK-like immunofluorescence was not 
observable, this observation was unexpected.
Although much of the work on pancreatic acinar cell receptors has 
been perfomed in the guinea pig, there is evidence that these cells are 
atypical, in having well developed receptors to VIP/secretin, which have 
no secretagogue action in many other vertebrate species. In vivo, in 
most mammalian species tested, secretin has a purely hydrelatic action, 
with no concomitant ecbolic effect (see Introduction, chapter 2) and it 
is therefore reasonable to _suppose that in these other species the 
pancreatic acinar cells do not possess secretin receptors. It is 
however probable that the c—AMP dependent second messenger system is 
still operative, as c-AMP and its derivatives have a secretagogue 
action in these cells in the rabbit (Ridderstap and Bonting, 1969) and 
mouse (Kulka and Sternlicht, 1968).
Grossman and Ivy (1946) first suggested that secretin acted on the 
duct cells of the exocrine pancreas, whilst CCK acted on the acinar
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cells. Despite the small amount of overlap that exists, this basic 
premise still appears to be substantially correct. This premise has 
received considerable support from the micropuncture studies by Schulz 
et al (1969), where they measured the composition of samples of 
pancreatic juice following administration of CCK and secretin.
It is also attractive to speculate that perhaps the c-AMP second 
messenger system is not present in these ascidian pre—pancreatic 
zymogen cells, although it must be stressed that the nature of the 
second messenger has not been directly examined. The effect of 
secretin and also VIP and glucagon, on enzyme secretion in the pacific 
hagfish (Eptatretus stouti) has been tested. Hagfish, like Styela, has 
a number of zymogen cells homologous with pancreatic acinar cells 
distributed through the intestinal epithelium (Barrington, 1972).
Whilst CCK-33 stimulates lipase secretion, secretin, VIP and glucagon 
have no effect (Vigna & Gorbman, 1979). This is entirely consistent 
with the current observations in Styela.
If the secretin-like immunofluoresence indicates a secretin-like
peptide product, which is not involved in enzyme secretion, then the 
question of its role remains unanswered. Recently extracts of Styela 
have been prepared at the Karolinska Institute and in London, in 
collaboration with Prof Mutt, which have a secretin-lixe action in cat 
and rat bioassays (Thorndyke and Bevis, 1983). The speculative 
suggestion has been made that the action of this peptide in the 
ascidian is on mucous cell secretion (Thorndyke and Bevis, 1984). This 
hypothesis is attractive, due to the physical presence of the secretin 
containing cells scattered amongst the ciliated mucous cells in the 
mucous caps (Thorndyke, 1977), in an ideal position to control their
output by a paracrine mechanism. Also, although secretin was
originally thought only to stimulate pancreatic secretion and hepatic
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bile secretion (Bayliss and Starling, 1902a) the list o£ its actions 
has grown considerably over the years and it has now been shown to play 
a role in the stimulation of gastric mucus secretion (Andre et al, 
1972; Kaura et al, 1980; Kowalewski et al, 1978; Vagne et al, 1982). 
The majority of assays performed were however on the CCK group of 
peptides and the results here were unexpected.
Studies of CCK analogues have made considerable reference to the 
importance of the sulphation of the tyrosine residue at position 7 from 
the C terminus for full potency (Chowdhury et al, 1976; Jensen et al, 
1980; Kaminski et al, 1977; Ondetti et al, 1970b). Desulphation or
translocation from position 7 to 6, as in gastrin, considerably reduces 
the activity both for gall bladder contraction and in the acinar cell 
system (Gardner and Jensen, 1983b).
It has however been suggested that the cholecystokinetic action of 
CCK is more reliant on the sulphation of the tyrosine than is the 
pancreozyminic activity (Mutt, 1982a). This claim is supported by the
comparative study carried out by Dockray (1973) in which CCK-8 was
about 4000 times more potent than pentagastrin as a stimulant of
pancreatic fluid secretion but only 2,500 times more potent than 
pentagastrin as a stimulant of protein secretion. This situation also 
occurs in the case of caerulein, where sulphation is less important for 
the pancreozyminic than the cholecystokinetic activity (Johnson et al,
1970). . It is arguable that this reflects the situation in Styela where 
it appears that sulphation of the tyrosine is unnecessary.
If this were the case then one might expect that the situation in 
lower vertebrates might reflect an intermediate situation. This does 
not seem to be the case with regard to studies on the cholecystokinetic 
action. Vigna and Gorbman (1977) have shown that in the coho salmon
i b i
(Oncorhyncbns ki.qiitch) sulphated gastrin and CCK are roughly equipotent 
in causing in vitro gall bladder contraction but their unsulphated 
counterparts are about 1000 times less active.
Unfortunately no studies have been performed on the effect of 
sulphation of the tyrosine on CCK/caerulein/gastrin mediated enzyme 
secretion in the gut or pancreatic homologues. Vigna and Gorbman 
(1979) have studied the effects of glucagon, VIP, secretin and CCK-33 
on gut enzyme (lipase) secretion from the primitive pre—pancreatic 
zymogen cells in the intestine of the pacific hagfish, Eptatretus 
stouti. In the same study they also tested the effect of gastrins-17-I 
and II (G-17 non-sulphated and G-17 sulphated) on gall bladder 
contraction, neither of them (nor CCK) being active. However they did 
not examine their effect on lipase secretion. Thus the question of 
whether or not other primitive pre-pancreatic systems are able to 
distinguish between sulphated and non-sulphated forms apparently 
remains unresolved.
Another unexpected finding was that CCK-8 is not more potent than 
CCK-33 in the Styela perfusion system. Following the original 
isolation of CCK, the octapeptide was reported to be about 2.5 times 
more potent on a molar basis than CCK-33 (Jorpes, 1968; Ondetti et al, 
1970; Rubin et al, 1969).
Evidence recently presented by Lamers et al (1983) and Solomon et 
al (1984) suggests that these early results were misleading, because of 
the differential adsorption of the peptides to glass and plastic, a 
problem which was not then recognised. Lamers et al find that CCK-8 
and CCK—33 are equipotent on a molar basis, which supports an earlier 
observation by Jensen et al (1981) that shows CCK-8, CCK-33 and CCK—39 
to be equipotent in their ability to stimulate enzyme secretion from
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the isolated porcine pancreas.
The response to the two CCK variants in Styela is however not 
equal in molar terms, but the larger form, CCK-33, is between 4 and 40 
times more potent. This would seem to be indicative of a fundamental 
requirement of more than the octapeptide sequence for full activity.
Straus et al (1978) have described an enzyme from porcine and 
canine brain with trypsin-like properties (ie cleavage of lysyl and 
arginyl peptide bonds) which appears to form CCK-12 and CCK-8 from 
CCK-33. Certainly limited degradation with trypsin of all larger forms 
of CCK produces CCK-12 in vitro which with more vigorous trypsin 
treatment can be converted to CCK-8 (Mutt, 1979). It is possible that 
a similar situation could be obtained in Styela, possibly with a more 
specific enzyme cleaving only the arg-ile bond, thus producing CCK-12. 
Preliminary observations, using gel filtration and region specific 
antisera suggest that a CCK-like peptide of about this size could be 
present in extracts of Styela gut (Thorndyke and Bevis, 1983).
Also surprising was the observation that caerulein is only a 
comparatively weak secretagogue in Styela. A 100 ug infusion of 
caerulein evokes approximately the same response as 10 ^g of CCK-8. 
This indicates that although the sulphation of the tyrosine at position 
7 is of no significance, the substitution of the methionine for 
threonine at position 6 reduces the potency ten-fold.
This result was unexpected as in vertebrate systems caerulein has 
been reported to be more potent (Jorpes, 1968) or at least similar in 
potency (Gardner, 1979b; Solomon et al, 1984) to CCK-8, which is not 
surprising considering how similar it is in structure (Anastasi et al, 
1968).
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It remains uncertain whether caerulein is truely phylogenetically 
old, or merely an evolutionary cul-de—sac, found in a group of 
amphibians which are highly specialised and a long way from the direct 
evolutionary descent of the higher vertebrates (Romer, 1971). Larsson 
and Rehfeld (1977) have suggested that it might represent the parent 
molecule from which both CCK and gastrin subsequently arose. However 
the evidence which they present is not incompatible with a more 
CCK-like precursor. Radioimmunoassays of Styela gut extracts (Thorndyke 
& Bevis,-1983) have revealed the evidence of a peptide similar in size 
to caerulein but more CCK-like in its antigenic behaviour.
The sharp discrimination between CCK-8 and caerulein observed in 
the present study suggests that caerulein is not present in these 
animals or that if it is, it plays some other role in their 
physiology. Although caerulein has been reported once in a 
sub-amphibian group (Van Noorden and Pearse, 1974), this was with an 
antiserum which readily cross-reacted with CCK and gastrin. Caerulein 
has not been demonstrated in the gastrointestinal tissue of any other 
vertebrate species (Mutt, 19830 or to have any biological effect in any 
sub-amphibian species. It is therefore possible that caerulein may not 
be a phylogenetically old peptide, but a recent invention of the 
Amphibia.
Another peptide, synthetic bombesin 6-14 nonapeptide, originally 
isolated as a tetradecapeptide from amphibian skin (Anastasi et al,
1971) was the most potent secretagogue tested in this assay. Bombesin 
was found to be about ten times more potent than CCK-8.
Bombesin is closely related to gastrin releasing peptide (GRP) 
(McDonald et al, 1978; 1979; 1980), indeed the nonapeptide, used in
this study, differs from porcine GRP nonapeptide by only one amino acid
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residue at position 7, which is Gin in bombesin but His in GRP.
Both bombesin and GRP are potent stimulators of gastric acid 
secretion. This effect is brought about by their release of gastrin 
from the G cells of the antral mucosa (Bertaccini et al, 1973; 1974; 
Erspamer, 1980). Bombesin is also known to have a direct secretagogue 
action on the pancreatic acinar cell (Jensen et al, 1978a; 1978b)
although its in vivo action may be due in part to its ability to induce 
the release of CCK, which also acts directly on the acinar cell 
(Erspamer et al, 1974).
Bombesin is also known to release a number of other regulatory 
peptides. These include enteroglucagon, raotilin, neurotensin (Bloom et 
al, 1979), gastric inhibitory peptide (Becker et al, 1978) and 
pancreatic.polypeptide (Taylor et al, 1978).
In view of this wide range of releasing effects and in particular 
the CCK and gastrin releasing effects, it is tempting to speculate that 
the abnormally high potency of bombesin nonapeptide in Styela may be 
due, at least in part, to a release of an endogenous secretagogue from
the endocrine-like cells in the gastric epithelium.
Another araphibian-skin peptide, physalaemin (Erspamer et al, 1977) 
a substance P related peptide, also acts as a secretagogue in Styela. 
At a comparable dose, by weight, physalaemin is more potent than
caerulein.
Specific physalaemin receptors, which act by increasing PI 
turnover, have been demonstrated to form part of the rich receptor 
complement of guinea pig acinar cells (Gardner and Jensen, 1980). That 
physalaemin appears more potent than caerulein in Styela, indicates 
that it is not acting on the CCK receptor but on a physalaemin
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receptor. The low potency of caerulein compared to CCK demonstrates 
the specificity of the CCK receptor. It is therefore unlikely that the 
action of physalaemin could be mediated through this specific CCK 
receptor as physalaemin is not CCK-like. It is not however possible to 
say anything about this physalaemin receptor and its specificity.
One other peptide, glucagon (which structurally belongs to the 
VIP/secretin/PHI group of peptides) was found to have no effect on 
enzyme secretion in Styela. This is perhaps not unexpected due to its 
structural similarity to secretin which has no secretagogue effect in 
Styela and because glucagon is not a pancreatic secretagogue in 
vertebrates (Deschodt-Lanckman et al, 1975).
Glucagon has been described as a secretagogue in mouse pancreatic 
acinar cells (Manabe and Steer, 1979; Singh, 1980a; 1980b) but this has 
been subsequently ascribed to an unknown contaminant in the natural 
glucagon preparations which had been used in the previous studies 
(Pandol et al, 1983).
Brief mention was made in the introduction to this chapter of 
specific receptor antagonists which have been studied in vertebrates, 
particularly the guinea pig, pancreatic acinar cells. With respect to 
the CCK receptor, three classes of antagonist have now been described.
The first class was described by Peikin et al (1979) who reported 
that butyryl derivatives of c-GMP, specifically Bt2c-GMP, are able to
specifically inhibit the action of CCK on the pancreatic acinar cell.
It is now known that CCK receptors in other tissues are also
specifically inhibited by Bt2c—GMP (Davison and Najafi—Farashah, 1981;
1982a; Hutchison and Dockray, 1980; Kasbekar et al, 1983; Poitras et 
al, 1980).
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The mechanism by which Bt2c-GMP acts is uncertain. It has been 
suggested that it does not act on the CCK receptor so as to block, its 
activation by CCK but that the nucleotide combines with CCK so as to 
interfere with its ability to bind to its receptors (Miller et al, 
1983). Gardner (1983) has however criticised this study and has 
disagreed with their conclusions.
A second class of CCK receptor antagonists, consisting of amino 
acid derivatives, was reported by Hahne et al (1981). Proglumide, a 
glutaramic acid derivative, and benzotript, an N-acyl derivative of 
tryptophan, are specific CCK antagonists in pancreatic acini as well as 
gall bladder, ileal (Davison and Najafi-Farashah, 1982b), and gastric 
muscle (Collins and Gardner, 1982). Other N-acyl derivatives of 
L-tryptophan have also been reported to inhibit CCK-stimulated amylase 
secretion (Jensen et al, 1983b).
A third class of antagonist consisting of COOH-terminal fragments 
of CCK, has also been described (Jensen et al, 1983a).
In the present study we found that addition of 5 mM Bt2c-GMP to 
CCK-33 and CCK-8 caused a highly significant reduction in the observed 
response. This is consistent with its effect on the CCK response in 
vertebrate systems. However the present doubt over the mode of action 
of Bt2c-GMP makes its unsafe to conclude that this is necessarily 
evidence for structural similarity between the ascidian and vertebrate 
CCK receptor.
It would perhaps be expected that the ascidian CCK receptor might 
be similar to its vertebrate counterpart. It has been reported that 
the insulin receptor is functionally more conserved in a range of 
vertebrates from cyclostome to human than is insulin (Muggeo et nl, 
1979a; 1979b). The present results however argue for a receptor with
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some structural differences, as has been pointed out earlier in this 
chapter.
It Is interesting that preliminary observations using this assay 
system have shown that infusion of only a few hundred nanograms of 
relatively impure acid extracts of Styela gut can evoke a response 
comparable to many micrograms of pure CCK (Thorndyke & Bevis, 1983). 
This discrepancy between the low potencies of sulphated and 
non—sulphated CCKs and the higher potency of impure extracts, argues 
against the receptor involved being the same as the CCK-receptor. 
Possibly the response observed with the CCKs represents only a weak 
interaction with either a primitive CCK receptor, or a receptor to an 
unknown hormone, which could perhaps be purified from Styela gut 
extracts, using this Styela perfusion system to follow the degree of 
purification.
None of the peptides described in this chapter have been used at 
'physiological* concentrations. This may indicate that there is only 
very weak hormone/receptor interactions or it may reflect a limitation 
of the method; ie the heart is the only vessel large and strong enough 
to allow cannulation and therefore the already sluggish circulation 
must perforce be halted. It is therefore possible that the 
concentration of peptide at the receptor Is much lower. Alternatively, 
if the secretion truely reflects a 'paracrine' release from adjacent 
cells a comparatively high molar concentration of peptide might occur 
locally, before being dispersed in the general circulation. Therefore 
to achieve that high concentration at the receptor, a non—physiological 
quantity of peptide would need to be infused into the general 
circulation.
The action of regulatory peptides in vertebrate systems can be
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divided into three modes of action (Krieger, 1983). The endocrine role 
is the original mechanism proposed by Bayliss and Starling in 1902. 
Peptides are released into the general circulation in response to some 
physiological stimulus and from there they provoke physically distant 
target cells to respond. By infusion of exogenous peptides at 
physiological concentrations characteristic biological activities can 
be observed (Grossman, 1977).
The neurocrine role of action pertains to the numerous peptide 
containing nerves of the gastrointesintal tract, for example 
somatostatin, CCK, VIP and substance P. Although the physiological 
role of these peptides is in most cases unresolved it is probable that 
they function as neurotransmitters or neuromodulators. However the 
neural products may in some cases be spread over a wider area, or even 
be released into the bloodstream as neurohormones. This type of action 
is well recognised in the control of the pituitary gland but it has 
also been proposed as a mode of VIP action (Fahrenkrug, 1979).
In the paracrine mode of action hormones are released into the 
local tissue fluid within an organ, to act purely as local hormones. 
This function is still hypothetical as it is difficult to examine 
experimentally. In the case of somatostatin a paracrine mechanism is 
argued for on structural grounds (Alumets et al, 1979; Kusumoto et al, 
1979; Larsson et al, 1979) as long processes extend from antral 
somatostatin cells to adjacent cells including G-cells.
One final question remains unresolved. Although secretin-like 
immunoreactivity has been clearly observed in the gastric epithelium, 
CCK-like immunoreactivity has proved impossible to localise by three 
different antisera which would react with mammalian CCK—33. The 
sensitivity of the gut to peptide secretagogues implies their presence
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and a CCK like peptide has indeed been identified in extracts of Styela 
gut (Thorndyke4 Bevis, 1983).
Weinstein (1972) has suggested on theoretical grounds that both 
the secretin/glucagon/VlP family and the gastrin/CCK family arose from 
a single parent molecule which he termed prosecgastrin. Holmquist et 
al (1979) have suggested that in lampreys small CCK/gastrin- and 
secretin/glucagon-like peptides may already be produced separately, 
while Van Noorden and Pearse (1974; 1976) have demonstrated that a
single endocrine cell type found in the gut of lamprey and the more 
primitive Branchiostoma, has the ability to react with both 
anti-glucagon and anti-gastrin sera. They suggest that this double 
immunoreactivity may be due to the presence of a single prosecgastrin 
type of prohormone. It is possible that this situation occurs in 
Styela.
It is well known that many small bioactive peptides are cleaved 
from larger precursor proteins that are processed during their 
migration through the cell into storage or transport vesicles to 
produce the active products. This proteolytic processing occurs after 
Golgi associated post-translational modification such as glycosylation, 
phosphorylation and sulphatlon have occurred. Proteolysis normally 
occurs at paired basic residues, suggesting that a small number of 
specialised tryptic proteases exist with great site selectivity but 
which can process many sites within the precursor.
Many prohormones contain a single active peptide although the 
'packaging' sequence, as in the case of insulin c-peptide may be 
co-secreted. However in 1977 the first of the multifunctional or
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polyprotein type of hormone precursor, proopiomelanocortin, was 
described (Mains et al, 1977).
Molecular biology and the techniques of gene cloning have provided 
an avalanche of hormone precursors, many of which contain more than one 
regulatory peptide within their structure. Examples include 
proenkephalin (Comb et al, 1982), provasopressin/neurophysin (Land et 
1, 1982), prooxytocin/neurophysin (Land et al, 1983) and
preprovasoactive intestinal peptide/PHM-27 (Itoh et al, 1983).
a
In view of this plethora of polyprotein type prohormones it does 
not seem unreasonable to postulate that the cap cells may contain a 
CCK-like product in addition to the secretin-like product. However, 
for some reason it is not possible to visualise it by 
immunocytochemical means.
If the CCK-like peptide is not located in the cap cells, then it 
is possible that they exist in some other E-L cell type. It is not 
impossible for example, that it is a product of the type 11 oesophageal 
cells, in addition to their insulin-like product. It is also possible 
although most Improbable that they are not sited in the 
gastrointestinal mucosa. In this case it is hard to see how they could 
respond to the presence of food stimuli in the gut.
E-L cells are however present elsewhere. E-L cells, which 
immunoreact with calcitonin antiserum, have been described adjacent to 
the iodine-binding thyroidal cells of zone 7 of the endostyle of Styela 
(Thorndyke and Probert, 1979). Fritsch et al, (1980) have demonstrated 
cells which immunostain with antisera to substance P, neurotensin and 
bombesin in the pharyngeal epithelium of Ciona intestinalis. This 
epithelium has not been examined for E-L cells in Styela.
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Neurosecretory cells have also been described in the ascidian 
neural ganglion (Dawson and Hisaw, 1964) and bombesin—, secretin—, 
VIP-, somatostatin-, substance P-, calcitonin-, CCK/gastrin-, 
raet-enkephalin-, ACTH- and prolactin-like immunoreactivity have also 
been demonstrated within the neural ganglion of a range of ascidian 
species (Fritsch et al, 1979; 1982; Georges and Dubois, 1979; 1984; 
Pestarino, 1983; 1984; Pestarino and Tagliafierro, 1982; Thorndyke,
1981; 1982). But considering the physical remoteness of these sites
from the gut and the primitive cardio-vascular system, coupled with the 
lack of evidence for direct innervation of the gut of Styela, it is 
improbable that they are producing peptides which have direct control 
over gastrointestinal functions.
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APPENDIX 1
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BUFFERS
Cacodylate buffer
Stock A: 0.2 M sodium cacodylate
4.28 g sodium cacodylate (mol wt 214) in 100 ml 
distilled water 
Stock B; 0.2 M HCl
1.7 ml hydrochloric acid in 100 ml distilled water 
pH 7.2 buffer: add 25 ml of A to 2.1 ml of B and make up to
100 ml with distilled water
Phosphate buffer
Stock A: 0.2 M sodium dihydrogen orthophosphate
3.12 g sodium dihydrogen orthophosphate (mol wt 156) 
in 100 ml distilled water 
Stock B: 0.2 M disodium hydrogen orthophosphate
2.83 g disodium hydrogen orthophosphate (mol wt 142) 
in 100 ml distilled water 
pH 7.0 buffer: add 19.5 ml of A to 30.5 ml of B and make up to
100 ml with distilled water 
pH 7.4 buffer: add 9.5 ml of A to 40.5 ml of B and make up to
100 ml with distilled water 
Tunicate Ringer
Devised by Thorndyke from data for the ionic composition of ascidian 
body fluids (Robertson, 1954).
Sodium chloride 25.90
Potassium chloride 0.75
Calcium chloride 1.05
Magnesium chloride 5.295
Sodium sulphate 1.63
Sodium bicarbonate 0.06
Glucose 1.00
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Acetate buffer
Stock A: 0.2 M acetic acid
1.2 ml glacial acetic acid in 100 ml distilled water 
Stock B: 0.2 M sodium acetate
1.64 g sodium acetate anhydrous (mol wt 82) in 100 ml 
distilled water 
Add X ml of A to y ml of B. Then make up to 100 ml with 
distilled water.
pH X ml A y ml B
3.8 44.0 6.0
4.0 41.0 9.0
4.2 36.8 13.2
4.4 30.5 19.5
4.6 25.5 24.5
4.8 20.0 30.0
5.0 14.8 35.2
5.2 10.5 39.5
Tris-HCL buffer 
Stock A: 0.2 M Tris
2.4 g Tris (hydroxymethyl) amino methane (mol wt 121) 
in 100 ml distilled water 
Stock B: 0.2 M HCL
1.7 ml hydrochloric acid in 100 ml distilled water 
pH 7.2 buffer: add 25 ml of A to 22.1 ml of B and make up to
100 ml with distilled water 
pH 7.6 buffer: add 25 ml of A to 19.2 ml of B and make up to
100 ml with distilled water
ISO
Phosphate buffered saline 
Sodium chloride 17g
Disodium hydrogen orthophosphate 2.56g 
Sodium dihydrogen orthophosphate 0.312 g 
Distilled water 2 1
FIXATIVES
Bouin
Saturated aqueous picric acid 75 ml 
Formaldehyde (40%) 25 ml 
Glacial acetic acid 1 ml
Will keep indefinitely if glacial acetic acid is not added until 
just before use. Seawater Bouin may be prepared by using 
saturated seawater picric acid
6% Glutaraldehyde
0.2 M sodium dihydrogen orthophosphate 48.75 ml 
(3.12 g in 100 ml distilled water)
0.2 M disodium hydrogen orthophosphate 76.25 ml 
(2.83 g in 100 ml distilled water)
25% glutaraldehyde
Check that pH is 7.0, add more disodium hydrogen orthophosphate if 
necessary. Then make up to 250 ml with distilled water and store 
in a stoppered glass vessel at 4°C.
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Marine fixative
25% glutaraldehyde 24 ml
0.2 M sodium cacodylate (made with seawater) 100 ml 
Distilled water 51 ml 
Filtered seawater 25 ml
This mixture should produce a solution of 1000 milliosmoles.
Adjust pH to 7.2 using 0.2 M HCl
STAINS
Reynold’s lead citrate (Reynolds, 1963)
Add 1.33 g of lead nitrate and 1.76 g of sodium citrate to 30 ml of 
distilled water. Shake vigorously for the first minute and each 5 
mins thereafter over a 30 min period. A heavy white precipitate of 
lead citrate is formed and this agitation facilitates formation.
Add 8 ml of freshly made 1 M sodium hydroxide (carbonate free) whilst 
stirring and dilute to 50 ml with distilled water. At this point 
the lead citrate precipitate dissolves. The stain is now ready for 
use, and should be stored at 4°C in a stoppered bottle. With age a 
white precipitate forms due to the absorption of atmospheric carbon 
dioxide. This resultant lead carbonate, if not removed, will 
contaminate sections. The stain must therefore be filtered, innnedi- 
ately before use, either through a No 50 filter paper or through a 
syringe fitted with a Millipore Swinnex filter containing an MF 
millipore filter with 0.2 pm diameter pores. If a Swinnex filter is 
used the solution may conveniently be stored in the syringe and 
filtered solution expelled when required. After staining, the grids 
should be washed first in 0.02 M NaOH, which will help to remove any 
stain contamination and then in several changes of distilled water. 
These solutions should also be filtered as described above.
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Masked metachromasia (Solcia et al, 1968)
Paraffin sections of 6% glutaraldehyde fixed tissues are brought to 
water and hydrolysed for 5 to 20 mins in 5 M hydrochloric acid at 
60 C. After washing briefly in distilled water they are stained 
for 2 to 3 mins in 0,1% toluidine blue in acetate buffer pH 5.0. 
Dehydrate, clear and mount.
Lead haematoxylin (Solcia et al, 1969a)
Paraffin sections of 6% glutaraldehyde fixed tissues are brought to 
water and stained in Solcia's lead haematoxylin* for 2 to 3 hrs at 
37°C. The depth of staining can be controlled visually by examining 
the sections under a microscope during the third hour. Rinse in 
distilled water. Dehydrate, clear and mount.
* Stabilised lead solution.
1) Add equal parts 5% aqueous lead nitrate and saturated aqueous 
ammonium acetate. Filter and add 2 ml of 40% formaldehyde
to each 100 ml filtrate. Store (indefinitely) at 4°C.
2) Dissolve 0.2 g haeraotoxylin in 1.5 ml 95% ethanol. Add 10 ml 
stock stabilised lead solution and dilute with 10 ml distilled 
water. Agitate for 30 mins then filter. Make up to 50 ml 
with distilled water.
Argentaffinity (Solcia et al, 1969b)
Paraffin sections of 6% glutaraldehyde fixed tissues are brought to 
water and stained for 30 to 45 mins at 60°C in preheated ammoniacal 
silver solution* Depth of staining can be controlled visually by 
examining the sections under a microscope. The slides are then 
washed in distilled water and fixed briefly in 0.5% sodium thiosul- 
phate. Dehydrate, clear and mount.
183
* Ammoniacal silver nitrate.
Add 0.880 sp grav ammonia to 5% aqueous silver nitrate until the 
brown precipitate is just clear. Then add more 5% silver nitrate 
dropwise until the solution once again becomes slightly turbid.
Argyrophilia (Grimelius, 1968)
Paraffin sections of Bouin fixed tissues are brought to water and 
treated for 3 hrs at 60°C in aqueous silver nitrate (30 mg AgNO^ 
in 100 ml acetate buffer pH 5.6). Then transfer sections directly 
to freshly prepared reducing solution* at 60°C. Control this 
reduction microscopically. Wash sections in distilled water, 
dehydrate, clear and mount.
* Reducing solution.
Add Ig hydroquinone (C^H^(0H)2) and 5 g anhydrous sodium sulphite 
to 100 ml distilled water.
Aldehyde fuchsin (Bussolati and Bassa, 1974)
Paraffin sections of Bouin, or 6% glutaraldehyde fixed tissues are 
brought to water and treated for 2 hr at room temperature with a 
freshly made solution obtained as follows. Mix 40 ml 0.5 M ammonium 
hydroxide, 40 ml 0.025 M copper sulphate (adjusted to pH 9.0 by 
adding a few drops of 0.880 sp grav ammonia) and 10 ml of 0.2 M sodium 
metabisulphite. The sections are then washed in running tap water 
and rinsed in distilled water. The sections are then stained for a 
few mins in aldehyde fuchsin*, the depth of staining being controlled 
microscopically. After several rinses in 95% alcohol the sections 
should be dehydrated, cleared and mounted.
184
* Aldehyde fuchsin.
Add 1 ml hydrochloric acid and 1 ml paraldehyde to 100 ml of 0.5% basic 
fuchsin in 70% alcohol. Keep the solution overnight at room temperature 
until the mixture darkens to deep violet. The stain works more 
rapidly and strongly when fresh but will keep for some time.
Toluidine blue stain (Huber et al, 1968)
Sodium tetraborate (borax) 1 g 
Toluidine blue 1 g 
Distilled water 100 ml
Dissolve the borax (which raises the final pH to about pH 11, and 
assists dye penetration) in the distilled water and then add the 
toluidine blue, with constant stirring. When completely dissolved 
filter and store in an amber dropping bottle. Sections are stained 
by covering them with a few drops of staining solution and heating 
them for half a minute in a spirit burner flame. The stain should 
not be allowed to boil as this may cause the sections to lift. Excess 
stain is then washed off in running water, air dried and then either 
viewed direct or mounted in DPX.
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TISSUE PROCESSING - EM
Fixation: all fixation should be performed using cold solutions (4°C).
1) Prepare marine fixative and cool to 4°C.
2) Transfer small pieces of tissue, not larger than 1 mm^ to the
marine fixative and leave for 2 hrs.
3) Transfer tissue to two changes of cacodylate buffer (pH 7.2)
over 1 hr.
4) Transfer tissue to minimal quantity of osmium tetroxide 1% in
cacodylate buffer (pH 7.2) for 1 hr.
5) Transfer to cacodylate buffer (pH 7.2) and leave overnight.
Dehydration: all dehydration should be performed using cold
solutions (4°C).
Transfer the tissue through the following series of alcohols for the 
stated times:
30% alcohol 15 min
50% ” 15 min
70% " 30 min
90% " 30 min
100% " 30 min
fresh 100% " 30 min
propylene oxide 10 min
fresh propylene oxide 10 min
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embedding
Prepare TAAB Laboratories epoxy resin as per their instructions. 
Remove tissue from cold propylene oxide and transfer to the following 
mixtures, at room temperature (in a fume hood):
resin : propylene oxide 1 : 1 3 hrs
resin : propylene oxide 3 : 1 overnight
resin : propylene oxide 7 : 1 3 hrs
resin : propylene oxide 15 : 1 3 hrs
transfer the tissue to fresh resin 3 hrs
transfer the tissue to fresh resin overnight
transfer the tissue to fresh resin in silicone rubber 
moulds and polymerise for 48 hrs at 60°C.
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APPENDIX 2
To record the response to each dose, ten consecutive measurements 
of the volume of pancreatic secretion were recorded, at 5 min intervals. 
To determine the response the 'volume of total, or additional, response' 
was determined as follows. The average basal rate was determined as 
the average of the first three and the last measurement (-10, -5,
0 and 35 mins) . This average value is then subtracted from each of 
the six outputs recorded over the 30 min period following dose 
administration.
Significance has been estimated by comparing the basal response 
(-10, -5, 0 and 35 mins) with the evoked response (5,10,15,20,25,30) 
by Student's t-test, using program t-distribution, statistics-10 
from the.Casio program library and a Casio FX-501P programming 
calculator.
RAT BIOASSAY
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a) Boots secretin: 500 ;ug
Time
a
(pi)
b
(pl) (pl)
d
(pl)
averag
(pl)
-10 6.25 6.75 5.5 6.25 6.2
-5 6.25 6.7 5.4 6.0 6.1
0 6.25 6.75 5.5 6.25 6.1
5 10.75 10.6 9.25 10.5 10.2
10 26.4 20.5 15.75 22.25 21.2
15 20.4 24.75 20.25 28.0 23.1
20 14.25 15.0 14.0 15.25 14.6
25 9.1 9.25 8.5 9.0 9.0
30 7.5 6.0 6.0 6.5 6.5
35 6.5 6.5 5.5 6.25 6.2
additional o/p 47.8
Boots secretin : 50 Pg
a b c d e
Time (pl) (pl) (pl) (pl) (pl)
f
(pl)
average
(pi)
-10 7.0 8.75 4.25 4.5 7.5 4.4 6 .6
-5 7.0 9.0 4.5 4.25 7.5 4.5 6.1
0 7.0 9.0 4.5 4.5 4.4 6.2 5'<l
5 10.0 19.75 10.5 9.25 12.75 7.5 11.6
10 18.1 18.5 20.1 19.5 14.5 14.25 17.5
15 12.25 11.2 17.4 13.3 10.0 12.25 12.7
20 8.5 10.5 8.4 7.7 8.75 5.75 7.0
25 6.9 10.1 4.75 6.25 8.25 5.75 7.0
30 7.0 9.5 4.0 5.0 7.75 5.0 6.4
35 7.0 9.1 4.5 4.25 7.5 4.75 
additional o/p
6.2
27.1 pl
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Boots secretin: 10 pg
Time
a
(pl)
b
(pl)
c
(pl)
average
(pl)
-10 5.1 5.0 8.5 6.2
-5 5.0 5.0 8.5 6.2
0 5.0 5.0 8.25 6.1
5 8.25 7.5 11.5 9.1
10 13.25 12.0 14.0 13.1
15 8.3 9.5 10.25 9.4
20 6.0 6.9 9.5 7.5
25 5.5 5.25 8.5 6.4
30 5.0 5.0 8.5 6.2
35 5.0 5.0 8.5 6.2
additional o/p 17.7 pl
Boots secretin: 5 pg
Time
a
(pl)
b
(pl) (^ )^
average
(pl)
-10 5.0 6.5 7.25 6.3
-5 4.8 6.5 7.0 6.1
0 5.0 6.75 7.0 6.3
5 10.0 10.25 9.25 9.8
10 7.0 9.5 10.25 8.9
15 6.5 8.5 9.0 8.0
20 5.75 7.5 8.0 7.1
25 5.25 7.0 7.25 6.3
30 5.0 6.5 7.25 6.3
35 5.0 6.5 7.25 6.3
additional o/p 9.3 pl
Boots secretin: 1 pg
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Time
a
(pl)
b
(pl)
c
(pl)
average
(pl)
-10 5.5 4.5 6.75 5.6
-5 5.6 4.5 6.75 5.6
0 5.5 4.5 6.5 5.5
5 6.25 5.5 7.75 6.5
10 6.0 4.75 6.75 5.8
15 5.75 4.25 6.25 5.4
20 5.5 4.25 6.5 5.4
25 5.5 4.5 6 .5 5.5
30 5.5 4.5 6 .6 5.5
35 5.5 4.5 6.5 
additional o/p
5.5
0.63 pl
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b) Porcine duodenal extract:
Dose
Time
(mins)
50 pg 
(pl)
100 pg
(pl)
200 pg
(pl)
400 pg 
(pl)
800 pg
(pl)
-10 5.5 5.75 5.8 5.5 5.5
-5 5.5 5.5 5.5 5.5 5.6
0 5.5 5.5 5.5 5.5 5.5
5 8.5 11.5 16.75 17.75 25.0
10 8.0 11.75 11.25 16.25 15.75
15 5.5 6.1 8.0 7.3 7.1
20 5.75 5.5 5.8 5.8 6.1
25 5.5 5.6 5.5 6.0 5.75
30 5.5 5.5 5.5 5.8 5.5
35 5.5 5.5 5.5 5.5 5.5
Addi­
tional
Output 6.25 15.0 19.8 26.9 32.3pl
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c) Porcine gastric extract
1.0 mg/kg
Time
a
(pl)
b
(pl)
c
(pl)
d
(pl)
avera
(pl)
-10 7.75 6.25 6.1 4.1 6.1
-5 8.0 6.25 6.25 4.0 6.1
0 8.0 6.0 6.1 4.25 6.1
5 8.0 6.1 6.25 4.5 6.2
10 7.9 6.25 6.1 4.25 6.1
15 8.0 6.1 6.25 4.25 6.2
20 8.0 6.1 6.25 4.25 6.2
25 7.9 6.1 6.25 4.25 6.1
30 8.0 6.25 6.25 4.1 6.2
35 7.9 6.1 6.25 4.25 6.1
2.0 mg/kg
Time
a
(pl)
no additional o/p
b
(pl)
average
(;il)
-10 9.1 4.25 6.7
-5 9.0 4.25 6.6
0 9.0 4.5 6.8
5 9.0 4.5 6.8
10 9.0 4.25 6.6
15 9.1 4.25 6.7
20 9.0 4.25 6.6
25 9.1 4.25 6.7
30 9.1 4.1 6.6
35 9.1 4.25 6.7
no additional o/p
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d) Styela gut extract:
1.0 mg/kg
Time
a
(pl)
b
(pl) (^ )^
d
(pl)
average
(pl)
-10 8.5 6 .0 7.5 4.75 6.7
-5 8.0 6.1 7.5 4.9 6 .6
0 8.25 6.1 7.5 4.75 6.7
5 8.6 6.0 7.5 4.9 6.8
10 8.4 6.25 7.5 5.0 6.8
15 8.4 6.1 7.25 4.9 6.7
20 8.25 6.1 7.25 4.9 6.6
25 8.5 6.0 7.25 4.9 6.7
30 8.25 6.0 7.25 4.9 6 .6
35 8.25 6.25 7.25 5.0 6.7
additional o/p 0.23p]
2.0 mg/kg
Time
a
(pl)
b
(pl) (pl)
d
(pl)
average
(pl)
-10 5.6 4.5 9.1 5.9 6.3
-5 5.5 4.75 9.25 5.6 6.3
0 5.5 4.75 9.25 5.9 6.3
5 6.5 5.0 9.5 5.9 6.7
10 6.0 4.75 9.25 5.9 6.7
15 5.4 4.5 9.25 5.4 6.1
20 5.25 4.75 9.25 5.4 6.2
25 5.5 4.75 9.1 5.9 6.3
30 5.4 5.0 9.1 5.6 6.3
35 5.5 4.75 9.0 5.6 6.2
additional o/p 0.4 pl
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5.0 mg/kg
Time
a
(pl)
b
(pl)
c
(pl)
average
(pl)
-10 5.0 6.5 5.25 5.6
-5 5.25 6.5 5.0 5.6
0 5.0 6.5 5.0 5.6
5 5.75 7.1 5.75 6.2
10 5.75 9.0 6.0 6.9
15 5.5 7.8 5.75 6.4
20 5.5 7.0 5.25 5.9
25 5.25 6.6 5.25 5.7
30 5.25 6.5 5.1 5.6
35 5.0 6.6 5.1 
additional o/p
5.6
3.1 pl
e) Styela pharynx extract:
5.0 mg/kg
Time
a
(pl)
b
(pl) (^ 1)
d
(pl)
avera;
yi)
-10 5.25 6.1 6.0 9.1 6.6
-5 5.25 6.0 6.1 9.1 6.6
0 5.0 6.0 6.0 9.0 6.5
5 5.25 6.1 5.75 9.1 6.6
10 5.25 6.0 6.1 9.25 6.7
15 5.25 5.75 6.0 9.0 6.5
20 5.0 6.0 6.0 9.0 6.5
25 5.25 6.0 6.1 8,75 6.5
30 5.0 6.1 6.1 9.0 6.6
35 5.0 6.0 6.1 9.0
no additional o/p
6 .6
19 j
TURKEY BTOASSAY 
a) Boots Secretin: 
0.5 mg/kg
Time
a
(pl)
b
(pl) (p^ )
average
(pl)
-10 14.6 10.1 12.7 12.5
-5 13.8 9.7 11.4 11.6
0 13.8 9.9 11.6 11.8
5 81.3 72.0 51.2 68.2
10 31.7 28.7 23.5 28.0
15 20.3 16.2 16.5 17.7
20 17.1 12.4 12.7 14.1
25 13.8 10.7 11.4 12.0
30 8.9 9.9 12.7 10.5
35 • 14.6 9.9 12.1 12.2
additional o/p 78.9 1
1.0 mg/kg
Time
a
(pl)
b
(pl) (pl)
average
(pl)
-10 17.1 10.5 12.1 13.2
-5 20.3 10.1 12.1 14.2
0 18.7 10.5 12.7 14.0
5 99.2 91.7 81.2 90.7
10 77.2 82.0 58.0 72.4
15 26.0 21.8 17.4 21.7
20 24.0 16.5 13.2 18.0
25 16.3 11.2 12.7 13.4
30 17.1 10.1 12.7 13.3
35 19.5 10.5 12.1 14.0
additional o/p 160.5 pl
2.0 mg/kg
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Time
a
(pi)
b
(pi)
c
(pi)
average
(pi)
-10 16.3 9.7 13.4 13.1
-5 14.6 9.7 12.7 12.3
0 15.4 9.2 13.8 12.8
5 143.1 126.2 92.3 120.5
10 108.1 88.0 101.4 99.2
15 43.1 38.4 35.0 38.9
20 32.5 31.1 28.2 30.6
25 22.8 22.8 18.1 21.2
30 27.6 14.2 13.8 18.5
35 17.9 9.2 13.4 13.5
additional o/p 253.3 pi
Porcine duodenal extract ;
2.0 mg/kg
Time
a
(pi)
b
(pi) (yl)
average
(pi)
-10 10.4 12.2 10.1 10.9
-5 10.1 11.9 10.4 10.8
0 10.7 12.5 10.4 11.2
5 13.1 14.7 14.4 14.1
10 12.5 14.4 13.7 13.5
15 11.2 12.5 12.5 12.1
20 10.7 12.2 10.4 11.1
25 10.7 12.2 11.2 11.4
30 10.1 11.9 10.1 10.7
35 10.4 12.2 10.4 11.0
additional o/p 7.1 pi
5.0 mg/kg
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a b c average
Time (pi) (/il) (yl) (pi)
-10 13.1 11.2 10.7 11.7
-5 12.8 10.o 9.9 10.9
0 12.5 10.5 9.9 11.0
5 24.4 : 28.7 19.5 24.2
10 16.3 19.5 21.8 19.2
15 14.4 14.6 16.3 15.1
20 12.8 10.7 11.2 11.6
25 12.5 11.2 12.7 12.1
30 12.5 12.2 10.5 11.7
35 12.8 10.5 10.1 11.7
additional o/p 26.7 pi
Porcine gastric extract :
5.0 mg/kg
a b c average
Time (pi) (pi) (pi) (pi)
-10 14.7 10.7 11.2 12.2
-5 13.5 10.1 12.2 11.9
0 13.1 10.1 10.5 11.2
5 14.4 10.1 10.7 11.7
10 13.5 10.5 11.7 11.9
15 13.5 10.1 11.4 11.7
20 13.8 10.5 11.4 11.9
25 14.1 9.8 11.2 11.7
30 13.1 10.1 11.4 11.5
35 13.5 9.8 12.2 11.8
no additional o/p
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d) Styela gut extract
1.0 mg/kg
2.0 mg/kg
Time
a
(pi)
b
(pi) (pi)
average
(pi)
a
(pi)
-10 10.1 10.7 12.8 11.2 10.4
-5 10.1 10.7 13.1 11.3 7.9
0 10.1 11.2 13.1 11.5 9.9
5 14.3 9.8 12.8 12.3 9.3
10 7.2 9.8 12.5 9.8 9.9
15 10.7 10.7 13.1 11.5 9.6
20 9.5 9.8 13.4 10.9 9.9
25 10.7 9.4 13.1 11.1 10.4
30 10.7 9.8 13.4 11.3 9.9
35 10.7 9.8 13.1 11.2 9.9
no additional o/p no additional
e) Styela pharynx extract
2.0 mg/kg
Time
a
(pi)
b
(pi) (pi)
averag(
(pi)
-10 11.8 12.7 13.5 12.7
-5 14.7 12.7 14.7 14.0
0 14.7 12.3 13.5 13.5
5 8.8 11.9 13.5 11.4
10 14.7 12.3 14.2 13.7
15 17.6 11.9 14.7 14.7
20 11.8 12.7 14.7 13.1
25 14.7 12.3 13.5 13.5
30 14.7 12.3 13.5 13.5
35 14.7 11.9 13.5 13.4
no additional o/p
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APPENDIX 3
A standard curve was constructed by measuring a range of 
concentrations of bovine serum albumin (BSA) using the Lowry method.
The absorbances were determined in the normal manner and a graph 
plotted of absorbance against protein concentration (Fig A1 ). This 
plot was linear over the range of values determined and, therefore, 
as all samples fell within this range, protein values could be 
extracted simply by multiplying the absorbance by a constant which 
was calculated to be 197.
ABSORBANCE (ABS)
BSA
mg/dl
1 2 3 Mean (mg/dl/AI
1 0.005 0.004 0.004 0.0043 233
2 0.007 0.011 0.010 0.0093 215
3 0.018 0.016 0.020 0.018 167
5 0.029 0.023 0.027 0.026 192
10 0.045 0.049 0.042 0.045 222
15 0.080 0.075 0.077 0.077 195
20 0.121 0.112 0.107 0.113 177
25 0.142 0.124 0.125 0.130 0192
30 0.164 0.152 0.156 0.160 187
40 0.196 0.188 0.201 0.195 205
50 0.267 0.256 0.274 0.266 187
Average 197
200
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Fig Al A standard curve of concentration of bovine serum 
albumin against absorbence, showing the range of 
concentrations over which linearity existed.
NO INFUSION
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LOWRY PROTEIN, mg/dl:
Ringer Mean ± SD
-50 10.1 10.8 9.3 8.1 11.8 10.1 1.4
-40 7.5 9.2 7.1 5.5 10.1 7.9 1.8
-30 5.7 7.9 4.9 5.3 7.9 6.3 1.4
-20 4.3 5.5 5.5 2.6 3.0 4.2 1.4
-10 3.9 5.9 2.8 3.0 1.8 3.5 1.6
0 1.6 5.1 2.2 2.6 1.4 2.6 1.5
10 1.0 4.3 2.8 4.1 1.8 2.8 1.5
20 0.8 2.6 3.4 3.4 2.2 2.4 1.1
30 2.0 2.0 1.4 1.8 1.2 1.7 0.4
40 . 1.8 0.2 0.0 2.2 0.8 1.1 1.0
50 0.4 0.8 2.2 3.6 0.4 1.5 1.4
60 0.6 0.8 1.0 1.4 0.0 0.7 0.5
ACID PHOSPHATASE, U/1:
Ringer Mean ± SD
-50 2.2 1.8 1.3 ' 2.7 1.9 1.98 0.52
—40 1.1 1.2 0.6 2.2 1.8 1.38 0.63
-30 0.8 0.7 0.3 1.5 1.1 0.88 0.45
-20 0.4 0.3 0.2 1.0 0.5 0.48 0.31
-10 0.4 0.2 0.3 0.8 0.4 0.42 0.23
0 0.1 0.4 0.3 0.4 0.3 0.30 0.12
10 0.4 0.2 0.2 0.3 0.1 0.24 0.11
20 0.4 0.3 0.1 0.4 0.4 0.32 0.13
30 0.4 0.0 0.2 0.1 0.3 0.13 0.12
40 0.1 0.1 0.0 0.0 0.0 0.06 0.05
50 0.3 0.1 0.1 0.2 0.0 0.14 0.11
60 0.4 0.0 0.1 0.1 0.3 0.18 0.16
202
CCK-8 (SULPHATED)
LOWRY PROTEIN, mg/dl
10 pg Mean ±SD 100 jjg Mean ±SD
-20 3.4 1.4 4.7 3.2 1.7 4.5 1.8 3.6 3.3 1.4
-10 2.6 1.6 2.8 2.3 1.6 2.6 4.6 3.0 3.4 1.0
0 1.6 1.4 2.4 1.8 0.5 2.4 4.0 2.4 2.9 0.9
10 4.9 12.8 4.3 7.4 4.7 17.2 25.8 13.6 18.9 6.3
20 2.6 4.9 1.2 2.9 1.9 6.1 13.2 7.5 8.9 3.8
30 2.0 2.6 0.6 1.7 1.0 5.9 3.6 4.7 4.7 1.2
40 1.2 2.2 1.4 1.6 0.5 2.6 1.8 3.0 2.4 0.6
50 1.6 1.2 0.8 1.2 0.4 2.6 0.6 1.6 1.9 1.1
60 0.2 1.6 1.4 1.1 0.7 1.8 1.0 2.2 1.6 0.6
LOWRY PROTEIN, mg/dl
200 ug Mean ±SD
-20 7.1 4.3 3.2 1.8 2.2 3.7 6.1 3.0 3.9 1.9
-10 9.7 5.5 1.4 1.6 2.8 2.4 2.0 1.4 3.3 2.9
0 5.1 4.5 2.0 1.8 1.4 0.6 1.0 1.0 2.2 1.7
10 20.5 17.8 25.8 12.0 10.9 31.0 38.7 34 .9 23.9 10.4
20 16.2 5.3 19.7 11.2 25.6 20.9 6.9 14 .2 15.0 7.0
30 12.4 3.6 2.4 2.4 5.5 9.7 4.9 5.5 5.8 3.6
40 13.0 3.0 0.2 2.2 4.3 5.5 3.4 5.3 4.6 3.8
50 4.9 2.0 0.0 1.0 4.3 4.0 1.8 3.4 2.7 1.7
60 4.1 3.9 1.4 0.8 2.6 3.9 1.6 3.0 2.7 1.3
203
CCK-8 (NON-SULPHATED)
LOWRY PROTEIN, mg/dl
100 6g Mean ±SD
-20 6.9 2.6 2.0 3.7 3.2 3.7 1.9
-10 5.3 2.2 1.2 3.0 3.2 3.0 1.5
0 3.7 1.0 2.2 1.6 2.4 2.2 1.0
10 13.8 18.9 14.8 9.3 24.5 19.8 8.7
20 - 12.0 11.0 5.7 16.4 9.9 11.0 3.8
30 5.5 4.3 3.7 4.5 8.1 5.2 1.7
40 6.3 1.4 2.4 2.6 2.4 3.0 1.9
50 3.7 2.6 2.4 1.0 1.8 2.3 1.0
60 3.9 2.6 1.8 2.8 1.6 2.5 0.9
ACID PHOSPHATASE, U/1
100 JJg Mean ±SD
-20 0.5 0.7 0.2 0.9 0.3 0.5 0.3
-10 0.6 0.7 0.2 0.3 0.0 0.4 0.3
0 0.3 0.9 0.4 0.6 0.2 0.5 0.3
10 1.2 6.0 4.8 7.6 4.8 4.9 2.4
20 0.4 2.6 3.4 4.6 2.4 2.7 1.6
30 0.3 0.5 0.3 0.6 1.3 0.6 0.4
40 0.1 0.2 0.2 0.3 0.2 0.2 0.1
50 0.1 0.3 0.1 0.2 0.3 0.2 0.1
60 0.2 0.1 0.2 0.0 0.2 0.14 0.1
CCK-33
LOWRY PROTEIN, mg/dl
204
10 hg Mean ±SD
-20 6.1 5.1 2.8 4.9 4.7 1.4
-10 2.0 3.6 2.8 2.2 2.6 0.7
0 2.0 4.5 2.6 1.8 2.7 1.3
10 9.7 14.0 19.1 12.6 13.9 4.0
20 4.7 10.3 8.7 6.1 7.4 2.5
30 3.7 6.1 4.1 4.5 4.6 1.0
40 4.3 6.3 4.5 2.0 4.3 1.8
50 5.3 5.1 1.8 3.0 3.8 1.7
60 3.4 2.0 3.2 2.6 2.8 0.6
LOWRY PROTEIN, mg/dl
100 jjg Mean ±SD
-20 1.0 5.3 3.4 6.9 3.2 3.9 2.3
-10 0.2 1.0 3.6 6.7 2.2 2.7 2.6
0 0.2 1.4 2.2 5.1 2.0 2.2 1.8
10 18.3 44.0 26.0 58.4 42.8 37.9 15.8
20 12.4 7.5 22.9 30.0 14.0 17.4 9.0
30 0.2 2.6 8.3 10.7 3.4 5.0 4.3
40 0 2.8 3.2 5.3 3.9 3.0 2.0
50 0 1.4 2.8 2.8 3.2 2.0 1.3
60 0.6 0.8 1.6 4.1 0.6 0.5 1.5
CCK-33 + 5 iiiM c-GMP
LOWRY PROTEIN, mg/dl
205
10 jjg Mean ±SD
-20 4.0 4.3 5.1 4.5 0.6
-10 0.8 3.2 3.6 2.5 1.5
0 0.4 2.4 2.0 1.6 1.0
10 1.6 8.9 5.3 5.3 3.7
20 1.4 4.9 3.4 3.2 1.8
30 0.6 3.0 2.4 2.0 1.2
40 0.4 1.6 2.2 1.4 0.9
50 3.7 1.6 1.2 2.2 1.4
60 1.8 1.0 2.0 1.6 0.5
CCK-8 (SULPHATED) + 5 mM c--CMP
LOWRY PROTEIN, mg/dl
10 Jjg Mean ±SD
-20 5.7 4.1 3.6 4.9 4.5 1.0
-10 3.6 3.2 2.6 3.4 3.2 0.4
0 3.4 3.6 2.2 3.0 3.0 0.6
10 12.6 6.7 11.6 13.0 11.0 2.9
20 8.1 3.4 7.3 9.7 7.1 2.7
30 4.1 4.3 3.6 4.5 4.1 0.4
40 3.6 4.3 1.4 3.6 3.2 1.3
50 2.8 2.4 2.0 3.0 2.5 0.4
60 2.8 3.4 1.8 2.4 2.6 0.7
BOMBESIN
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LOWRY PROTEIN,
0.1 jjg
mg/dl
Mean 1.0 jjg Mean ±SD
-20 0.6 2.6 1.6 2.8 3.0 7.9 4.5 2.9
-10 0.4 2.0 1.2 2.0 3.4 5.5 3.6 , 1.8
0 1.0 1.2 1.1 1.8 2.0 3.6 2.4 1.0
10 8.5 3.7 6.1 15.0 19.5 10.3 14.9 4.6
20 1.8 1.4 1.6 4.5 6.5 7.1 6.1 1.3
30 1.4 1.0 1.2 1.8 3.6 3.4 2.9 1.0
40 0.8 0.8 0.8 2.4 3.2 3.2 2.9 0.5
50 0.8 0.6 0.7 1.6 1.6 3.0 2.0 0.8
60 0.4 0.0 0.2 2.2 1.2 2.0 1.8 0.5
LOWRY PROTEIN, mg/dl
10 Jjg Mean ±SD
-20 2.0 2.8 3.4 5.13 3.3 1.3
-10 2.8 1.2 2.4 2.6 2.2 0.7
0 2.2 0.8 1.8 1.8 1.6 0.6
10 17.2 26.2 23.9 18.2 24.4 8.7
20 9.7 9.5 16.2 8.3 10.9 3.6
30 4.9 5.1 5.5 4.5 5.0 0.4
40 2.8 3.6 3.0 1.6 2.7 0.8
50 1.2 2.2 2.0 2.6 2.0 0.6
60 1.2 2.0 2.8 1.6 1.9 0.7
PHYSALAEMIN
LOWRY PROTEIN, mg/dl
207
100 )Jg Mean ±SD
-20 6.5 2.4 5.7 3.2 4.4 2.0
-10 2.8 1.6 1.8 2.0 2.0 0.5
0 2.2 2.0 2.0 1.8 2.0 0.2
10 26.6 7.3 10.9 8.2 13.3 9.0
20 12.6 5.3 4.5 4.7 6.8 4.0
30 6.9 3.3 3.6 2.8 4.1 1.9
40 4.7 3.6 2.0 1.6 3.0 1.5
50 3.0 2.8 1.8 1.2 2.2 0.8
60 1.8 2.0 1.6 0.8 1.5 0.5
CAERULEIN
LOWRY PROTEIN , mg/dl
100 ^g Mean ±SD
-20 3.6 3.2 5.7 4.1 1.4
-10 2.2 1.2 2.4 1.9 0.6
0 1.2 0 2.2 1.1 1.1
10 7.1 12.2 4.9 8.1 3.7
20 5.5 6.5 4.3 5.5 1.1
30 3.6 2.6 3.4 3.2 0.5
40 1.6 1.6 2.8 2.0 0.7
50 1.8 0.6 2.6 1.6 1.0
60 1.0 1.0 2.0 1.3 0.6
SECRETIN
LOWRY PROTEIN, mg/dl
208
100 jjg Mean ±SD
-20 3.2 4.8 7.1 2.6 4.4 2.0
-10 ' 2.4 2.6 5.7 1.8 3.1 1.8
0 2.6 2.2 4.6 4.0 3.3 1.1
10 3.6 2.2 0.4 1.6 1.9 1.3
20 3.4 2.0 1.2 2.0 2.1 0.9
30 . 2.0 1.2 4.6 2.6 2.6 1.4
40 2.0 0.8 5.0 1.4 2.3 1.8
50 2.4 0.4 2.8 0.6 1.5 1.2
60 1.6 0.4 0.8 0.0 0.7 0.7
ACID PHOSPHATASE, U/1
100 jjg Mean ±SD
-20 0.5 0.6 1.2 0.4 0.68 0.36
-10 0.3 0.6 1.0 0.6 0.63 0.29
0 0.1 0.6 1.0 0.2 0.48 0.41
10 0.4 0.8 0.8 0.2 0.55 0.30
20 0.8 0.3 0.8 0.6 0.63 0.24
30 0.9 0.4 0.4 0.0 0.43 0.37
40 0.6 0.3 0.7 0.2 0.45 0.24
50 0.9 0.0 0.3 0.4 0.40 0.37
60 0.4 0.0 0.7 0.3 0.35 0.29
SECRETIN
LOWRY PROTEIN, mg/dl
208
100 Pg Mean ±SD
-20 3.2 4.8 7.1 2.6 4.4 2.0
-10 ' 2.4 2.6 5.7 1.8 3.1 1.8
0 2.6 2.2 4.6 4.0 3.3 1.1
10 3.6 2.2 0.4 1.6 1.9 1.3
20 3.4 2.0 1.2 2.0 2.1 0.9
30 2.0 1.2 4.6 2.6 2.6 1.4
40 2.0 0.8 5.0 1.4 2.3 1.8
50 2.4 0.4 2.8 0.6 1.5 1.2
60 1.6 0.4 0.8 0.0 0.7 0.7
ACID PHOSPHATASE, U/1
100 Ug Mean ±SD
-20 0.5 0.6 1.2 0.4 0.68 0.36
-10 0.3 0.6 1.0 0.6 0.63 0.29
0 0.1 0.6 1.0 0.2 0.48 0.41
10 0.4 0.8 0.8 0.2 0.55 0.30
20 0.8 0.3 0.8 0.6 0.63 0.24
30 0.9 0.4 0.4 0.0 0.43 0.37
40 0.6 0.3 0.7 0.2 0.45 0.24
50 0.9 0.0 0.3 0.4 0.40 0.37
60 0.4 0.0 0.7 0.3 0.35 0.29
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GLUCAGON
LOWRY PROTEIN, mg/dl
100 ^8 Mean ±SD
-20 3.7 5.3 3.2 2.0 3.6 1.4
-10 3.2 1.4 2.8 1.8 2.3 0.8
0 0.8 0.8 2.0 2.0 1.6 0.6
10 2.2 0.8 1.6 2.6 1.8 0.8
20 1.2 0.6 1.0 1.8 1.1 0.5
30 1.0 0.8 1.0 1.6 1.1 0.3
40 2.0 1.6 0.4 1.0 1.2 0.7
50 1.2 1.6 0.8 0.8 1.1 0.4
60 0.8 1.6 1.2 0.6 1.0 0.4
SIGMA CCK (TECHNICAL)
LOWRY PROTEIN, mg/dl
210
0 |Jg Mean ±SD
-50 7.5 10.0 11.3 8.1 12.5 9.9 2.1
-40 5.5 8.1 7.7 7.5 7.7 7.3 1.0
-30 4.9 6.5 5.1 4.1 4.7 5.1 0.9
-20 4.1 3.0 4.1 3.7 3.3 3.7 0.5
-10 2.6 2.2 3.9 3.3 2.2 2.8 0.8
0 1.0 2.0 3.0 3.5 1.4 2.2 1.1
10 1.4 1.2 2.8 3.2 0.6 1.8 1.1
20 0.6 1.8 2.2 2.6 1.0 1.6 0.8
30 1.0 1.0 2.0 2.6 0.4 1.6 0.8
40 1.2 0.8 0.8 3.5 0.0 1.3 1.3
50 0.6 0.0 1.8 0.4 0.2 0.6 0.6
60 0.6 0.0 3.3 0.8 0.2 1.0 1.4
ACID PHOSPHATASE, U/1
0 iJg Mean ±SD
-50 1.6 1.4 1.9 1.5 2.0 1.68 0.26
—40 1.1 1.0 0.8 0.5 1.8 1.04 0.48
-30 0.8 0.4 0.7 0.2 1.1 0.64 0.35
-20 0.2 0.6 0.4 0.2 0.5 0.38 0.18
-10 0.3 0.4 0.5 0.0 0.5 0.34 0.21
0 0.2 0.3 0.2 0.4 0.3 0.28 0.08
10 0.5 0.2 0.2 0.0 0.3 0.24 0.18
20 0.4 0.1 0.0 0.1 0.4 0.20 0.19
30 0.4 0.0 0.2 0.2 0.3 0.22 0.15
40 0.1 0.1 0.3 0.0 0.0 0.10 0.12
50 0.3 0.1 0.0 0.1 0.2 0.14 0.11
60 0.4 0.0 0.1 0.1 0.3 0.18 0.16
SIGMA CCK (TECHNICAL)
LOWRY PROTEIN, mg/dl
211
100 Jjg Mean ±SD
-50 13.0 10.2 8.7 11.6 10.9 1.9
-40 8.2 8.1 4.7 7.5 7.1 1.6
-30 4.9 7.1 2.2 6.3 5.1 2.2
-20 4.5 3.9 2.4 5.1 4.0 1.2
-10 3.0 4.5 1.6 4.1 3.3 1.3
0 3.0 3.5 1.6 3.2 2.8 0.9
10 3.5 5.1 6.1 6.5 5.3 1.3
20 . 4.3 7.0 6.3 3.5 5.4 1.5
30 4.3 5.6 4.3 5.9 5.1 0.9
40 3.5 5.3 3.7 3.0 3.9 1.0
50 3.0 4.1 2.8 2.0 3.0 0.9
60 . 3.0 1.0 3.0 0.6 1.9 1.3
ACID PHOSPHATASE, U/1
100 Jjg Mean ±SD
-50 1.3 1.5 2.3 1.5 1.65 0.44
-40 0.6 0.5 1.7 0.7 0.88 0.56
-30 0.3 0.2 0.8 0.4 0.43 0.26
-20 0.2 0.0 0.8 0.2 0.30 0.35
-10 0.3 1.0 0.4 0.4 0.53 0.32
0 0.3 0.3 0.5 0.2 0.33 0.13
10 0.4 0.5 0.6 0.6 0.53 0.10
20 0.5 0.3 0.2 0.5 0.38 0.15
30 0.4 0.2 0.3 0.5 0.35 0.13
40 0.2 0.3 0.1 0.3 0.23 0.10
50 0.0 0.3 0.1 0.1 0.13 0.13
60 0.1 0.1 0.0 0.1 0.08 0.05
SIGMA CCK (TECHNICAL)
LOWRY PROTEIN, mg/dl
212
200 jjg Mean ±SD
-50 10.2 10,8 13.4 8.1 7.5 10.0 2.4
-40 8.1 8.5 12.2 5.1 6.1 8.0 2.7
-30 6,5 7.1 8.3 5.5 5.1 6.5 1.3
-20 4.3 3.7 5.1 4.5 3.5 4.2 0.6
-10 1.8 3.3 3.9 3.5 4.1 3.3 0.9
0 1.0 3.5 2.0 3.0 3.2 2.5 1.0
10 15.2 10.0 20.1 17.5 10.2 14.6 4.4
20 11.8 8.5 15.0 16.0 9.1 12.1 3.4
30 8.1 5.3 7.5 12.6 7.1 8.1 2.7
40 5.1 4.1 6.5 7.3 4.1 5.4 1.4
50 4.3 3.5 5.5 6.9 3.5 4.8 1.4
60 3.7 3.5 4.3 4.1 1.8 3.5 1.0
ACID PHOSPHATASE, U/1
200 jjg Mean ±SD
-50 . 2.3 1.7 1.9 1.8 1.3 1.8 0.36
-40 1.2 0.8 1.7 1.0 0.9 1.12 0.36
-30 0.8 0.7 0.8 0.5 0.6 0.68 0.13
-20 0.4 0.4 0.4 0.3 0.4 0.38 0.04
-10 0.4 0.5 0.2 0.2 0.3 0.32 0.13
0 0.1 0.4 0.2 0.2 0.3 0.24 0.11
10 0.9 0.6 0.5 0.8 0.7 0.7 0.16
20 0.7 0.6 0.2 0.5 0.4 0.48 0.19
30 0.5 0.2 0.2 0.5 0.4 0.36 0.15
40 0.4 0.1 0.3 0.1 0.2 0.22 0.13
50 0.0 0.3 0.1 0.3 0.2 0.18 0.13
60 0.2 0.1 0.0 0.1 0.0 0.08 0.08
SIGMA CCK (TECHNICAL)
LOWRY PROTEIN, mg/dl
213
400 jjg Mean ±SD
-50 10.6 9.1 12.0 8.1 9.9 1.7
-40 8.5 7.4 5.9 8.9 7.7 1.3
-30 7.1 6.3 3.5 4.7 5.4 1.6
-20 4.1 3.2 2.6 5.5 3.8 1.3
-10 3.3 4.1 2.8 5.9 4.0 1.4
0 2.6 3.5 1.6 4.9 3.2 1.4
10 23.6 12.6 18.1 16.0 17.6 4.6
20 20.1 15.6 22.1 6.5 16.1 6.9
30 16.9 7.1 16.0 11.0 12.8 4.6
40 6.5 4.3 5.9 6.5 5.8 1.0
50 6.7 3.0 5.5 5.7 5.2 1.6
60 4.5 2.2 3.5 4.1 3.6 1.0
ACID PHOSPHATASE, U/1
400 jjg Mean ±SD
-50 1.8 2.1 1.1 1.0 1.50 0.54
-40 1.2 0.8 0.6 0.4 0.75 0.34
-30 0.7 0.4 0.2 0.3 0.40 0.22
-20 0.3 0.4 0.1 0.1 0.23 0.15
-10 0.2 0.2 0.0 0.0 0.10 0.12
0 0.4 0.0 0.2 0.5 0.28 0.22
10 1.2 1.7 0.2 2.5 1.40 0.96
20 0.6 1.5 0.5 1.5 1.03 0.55
30 0.4 0.8 0.5 0.9 0.65 0.24
40 0.5 0.4 0.5 0.4 0.45 0.06
50 0.0 0.4 0.3 0.4 0.28 0.19
60 0.5 0.0 0.1 0.3 0.23 0.22
SIGMA CCK (TECHNICAL)
LOWRY PROTEIN, mg/dl
214
100 jig Mean ±SD
-50 12.0 16.4 10.2 9.9 12.1 3.0
-40 7.5 7.9 7.1 5.7 7.0 0.9
-30 6.5 7.1 5.3 6.3 5.8 1.2
-20 4.7 4.5 4.3 2.2 3.9 1.2
-10 4.1 3.0 3.3 1.8 3.1 1.0
0 2.6 3.0 3.2 1.0 2.4 1.0
10 37.2 34.9 26.2 38.6 34.2 5.6
20 48.5 42.8 49.3 28.6 42.3 9.6
30 34.1 25.0 32.1 21.1 28.1 6.1
40 18.1 13.2 15.6 10.6 14.4 3.2
50 21.0 12.0 8.5 4.9 9.4 3.4
60 9.1 10.8 7.1 2.2 7.3 3.7
ACID PHOSPHATASE, U/1
1000 Jjg Mean ±SD
-50 1.8 1.0 1.2 0.8 1.45 0.41
-40 0.9 0.6 0.6 0.9 0.75 0.17
-30 0.2 0.5 0.5 0.7 0.48 0.21
-20 0.0 0.4 0.3 0.5 0.30 0.22
-10 0.4 0.3 0.7 0.4 0.45 0.17
0 0.1 0.4 0.4 0.2 0.23 0.15
10 2.0 0.7 2.5 2.0 2.05 0.33
20 2.2 2.2 5.8 5.2 3.85 1.92
30 0.3 0.4 3.6 3.2 2.38 1.20
40 1.1 0.9 1.0 3.0 1.50 1.00
50 0.8 1.1 0.4 1.2 0.88 0.36
60 1.0 0.8 0.6 1.0 0.85 0.19
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APPENDIX 4
Amino acid abbreviations:
Ala alanine
Arg arginine
Asn asparagine
Asp aspartic acid
Cys cysteine
Gin glutamine
Glu glutamic acid
Gly glycine
His histidine
H e isoleucine
leu leucine
Lys lysine
Met methionine
Phe phenylalanine
Pro proline
Ser serine
Thr threonine
Trp tryptophan
Tyr tyrosine
Val valine
Abbreviations :
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APPENDIX 5
ACh
c-AMP
Bov
BSA
Bt2C-GMP 
chick 
CCK 
CCK-8 
CSV 
CTIP 
DOPA 
E-L 
FIF 
FITC 
■ G-17 
-GDP 
GIP 
GRP 
5-HT 
5-HTP 
IP 
PAP 
PBS 
PHI
PHM
Por
PYY
PI
RER
SER
VIP
acetylcholine
3’:5’-cyclic monophosphate 
bovine
bovine serum albumin
dibutyryl guanosine 3 5 '-monophosphate 
chicken
cholecystokinin 
cholecystokinin octapeptide 
cardio-stomacic vessel
concentrate of thermostable intestinal peptides
dihydroxyphenylalanine
endocrine-like
formaldehyde-induced fluorescence 
fluorescein isothiocyanate isomer 1 
gastrin heptadecapeptide (1-17)
-glycerphosphate dehydrogenase
gastric inhibitory peptide
gastrin releasing peptide
5-hydroxytryptamine
5-hydroxytryptophan
intraperitoneal
peroxidase anti-peroxidase
phosphate buffered saline
peptide with n terminal histidine and
c terminal isoleucine
peptide with n terminal histidine and
c terminal tyrosine
porcine
peptide with n terminal tyrosine and 
c terminal tyrosine 
phosphatidylinositol 
rough endoplasmic reticulum 
smooth endoplasmic reticulum 
vasoactive intestinal peptide
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Endocrine Cells in the Oesophagus
of the Ascidian Sty ela clava^
a Cytochemical and Immunofluorescence Study
P.J.R. Bevis and M.C. Thorndyke*
D e p a r tm e n t  o f  Z o o logy ,  Bedford  College,  L o n d o n ,  E n g lan d
Summary. Immunocy tochemical studies have demonstrated the occurrence of 
an insulin-immunoreactive cell type in the oesophageal epithelium of the 
Ascidian Styela ciava. Staining with aldehyde fuchsin has demonstrated a 
number of similar small, triangular, cells located on the basement membrane, 
which may have an endocrine function. Argyrophilic cells have also been found, 
suggesting the presence of a second endocrine cell type. The absence of 
argentaffin cells has led us to believe that the cells so far observed do not 
produce biogenic amines such as 5-HT (5-Hydroxytrvptamine). The nature of 
these cells is discussed with reference to endocrine-like cells found in the 
digestive tracts of other protochordates.
Key words: Endocrine cells - Gut epithelium - Ascidian (Stycia ciava) - Insulin­
like immunoreactivity - Light microscopy.
Introduction
Sufficient histological, cytochemical and ullrastructural evidence now exists to 
provide a good scheme for classification of endocrine cells in the gut of higher 
vertebrates. (Andrew 1976a. b; Capella et al.. 1969; Pearse. 1969.1971. 1974; Polak 
et al.. 1976; Solcia et al., 1973. 1975.) These cells share a number of cytochemical 
; and ultrastructural characteristics, possibly due to their common origin in
neuroectodermal tissue (Pearse. 1969). The discovery of cells with similar 
I characteristics in the digestive tracts of the lower vertebrates (Ostberg et al.. 1976;
I Van Noorden and Pearse. 1976; Van Noorden. et al., 1972) and invertebrates
! (Fritsch, 1976; Fritsch and Sprang. 1977; Fritsch et al.. 1976; Kataoka and Fujita,
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1974; Thorndyke and Bevis. 1977; Van Noorden and Pearse. 1976) has led to the 
suggestion that these cells may also produce polypeptide hormones.
However, convincing immunological evidence in favour of this content on is 
limited in invertebrates to the description of cells with glucagon-like, gastrin-like or 
insulin-like immunoreactivity in Amphioxus. (Van Noorden and Pearse, 197( j and 
insulin-like immunoreactivity in the gut of the bivalve Mytilus Fritsch et al.,
1976).
The present study was undertaken subsequent to the observation of endocrine- 
like cells in the oesophagus of Sryela ciava (Thorndyke and Bevis. 1977). in an 
attempt to determine the nature of their products.
Materials and Methods
Specim ens o f  SiyeUi c k n a  col lected in the  P o r t s m o u t h  a rea  were  t ra n s p o r te d  to  L o n d o n  in a e ra ted  
seawater ,  a n d  tr ansfe rred  to c ircu la t ing  sea w a ter  a q u a r ia  a t  10 C. T h e  o e so p h a g u s  was rap id ly  excised 
f rom each an im al ,  t rans fe r red  to  Bouin  fixative for 3 h  and  followed by d e h y d ra t io n  in g rad e d  e th a n o ls  
and  s ta n d a rd  pa ra ff in  wax e m b e d d in g  an d  sectioning. These  sections were  then  s ta ined  fo r  a rg y ro p h i l ia  
(Grimelius.  1968). a rgen ta f f in i ty  (Solcia  el al.. 1969). m a sk ed  m e ta c h ro m as ia  (Solcia  et al.. 1968). 
a ldehyde  fuchsin  o r  im m unof luorescence .
In tm iinn/hinrescencc. Para ff in  sections  ( 6 p )  were  t ransferred  to a lbum in ised  slides, dr ied  o v e rn ig h t  a t  
3 7 ' C. a n d  th en  im m ersed  in xylene  a n d  pe t ro leum  e th e r  to rem ove  the  wax. Im m u n o f lu o re s ce n c e  
sta ining was  by  the  indirect fluorescent a n t ib o d y  techn ique  (C o o n s  et al.. 1955). T he  sec t ions  were  
treated with  ant i  s e rum  to  bovine insul in (W ellcom e  Reagen ts  Ltd. . Eng land)  p ro d u c e d  in gu inea  pig. 
a n d  diluted 1 : 1 0  with  0.01 M p h o s p h a te  buffered  saline I PBS) pH 7.0. Fo l lowing  incu b a t io n  fo r  48 h a t 
4 C. the slides were  washed in PBS,  tr ea ted  fo r  1 h at r o o m  tem p e ra tu re  using F I T C  c o n ju g a te d  swine 
an t i -gu inea  pig serum  (N o rd ic  Im m u n o lo g ica l  L ab o ra to r ie s )  a n d  d ilu ted  1: :10 with PBS. T h e  s lides 
were  again  washed in several  c hanges  o f  PBS.  m o u n te d  in buffered glycerine (9 pa r ts  glycerine to  1 pa r t  
PBS) an d  exam ined  with a Zeiss  Universal  E pi -f luorescent p h o tom ic roscope .  C o n t ro l  s ta in ing  was  
carr ied  ou t  us ing a n o n - im m u n e  serum.
Results
Jniniiinojhiorcsccncc. Positive immunofluorescent staining was observed through­
out the oesophagus, these cells appearing to extend upwards from a broad base on 
(he basement membrane to a slender proeess reaching towards the gut lumen 
(Fig. 1 a).
Cyiochcnii.stry. Aldehyde fuchsin-positive cells were found in the same position as 
immunolluorescent cells, but they were seen to be far more numerous (Fig. 1 b). The 
dcn.se population of oesophageal mucous cells was also stained, but as these 
invariably occupy an apical position ad jacent to the gut lumen, they do not interfere 
w ith observation of cells on the basal lamina.
Tests for argentaffinity gave negative results as did methods for masked 
metachromasia. However. Grimelius' method for argyrophilia proved positive 
(Fig. Ic), staining distinctly granular cells which also rested on the basement 
membrane.
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Fig.  l a - c .  L ight p h o to m ic r o g r a p h s  showing  oe sophagea l  ep i the l ium  o f  S /y e la  ciava. a Insul in-  
im m u n o r ea c t iv e  cell ( a r row )  fo l low ing  im m uno t luo re sc ence  s ta in ing  with  a n t i s e ru m  to insulin,  x 1160. 
b .Aldchvde  fuchs in  s ta ined  cell ( a r r o w )  rest ing on the  basem en t  m e m b r a n e ,  x  650. c .Argyrophil ic cell 
( a r ro w ) ,  showing  distinct g ra n u le s  c lustered to w a rd s  the base  o f  the  epithe l ium ,  the  in te rvening  
u n s ta in e d  area being due  to  th e  p lan e  o f  sect ion. '  1250. B M  b a se m e n t  m e m b ra n e ,  L  lum en ,  M  apical 
m u c o u s  cells
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Discussion
This present demonstration of insulin-like immunoreactivity in the oesophagus of 
the Ascidian Styela ciava supports the initial findings of insulin immunoreactivity in 
gut extracts of C/’o/tr/(Davidson et al., 1971; Falkmer,Falkmer and Wilson, 
1967), and the more recent insulin immunofluorescence observed in Amphioxus 
(Van Noorden and Pearse, 1976). In this latter case, as in the present study, cross 
reactivity was weak, and positive staining only obtained using more extreme 
conditions than those normally employed with mammalian tissues.
This however, might be anticipated since immunofluorescence is a highly 
specific technique, and protochordate polypeptides could be expected to be 
immunologically quite different from their mammalian counterparts. Neverth-. less, 
there must be some similarities for even weak staining to have taken place. It is 
possible that anti-chicken insulin, if available, might produce better results in 
tunicates, as Ascidian insulin, extracted from the gut of Ciona intestinalis has been 
found to be antigenically more similar to chicken insulin than mammalian insulins 
(Falkmer and Wilson,1967).
The numbers, appearance and position on the basement membrane of the 
aldehyde fuchsin-positive cells described in the present study match the distribution 
and appearance of the granular oesophageal cells of Styela seen at the 
ultrastructural level (Thorndyke and Bevis, 1975). In Amphioxus, insulin 
immunofluorescent cells have been shown to be also aldehyde fuchsin-positive (Van 
Noorden and Pearse, 1976). However, the immunofluorescent cells in Styela 
oesophagus are observed less frequently than aldehyde fuchsin-positive cells, this 
may be due to difficulties in observing small, weakly fluorescing cells, or it may. 
represent a real differentiation amongst aldehyde fuchsin-positive cells, only some 
of them producing an immunoreactive insulin-like factor. In this regard it is of 
interest that only a single granular cell type (Type II) can be distinguished in Styela 
oesophagus at ultrastructural level (Thorndyke and Bevis, 1975), thus any 
difference is necessarily a subtle one.
In Amphioxus, glucagon/gastrin immunoreactive cells have been shown to be 
argyrophilic (Van Noorden and Pearse, 1976), thus the finding of argyrophilic cells 
in Styela oesophagus may indicate thatSmVu type II cells include glucagon gastrin­
like cells as well as insulin-like cells, the difference being indistinguishable at the 
ultrastructural level. A similar situation obtains in Ciona where both argentaffin 
and argyrophilic cells have been reported (Fritsch, 1976), while ultrastructural 
evidence points to only a single endocrine-like cell type (Fritsch and Sprang, 1977). 
It seems that only further work with anti-glucagon and anti-gastrin will show 
whether the argyrophilic cells indeed represent a genuine third endocrine cell type in 
Styela, as suggested for Amphioxus {Van Noorden and Pearse, 1976).
Despite general agreement that the endocrine-like cells found in pro­
tochordates may produce a polypeptide hormone or hormones (Biuw and Hulting, 
1971 ; Burighel and Milanesi, 1975; Kataoka and Fugita, 1974; Fritsch and Sprang, 
1977; Thorndyke and Bevis, 1975; Van Noorden and Pearse, 1976), it is as yet 
unknown whether they play a real physiological role in these animals. It may be that 
these cells, and their hormone-like products are simply homologues of the 
vertebrate endocrine system with no major physiological function existing for them
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al ihis pniTiitixc cvoluuonarx stage. Ii is pcriiaps rele\ani that the gastropod 
mollusc. Sirophochcitiis oh/oneus. a pnmiti\e protosiome. has been shown to 
metabolise glucose loads more rapidh loi lowing treatment with insulin (Marques 
and Falkmer. 1976). Clearly, a similar series ot' experiments in protochordates 
w ould pro\e an in\ aluable aid in the interpretation ot'current cytochemical reports. 
Preliminary investigations in Ciona iniL'siinalls{Bc\\'> and Thorndyke. unpublished 
observations) show that a glucose induced h\perglycaemia can be produced, and 
thus an investigation of this nature should be feasible.
In conclusion, the present stud\ supports the initial indications of an insulin 
producing endocrine cell, located in Stycia oesophagus (Thorndske and Bevis. 
19751 It lurther suggests the possibility of a second, argyrophilic. oesophageal 
endoc me cell, which as yet has not been distinguished at ultrastructural level 
These 'esults further support the need tor intensified research in this area of key 
evolutionary importance, in order to promote a clear picture of the development of 
the complex, vertebrate gastrointestinal endocrine system.
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Comparative Studies on the Effects of Cholecystokinins, Caerulein, 
Bombesin 6-14 Nonapeptide, and Physalaemin on Gastric Secretion
in the Ascidian Styela c/a va ^
M i c h a e l  C. T h o r n d y k e  a n d  P e t e r  J. R. B e v is ^
D epartm en t o f  Z oology , B edford  C ollege, London, England  
A ccepted Septem ber 20, 1983
The effects o f  cholecystokinins (CCK), caerulein, bombesin 6-14 nonapeptide (bombesin), 
and physalaemin on gastric secretion in S tyela  ciava  w ere measured using a perfusion 
technique. Varying concentrations o f  both CCK 33 and CCKg produced a significant dose- 
dependent response. D ose for d ose, CCK 33 was more potent than CCKg, while the assay  
was unable to show  any discrimination betw een sulphated and nonsulphated forms o f CCKg.
The specific CCK inhibitor BtjcGM P significantly reduced the response to both CCK 33 and 
CCKg. Both caerulein and physalaemin were effective although with a considerably reduced 
response compared with CCK. Bom besin was the m ost potent o f all secretagogues tested  
while glucagon w as without effect on gastric secretion. It is suggested that the primitive 
prepancreatic zym ogen cells in S tyela  possess a receptor or receptors with an ability to 
recognise those peptides which are also active on vertebrate pancreatic acinar cells. It is 
further suggested that while the results indicate a receptor system  less sophisticated than 
that found in vertebrates, they also imply the presence o f  an endogenous polypeptide hor­
mone or horm ones with a sequence which might be expected to show  similarities to more 
than one vertebrate gastrointestinal peptide.
In recent years the role o f secretagogues 
in the contro l o f acinar cell zym ogen secre­
tion in the m am m alian exocrine pancreas 
has been the subject o f intense investiga­
tion (G ardner and Jensen , 1980; G ardner et 
al., 1980; Jensen  and G ardner, 1979; Jensen 
et a l.,  1978, 1981; S ch u lze  and  S to lze ,
1980). Such s tud ies have  show n th a t the  
m ammalian pancreatic  acinar cell carries a 
num ber o f specific receptors which fall nat­
urally into at least six classes according to 
their ability to in teract w ith various secre­
tagogues and specific inhibitors. In this way 
recep tor classes have been identified which 
bind peptides from  the secretin , cholecys­
tokinin (CCK), bom besin 6-14 nonapeptide
' A preliminary report o f part o f this work was pre­
sented at the Ninth International Symposium  on Com­
parative Endocrinology, Hong K ong, 1982.
 ^ Present address: Endocrine Unit, Royal Postgrad­
uate M edical S c h o o l, D u can e R oad , L on d on  W I2  
OHS, England.
(bom besin), and substan ce  P fam ilies as 
well as those responsive to acetylcholine 
and  c h o le ra  to x in  (G ard n e r and  Je n se n , 
1980; Jensen  and G ardner, 1979; Jensen et 
al., 1978, 1981). Detailed investigation of 
the structural requirem ents for the action 
o f CCK  and related peptides on enzym e se­
c re tio n  in the  m am m alian pan creas  high­
light the im portance of the sulphated ty ro ­
sine at position 27 (position 7 from  the C 
term inus). Thus, desulphation or a change 
in position o f the sulphated tyrosine from  7 
to  6  (as in gastrin ) co nsiderab ly  reduces 
p o te n c y  a lth o u g h  no t a lw ays e fficacy  
(G ardner et al., 1980). Such subtle a ltera­
tions in sequence  allow  for the so p h is ti­
cated  target specificity achieved in m am ­
m als w here pep tides o f the  C C K /gastrin  
com plex are also involved in the control o f 
gall bladder contraction and gastric acid se­
cretion (D ockray, 1979, 1981).
In low er vertebrates the role of peptides
251
0016-6480/84 $1.50
Copyright © 1984 by Academic Press. Inc.
All rights o f reproduction in any form reserved.
252 T H O R N D Y K E  A N D  B E V IS
in the regulation o f gastro intestinal function 
is less clearly defined. In particular, the in­
terrelationships betw een peptide horm ones 
o f the classes noted  above and the evolu­
tion of endocrine control o f pancreatic  en­
zym e se c re tio n  hav e  re c e iv e d  re la tiv e ly  
little attention . S tudies on the m ost ancient 
vertebrates, the agnatha, indicate a role for 
C CK  in the stim ulation o f gut enzym e se­
cretion w hich predates the evolutionary ap­
p e a ra n c e  o f  the  e x o c rin e  p a n c re a s  as a 
d isc re te  and  se p a ra te  o rgan  (V igna and  
G orbm an, 1979). This secretory  response 
was noted in the absence o f any effect on 
gut o r gall b ladder sm ooth m uscle activity. 
F urther support for a prim itive role of CCK  
in the regulation o f prepancreatic  gut secre­
tion cam e in a recent study on the stim u­
lation by C CK  o f gastric enzym e secretion 
in the p ro tochordate  ascidian Styela ciava 
by the presen t authors (Bevis and T horn­
dyke, 1981). Such studies strongly support 
the idea of the early em ergence of an en­
docrine (or p e rh ap s  pa rac rin e) co n tro l o f 
digestive enzym e sec re tio n  in ch o rd a tes . 
H ow ever, m ore com plete inform ation con­
cerning the responses o f p ro tochordate  p re­
pancreatic zym ogen cells to the established 
secretagogues o f m am m alian acinar cells is 
lacking. This p resen t study, therefore, in­
vestigates in som e detail the response of 
such  p re p a n c re a tic  zym ogen  ce lls  to  a 
num ber of these secretagogues.
M A TER IA LS AND M ETH O D S
M aterials. ( / )  Animals. Specim ens o f  S. ciava  were 
collected in the Portsmouth area and transported to 
L ondon in aerated  seaw ater . A n im als w ere su b se ­
quently maintained in a fasting condition in a circu­
lating seawater aquarium at 1 0 °.
(2) H orntones. Bom besin 6-14 nonapeptide, caeru­
lein (caeruletide), and physalaem in w ere the kind of  
gifts o f  Roberto de Castiglione, Farmitalia. Pure por­
cine CCK 33 was a gift from Professor Viktor Mutt, 
Stockholm , and synthetic sulphated CCKg (Sincalide) 
was a gift from Squibb. Synthetic nonsulphated CCKg 
was purchased from Peninsula Laboratories Inc. and 
glucagon from  C alb ioch em . D ibutyryl cy c lic  GM P  
(Bt^cGMP) was purchased from Sigma Chemical Co.
E xperim ental. The stom ach o f  each specim en was
perfused  w ith artificial se aw ater  (Syn th etica l ac­
cording to a procedure described previously (Bevis 
and Thorndyke, 1981). Artificial seawater was intro­
duced through an oesophageal cannula at a flow rate 
o f  28 p,l/min and the perfusate co llected  as 1 0 -min al­
iquots through a tube inserted through the intestine 
into the distal end o f  the stom ach. Perfusate samples 
w ere collected over 2  h with the test infusion being 
given after 60 min. Freshly prepared test substances 
w ere infused in 200 p.1 o f  tunicate Ringer through a 
cannula placed in the card io-stom aic vessel. A  single 
dose o f  test peptide was given to each animal. Our 
previous stu d ies (B ev is  and T h orn d yk e, 1981) had 
shown that perfusate protein levels provided a con­
venient index o f enzym e output and this method was, 
therefore, adopted in the present investigation. Fur­
thermore, histological studies o f  postexperim ental an­
im als sh ow ed  no ev id e n c e  o f  m ucous secretion  or 
sloughing o f  cells, although they did indicate an in­
crease in zym ogen secretion. Thus perfusate protein 
was estim ated by the Low ry m ethod (Lowry et a i ,  
1951) in duplicate 100-p.l fractions o f  each 10-min ali­
quot.
Full details o f  the experim ental procedure and its 
rationale may be found in the earlier publication (Bevis 
and Thorndyke, 1981).
S ta t is t ic a l  a n a ly s is .  D iffer en ces  b etw een  means 
were considered to be significant if, using Student’s t 
test, P  <  0.05. Values are expressed as the mean ± 
SEM .
R ESU LTS
All form s o f CC K  tested  induced a sig­
nificant elevation o f perfusate  protein  ( = 
enzym e) levels , w ith  m axim al levels oc­
c u rrin g  w ith in  1 0 -1 5  m in o f  horm one 
a d m in is tra tio n  (F igs. 1, 2). R eco v e ry  to 
near-basal levels took place w ithin approx­
im ately 50 min, although at higher doses the 
elevated levels w ere m ore long lasting. It is 
notable tha t dose for dose, C C K 3 3  was more 
p o te n t th an  CCKg. M axim um  pro tein  
output w ith C C K 3 3  a t 2.6 x  1 0 and 2.6 
X 10“  ^M  was 37.9 ±  7.9 and 13.9 ±  2.0 
mg/dl, respectively, while som ew hat higher 
doses of CCKg, 1.1 x  10""^ and 1.1 x 10“  ^
M ,  increased protein  levels to 18.9 ±  4.5 
and 7.4 ±  3.3 mg/dl, respectively. Figure 3 
show s, com paratively, the effect o f similar 
(1.1 X 10''^ M) infusions o f sulphated and 
n o n su lpha ted  CCKg. T he ind ica tions are 
tha t, in our hands, they are equipotent. In 
those experim ents w here the specific CCK
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F ig. 1. E ffect o f  sulphated CCKg on perfusate protein levels. Infusions o f  1.1 x  10“* Af (O, n =  
3), l .I  X 10“ '* M  (Ô , n =  3), and 22 x  10“  ^M  ( # ,  n =  8 ) CCKg all produced levels o f perfusate 
protein significantly higher than controls. Mean ±  SEM .
inhibitor B t2cGM P (5 m M )  was inflused to ­
gether w ith CCKg and C C K 3 3  the  elevation 
o f perfusate protein  levels w as significantly 
reduced w hen com pared to  tha t achieved 
with either adm inistered alone (Fig. 4). It is 
also w orth  noting th a t these data  again con­
firm  th e  g re a te r  e ffec tiv en ess  o f  C C K 3 3  
o v e r CCKg (S in ca lid e). In  th is  re g a rd  it 
would be o f in terest to investigate the ef­
fectiveness o f CCK 4 , the C-term inal frag­
m ent o f which contains the active site for 
C CK  and gastrin. U nfortunately C C K 4  was
40-1
3 0 -
20-
10-
-20 10 100 20 603 0 5 040
Minutes
F ig. 2. Eflfect o f  CCK 33 o" perfusate protein levels. Infusions o f  2.6  x  10“ ® A/ (O , « =  4) and 2.6  
X I0 “* At ( • ,  n =  5) both produced levels o f  perfusate protein significantly higher than controls. 
Mean ±  SEM .
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no t av a ilab le  fo r tr ia l. T he e ffec t o f 
B t2cGM P on bom besin- and physalaem in- 
in duced  se c re tio n  w as n o t te s te d . T ests 
with physalaem in and caerulein w ere also 
effective but here the secretory  response in­
duced was low er than that seen with sim ilar 
doses o f C C K , although the tim e course of 
the response rem ained the sam e (Fig. 5). 
Thus, 7.7 X 10~^ M  physalaem in and 7.3 
X 10“  ^ M  c a e ru le in  p ro d u c e d  m axim al 
levels o f 13.3 ±  5.2 and 8.1 ±  2.6 mg/dl, 
respectively, w ithin 1 0  min o f adm inistra­
tion.
The m ost effective of all secretagogues 
tested  was bom besin. H ere, treatm ent with 
9 X 10“  ^M  bom besin induced a  maximal 
level o f 24.4 ±  5.0 mg/dl secretory  protein 
within the first 1 0 -min postinfusion period 
(Fig. 6 ). Trials with glucagon (2.9 x  10"^ 
M) produced no significant effect on gastric 
protein secretion  (Fig. 5).
DISCUSSION
T he re su lts  p re se n te d  ab o v e  in d ica te  
c lea rly  th a t a  n u m b e r o f  v e r te b ra te  gas- 
troen teropancreatic  (CEP) peptides stim u­
late the release o f gastric enzym e secretion 
in S. ciava, m easured as Low ry protein. 
This seem s to imply the p resence o f a pop­
ulation o f prepancreatic  zym ogen cells with
a recep to r com plem ent able to  recogn ise  
certa in  v e rteb ra te  gut p ep tide  horm ones 
(Figs. 1 -6 ). In m am m als, pancreatic  acinar 
cells p ossess a soph istica ted  a rray  o f  re ­
cep to r classes, w here acetylcholine, phys­
alaem in (with substance P, eledoisin, and 
k ass in in ), b o m b esin  (w ith  lito r in , ran a - 
tensin, and alytesin), secretin  (with vaso­
active in testina l pep tid e , V IP), and  C C K  
(with caerulein and gastrin) each dem and 
their ow n recep to r class. There is, in ad­
dition, a sixth class with cholera toxin as 
the involved agonist.
D etailed  investigation  o f s tru c tu re -a c -  
tiv ity  re la tio n sh ip s  w ith in  the  C C K  re ­
cep tor class by G ardner and his colleagues 
(G ardner and Jensen , 1980; G ardner et al., 
1980; Jensen et a i ,  1981) em phasise the im­
portance o f the sulphated tyrosine residue 
at position 7 from  the C term inus as a re ­
quirem ent for full potency. D esulphation or 
translocation  from position 7 to 6  from  the 
C term inus, as in gastrin, considerably re ­
duces activity in the acinar cell system . In 
a similar way these alterations also curtail 
the gall bladder sm ooth-m uscle-contracting 
or cholecystokinetic effect o f C C K , while 
at the same time conferring greater efficacy 
in the stim ulation of gastric acid secretion  
as the molecule becom es m ore gastrin-like.
30-,
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Minutes
F ig. 3. Comparative effects o f  1.1 x  IQ-^ M  each, sulphated ( 0 ,  n =  3) and nonsulphated ( # ,  n 
■ 3) CCKg. N o  significant difference in response was observed. Mean ±  SEM .
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F ig. 4. Effect o f  1.1 x  10“ "*M  sulphated CCKg, with ( € ,  « =  4) and without (O , n =  4) Bt^cGMP 
(5 m M ). This specific CCK inhibitor significantly reduces the normal CCK response. Mean ±  SEM .
A n o th e r u n iq u e  fe a tu re  o f  th e  C C K  re ­
ceptor class is the efficiency o f the com ­
p e titive  an tag o n is t B t2 cGM P. P resen ce  o f 
this m oiety specifically inhibits the in ter­
ac tio n  o f  C C K  and  s tru c tu ra lly  re la te d  
form s w ith  its  re c e p to r  (D o ck ray , 1981; 
D ockray et al., 1980; Jensen  et al., 1981; 
Peiken et al., 1979). In low er vertebrates 
the situation is less well know n, largely due 
to  the lack  o f pub lished  investig a tio n s in 
this field. In the agnatha, as in ascidians, 
there is no d iscrete exocrine pancreas and 
zym ogen cells may be found scattered  spo­
rad ica lly  in th e  in te s tin a l m u co sa  (B a r­
rington, 1972). Vigna and G orbm an (1979) 
show ed that, in E ptatretus, the secretion o f 
lipase from the intestinal cells could be in­
duced  by  po rc ine  C C K 3 3  w hile sec re tin , 
VIP, and glucagon were w ithout effect. Ag­
onists for o ther m am m alian acinar cell re­
cep to r classes w ere not tested . It is an a t­
trac tiv e  hyp o th esis  th a t th is could  re p re ­
sent a  prim itive action of CCK  before the 
evolutionary developm ent o f the pancreas 
as a  se p a ra te  o rgan  and  indeed  it seem s 
likely that this gastrointestinal role for CCK  
predates its cholecystokinetic effect since, 
w hen  te s te d  on sm o o th  m uscle  p re p a ra ­
20-1
-20 - 1 0 0 10 605020 30 40
Minutes
F ig. 5. Comparative effects o f  physalaem in, 7.7 x  =  4), caerulein, 7.3 x  lO '^M  ( # ,
n =  3), and glucagon, 2.9 x  10“^ M (O , n =  4). Both physalaemin and caerulein induced a significant 
increase in perfusate protein levels, while glucagon was without effect. Mean ±  SEM .
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Fig. 6 . Effect o f  bombesin (bom besin 6-14 nonapeptide) on perfusate protein levels. Infusions o f  9 
X  10" ® M (* , « =  4), 4.5 X 1 0 " * M (O ,/I  =  3), and 4.5 x  10"’ M (O , « =  3) all increased perfusate 
protein levels. Mean ±  SEM .
tions from  E pta tretus  gall bladder and in­
te s tin e , C C K  fa iled  to  in d u ce  any  c o n ­
tractions although acetylcholine was fully 
effective (Vigna and G orbm an, 1979). Sup­
p o rt fo r su ch  a p rim itiv e  ro le  fo r  C C K  
comes from  previous studies on ascidians 
by the p re sen t a u th o rs . In  th e se  anim als 
there is neither d iscrete pancreas nor gall 
bladder hom ologue or indeed any gut-as­
sociated sm ooth m uscle (Bevis and T horn­
dyke, 1981). In this way control o f gastroin­
testinal cell secretion  may well be the m ajor 
regulatory role for such G E P peptides as 
are present. It should be noted here that the 
term s “ stom ach”  and “ g astric ,”  as applied 
to ascidians, are used largely as a m atter o f 
convenience and should not be com pared 
directly  to  th e ir  v e rteb ra te  co u n te rp a rts . 
Thus, the stom ach in Styela  is a  com plex 
organ w here both intra- and extracellular 
digestion take place. The gastric epithelium  
is characterized by m ucus-producing cells, 
endocrine cells, absorptive cells, and a dis­
crete population o f prepancreatic  zym ogen 
cells (T h o rn d y k e , 1977; T h o rn d y k e  and 
Bevis, 1978; Bevis and T horndyke, 1979,
1981).
In our earlier study (Bevis and T horn­
dyke, 1981) we show ed that porcine CCK
and CCKg stim u la ted  th e  re le a se  o f  se ­
cretory  proteins in the Styela  perfused 
stom ach preparation  (presum ably from  the 
prepancreatic  gastric zym ogen cells). The 
current investigation extends this w ork and 
suggests that even a t this relatively early 
stage in chordate evolution, zym ogen cells 
already possess the beginnings o f the rich 
recep tor com plem ent seen in higher verte­
b ra tes  and m am m als in particu la r. T hus, 
th e se  p rim itiv e  zym ogen  ce lls  a p p e a r  to  
have receptors sensitive no t only to  a va­
riety  of CCK  m olecules and related  pep­
tides such as caerulein, but also to  bom ­
besin and physalaem in, each a represen ta­
tiv e  ag o n is t o f  a  m ajo r re c e p to r  c la ss  in 
m am m alian acinar cells (Figs. 5, 6 ). M ore­
over, this sensitivity has certain  elem ents 
o f the specificity seen in higher form s as 
evidenced by the ability of B t2cG M P to an­
tagonise the CCK  effect (Fig. 4). How ever, 
s ince  s tu d ies  on c o m p e titiv e  e ffec ts  b e ­
tw een these peptide classes have not been 
undertaken, it is im possible to  say, at this 
stage, to w hat extent we are dealing with a 
n u m b er o f  d iffe ren t re c e p to r  ty p es  or 
w h e th e r th e se  an im als hav e  a single 
broadly specific recep to r which identifies a 
range of G F P  peptides. I t is recognised, of
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course, tha t the doses o f peptides used in 
the presen t study do represen t levels nor­
m ally consid ered  pharm aco log ical in v e r­
tebrates, and in this respect fu rther exper­
im ents on the effect o f B tjcG M P on bom ­
besin- and physalaem in-induced secretion 
could be instructive. H ow ever, it should be 
noted that there is a  certain  degree o f spec­
ificity here since both glucagon (Fig. 5) and 
secretin (Bevis and T horndyke, 1981) are 
to ta lly  w ith o u t e ffec t. F u rth e rm o re , th e  
need to apply such doses should not be to ­
ta lly  u n e x p e c te d  in an  an im al so fa r  re ­
m oved from  the m am m alian line. Clearly 
there is a low er level o f zym ogen cell so­
phistication in ascidians since they are ap­
paren tly  unab le  to  d istingu ish  su lp h a ted  
and nonsulphated form s o f C C K . This is in 
accord w ith a  pattern  o f evolutionary pro­
gression w hereby in fishes we do indeed 
see the beginnings o f s tru c tu re -ac tiv ity  re ­
lationships. Thus in coho salm on, studies 
on gall bladder activity  show  that although 
change in position o f the sulphated tyrosine 
from  7 to 6  from  the C term inus has little 
or no effect on activity, desulphation o f this 
residue dram atically reduces C CK  potency 
(Vigna and G orbm an, 1977). Such evolu­
tionary changes are likely to  be the  result 
o f a  com plex set o f adaptive m echanism s, 
including the developm ent o f jaw s together 
with a separate  stom ach. It is also likely 
that is was during this period in the  evolu­
tionary developm ent o f gastrointestinal reg­
ulatory m echanism s that a  role for CC K / 
gastrin in the control o f gastric acid secre­
tion em erged (see Vigna, 1983). It was no­
table in our earlier study tha t secretin  was 
w ithout detectable effect on the prim itive 
zym ogen cells in Styela  (Bevis and T horn­
dyke, 1981), although it rem ains a specu­
lative possibility that secretin  is concerned 
with the separate  control o f m ucous cell se­
cretion). This w ould imply tha t, notw ith­
standing our earlier com m ents suggesting 
the presence o f a  ra ther broadly specific re ­
cep tor o r recep to r class on these p repan­
creatic  zym ogen cells, there  is clearly an
elem ent o f specialization in tha t, w hatever 
the receptor com plem ent may be on these 
ce lls , recep to rs  akin  to  the  sec re tin /V IP  
class or classes are evidently absent.
In m am m als, acinar cell recep to r classes 
m ay be g ro u p ed  in to  su p e r  c la sse s  a c ­
cording to the second m essenger em ployed. 
The secretin/V IP class is unique am ong the 
peptides in operating through a cAM P-de- 
pendent system ; all rem aining peptides uti­
lize calcium  as a second m essenger. It is an 
attractive possibility to suggest that in ev ­
olutionary term s, receptors on prim itive zy­
mogen cells o f the type found in ascidians 
invoke calcium  as their in tracellular m es­
senger and that only later does cAM P b e­
com e involved as part o f the secretin/V IP 
recep to r com plex. Such a hypothesis is in 
accord  w ith the p resen t results and those 
from  our earlier study, although it should 
be po in ted  ou t th a t we have no t in v es ti­
g a ted  th e  seco n d  m essen g e r sy s tem  in 
S ty e la  zym ogen  ce lls and  th e re fo re  th is  
possibility rem ains speculative.
Finally, it is w orth noting that recep to r 
sp ec ific ity  and  d ev e lo p m en t go h an d  in 
hand w ith peptide horm one evolution and 
c learly  the  ap p aren t lack  o f re c e p to r so ­
phistication in Styela  zym ogen cells could, 
in part, reflect the nature of the endogenous 
peptides or peptides for which the recep to r 
or recep to rs have becom e adapted. In o ther 
w o rd s, th is  p resen t rep o rt highlights th e  
p roblem  o f  horm one versus ho rm one re ­
cep to r evolution. In our earlier publication 
(Bevis and T horndyke, 1981) we noted that 
there was som e difficulty in identification 
o f the native ascidian peptide in tha t im­
m unofluo rescence  stud ies ind ica ted  a se ­
cretinlike peptide ra ther than a CCK-like 
m olecule. In spite o f this difficulty it was 
su g g ested  th a t the  en d o g en o u s a sc id ia n  
m o lecu le  m ight be an e x te n d e d  p e p tid e  
w ith  sev era l s ite s  o f  b io log ica l ac tiv ity . 
Thus full recep to r occupancy might require 
a num ber of distinct am ino acid groupings. 
This point receives som e support from  the 
apparently  greater effectiveness o f C C K 3 3
258 T H O R N D Y K E  A N D  B E V IS
over CCKg (Fig. 1, 2), and argues in Styela  
for receptors with a requirem ent for more 
than the C-term inal octapeptide sequence 
o f CCK. F urtherm ore, recent collaborative 
s tu d ie s  using  sem ip u rified  S ty e la  gu t 
e x tra c ts  (T h o rn d y k e , B ev is , D im aline , 
D ockray  and  M utt, unpub lished  o b se rv a ­
tions) have show n that Styela  gastric en­
docrine cells do indeed elaborate a  peptide 
with ra ther m ore CCK-like than caerulein- 
like properties based upon bioassay and ra­
dioim m unoassay ra ther than im m unocyto- 
chem istry alone. Indeed , indications are for 
a p ep tid e  so m ew h a t la rg e r th a n  CCKg. 
M oreover, w hen such partially  purified ex­
tra c ts  w ere  te s te d  in th e  S ty e la  g astric  
assay preparation , they w ere found to be 
considerab ly  m ore p o te n t th an  any p re s ­
ently tested  peptide (Thorndyke and Bevis, 
u n p u b lish ed  d a ta ) . I t  cou ld  th e re fo re  be 
that the native peptide (or peptides), w hen 
fully ch a ra c te rise d , will p rove  to  have a 
com position  and seq u en ce  w hich cro sses  
the peptide class barrier and com es close 
to being the prosecgastrin  m olecule which 
has been the highly prized ancestral peptide 
sought by com parative gastrointestinal en­
docrinologists for a num ber o f years. In­
d eed , m am m alian  b io a ssa y  o f  th e  sam e 
semipurified ex tracts referred  to  above do 
have secretin/V IP-like activity in addition 
to their CCK-like features (Thorndyke and 
Bevis, 1983). S tudies currently  underw ay in 
this and collaborating laboratories are going 
some way to answ er these questions.
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A Cytochemical and Immunofluorescence Study 
o f Endocrine Cells in the Gut 
of the Ascidian Stye la  ciava
PJ.R. Bevis and M.C. Thorndske*
D e p a r tm e n t  o f  Z oo logy ,  B edford  College.  L o n d o n .  I ng land
Summary. Strong secretin-like iinmunoriiiorescence has been demonstraled in 
endocrine-like cells from the gastric epithelium o\'Siycla. These cells also slain 
with lead haematoxylin and exhibit a brilliant formaldehyde-induced lluores- 
cence, but do not show any other cytochemicid features characteristic of the 
mammalian APUD series. Tests with antisera to glucagon, gastrin and 
somatostatin all proved negative. In the oesophagus tests with all lour antisera 
pro\ ed negative. The significance of these results is discussed in relation to the 
phylogeny of vertebrate gastro-intestinal hormones.
Key words: Endocrine cells Cut epithelium .Ascidian (Siyclu ihna)
I m m u n o II u o re seen ce C'vtochemistrv.
The general ultrastructural appearance and c\ tochemisiry of cndocrinc-like cells m 
the gastrointestinal tract of protochordates is now becoming well documented 
(Bevis and Thorndyke. 197S; Burighel and Milanesi. P)75; fritsch, 1^ 76: fritsch 
and Sprang, 1977; f ritsch el al.. 197S: Thoriuhke and Bc\is. I97S: \ an Noorden 
and Pearse. 1976). 1 hese basal granulated cells appear to elaborate peptides which 
have immunologicalb similar counterparts in the \crtcbratc gastro-entcro- 
pancreatic endocrine system. Thus, cells showing insulin-like, glucagon-like. 
gastrin-like and somatostatin-like immunoreactn it\ ha\ e been ticmonstratcil in I lie 
gut of several protochordate species ( Be\ is and Thorndy ke. 197S; 1 ritsch et al.. 
1978: Van Noorden and Pearse. 1976).
No clear pattern has emerged and this present study is an attempt to clarify the 
situation, followine the successful demonstration ol insulin-like immiiiuMeactix it\
S e n d  o ffp r in t rcquvsis to: D i M .C  T t io rn i l \k c .  DcparlniL'nl ot / i> i ' lo g \ .  Bciiloii l I ollcgc. Kcgoiit 's 
Pa rk .  L o n d o n  N W t  4N S.  L ng land
A ikn o w lcd g cm en ts :  T he  a u th o r s  arc  grate fu l to  Mi l ) a \ i d  H o u g h to n  an d  his stal l ol tlie \ d n i i r a l l s  
M ar in e  Tr ia ls  S ta t ion .  P o r t s m o u th  for ass is tance  in ihe collection ol a n im a ls .  1 his research was carr ied  
ou t  d u r ing  the  tenu re  o f  S t< ( . gran t  no. B P f i  SZ^t^i to  one  o f  us (M  C .T . l  T he  localization  o f  
po lypep t ide  h o rm o n e s  in the  p h a ry n x  a n d  gut ol p ro to c h o rd a te s
(l.;0:-"6(A 71) (lino 01 3c) SOI.20
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in cndocrinc-likc colls o\ Sfvclu oesophagus {Be\ is and Thorndyke. 19 /8 ) hy testing 
tor secretin, gastrin, glucagon and somatostatin immunoreacti\ ity in one species. 
Sivchi ciava.
Materials and .Methods
.Specimens of Styela ciava. collected in the Portsmouth area, were transported to London in aerated 
seawater and transferred to circulating seawater aquaria at 10 C. .Animals were rapidly dissected, small 
pieces ol stomach and oesophagus excised and transferred either to Bouin fixatixe in seaw ater lor 3 h or 
h''„ glutaraldchyde. Tollowinc standard paraffin wax embedding, sections were cut. and stained for 
argyrophilia (Grimelius. 1%S). argentaffinity (Solcia et al.. l% 9a). masked metachromasia (Solcia et 
al.. 196S). lead haematoxylin (Solcia et al.. 1969b). aldehyde fuchsin. or were used in immunofluores­
cence tests. Additional samples o f stomach and oesophagus were freeze dried and formaldehyde vapour 
fixed (Faick et al.. 1962) for the demonstration o f  biogenic amines by formaldehyde induced 
fluorescence (FIT).
Invmaiofhiarc.'iccncc. Antibodies to porcine secretin were raised in New Zealand white rabbits. The 
antigen was conjugated to bovine serum albumin by coupling with 1-ethyl-3 (3-dimethyl-aminopropyl) 
carbodiimide hydrochloride (Sigma) (Goodfriend et al.. 1964). The product was then emulsified in 
Freund's complete adjuvant and injected in multiple subcutaneous sites at 0. 1 and 6  months. Bouin- 
fixed sections (6  pm) were transferred to albuminised slides, dried overnight at 37 C and then dewaxed 
in xylene and petroleum ether. Immunofluorescence staining was carried out according to the indirect 
antibody technique (Coons ct al.. 1955). Sections were treated with anti-porcine secretin serum prepared 
by the authors, or with anti-glucagon anti-synthetic human gastrin, anti-synthetic somatostatin or anti- 
porcine secretin: all produced in rabbits, and all the kind gift o f Julia Polak and Susan Van Noorden. 
Royal Postgraduate Medical School. London. Dilutions with phosphate buffered saline (PBS) were in 
the range 1 ' 50 to 1: 10.000
Control staining included the use o f non-immune rabbit serum. PBS. or diluted immune serum 
preabsorbed overnight at 4 C with the appropriate antigen. Positive controls w ere also carried out using 
known positive mouse tissues
f  ollowing incubation for 18 h in humid containers at room temperature, sections were washed in 
PBS and treated for I h with LITC conjugated swine anti-rabbit scrum ( Nordic) diluted 1: 30 with PBS. 
Following a further wash in PBS the sections were mounted in buffered glycerine i9 parts glycerine to 1 
part PBS I and examined w ith a Zeiss L niversal Fpi-lluorescence photomicroscopc
Results
Cyiachcnti.stry. I ntlocrinc-like cells in the cap region ol the gastric epithelium 
showed bright lluorescence with FIF (Fig. lb) and positive staining with lead 
haematoxylin (Fig. Ic). Tests for argyrophilia. argentaflniity. masked metachro­
masia and aldehyde fuchsin were all negative. This is in direct contrast to the 
reactions of oesophageal endocrine-like cells whose cytochemistry is reported 
elsewhere (Bevis and Thorndyke. 1978).
htiiiutiiofiiiair.svciuv. Gastric endocrine-like cells exhibited positive immuno- 
lluorescence with both anti-secretin preparations used (Fig. la). Brilliant, long, 
slender cells extending frofn basement membrane to gut lumen were obserxed at 
atitiserum dilutions from 1:50 to 1:10.000. Positive control cells in mouse 
duodenum also showed strong fluorescence with these antisera but only at dilutions 
down to 1: 1.000. No positixe immunostaining xvas obserxed xvith anti-elucaeon.
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Fig. 1 a -c . Photomicrographs o f the cap region from the gastric epithelium o f  Siyela ciava. a 
Immunofluorescence o f cells after treatment with dilute anti-secretin serum, x 300. b Formaldehyde 
induced fluorescence, x 200. c Lead haematoxylin, x 200. L, gut lumen
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anti-gastrin or anti-somatostatin although positive controls using mouse tissue in 
parallel proved positive.
In the oesophagus, no positive immunostaining was observed with any of the 
anti-sera tested.
Discussion
Earlier work has shown that the gastrointestinal tract of the ascidian Styela ciava 
contains at least two types of granulated endocrine-like cell (Thorndyke and Bevis. 
1978). Type II cells, which are restricted to the oesophageal epithelium, have been 
shown to exhibit insulin-like immunoreactivity together with a number of other 
characteristics typical of vertebrate gut endocrine cells (Bevis and Thomdvke,
1978).
This present study confirms the individuality of Type I gastric endocrine-like 
cells, which exhibit a brilliant secretin-like immunoreactivity together with various 
APUD characteristics quite distinct from those found in Type II cells. Furthermore, 
it is clear that the secretin-like immunoreactivity is specific since two quite distinct 
anti-secretin preparations were successfully used, while parallel studies using anti­
glucagon, anti-gastrin and anti-somatostatin sera all proved negative. Similar 
studies using these four anti-sera on the oesophageal Type II cells of Styela were all 
negative.
This is in sharp contrast to the situation which obtains in Ciona intestinalis, 
where both gastrin-like and somatostatin-like immunoreactivity has been localised, 
while insulin-like and secretin-like factors are apparently absent (Fritsch et al., 
1978 ). In addition, the gut of another, more advanced and perhaps more specialised 
protochordate, amphioxus, has been shown to include endocrine cells with insulin­
like, glucagon-like and gastrin-like immunoreactivity (Van Noorden and Pearse.
1976).
Thus the gastrointestinal endocrine relations within this phylogenetically 
important group of animals seems far from clear and show a greater degree of 
divergence than might have been anticipated. This serves to highlight our 
inadequate knowledge of such invertebrate groups. Preliminary results from related 
ascidian studies (Thorndyke and Bevis, to be published) indicate that while 
secretin-like activity is found in Dendrodoa grossularia, it is absent from Ascidiella 
aspersa. Indeed, no other immunocytological demonstration of this hormone in 
lower chordates or invertebrates has been recorded since its demonstration in 
canine and human intestines (Polak et al., 1971 a-b).
Secretin-like activity has, however, been demonstrated by bioassay in intestinal 
extracts from lampreys (Barrington and Dockray, 1970; Nilsson, 1973). Unfor­
tunately subsequent immunocytochemical tests failed to identify the site of secretin 
production (Van Noorden and Pearse, 1974).
Clearly our knowledge of vertebrate gastrointestinal hormone phylogeny is 
incomplete and schemes that have been presented include a degree of speculation. 
However, both morphological and biochemical evidence suggests that insulin, 
glucagon, gastrin and secretin may all have a common evolutionary origin 
(Adclson, 1971; Track, 1973). With the present demonstration of secretin-like
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activity in Siyela. all of these key gut hormones have now been located in the 
protochordate gastrointestinal tract. It must be noted, however, that some of these 
hormones are also found in protostomian phyla. Thus gastrin has been 
demonstrated immunologically in molluscs (Straus et al.. 1975 ) and the presence of 
molluscan insulin has been demonstrated by various means (Davidson et al., 1971 ; 
Fritsch et al.. 1976; Marques and Falkmer. 1976). Basal granulated endocrine-like 
cells have been observed in both bivalve and gastropod molluscs (Boquist et al.. 
1971 ; Fritsch and Sprang, 1977) and similar cells have been observed in the 
gastrointestinal system of Macropipuspuber (Decapoda) (Thorndyke and Trinder, 
unpublished observations). These findings give support to the idea that the 
vertebrate gastrointestinal endocrine system may have originated in the primitive 
invertebrate gut, perhaps even before the separation of protostomian and 
deuterostomian lines.
In this regard it is of great interest that in recent studies on the differentiation of 
mammalian gut endocrine cells (Larsson and Jorgensen. 1978) it was found that 
secretin producing cells pass through a developmental stage where they also store a 
biogenic amine, as demonstrated by formaldehyde-induced fluorescence. At this 
stage in their differentiation then, these mammalian cells display a remarkable 
similarity to the secretin immunoreactive cells of Sryela.
The gastric Type I cells of the present study show an unusually high 
immunological sensitivity, being ten times more sensitive to porcine secretin 
antibodies than were mouse control tissues. This may indicate an unusually high 
concentration of a secretin-like factor in Sryela-. equally it may represent a much 
closer antigenic similarity between Styela “secretin" and porcine secretin than might 
have been anticipated. Investigations currently in progress are designed to 
determine whether this secretin-like factor is also active in a bioassay.
As with the demonstration of insulin-like material in Styela (Bevis and 
Thorndyke. 1978) it is not known what role, if any. the secretin-like material might 
play in the animal's normal physiology. It would seem likely, however, that the 
production of such apparently large quantities of this material, in an active organ 
like the stomach, has some functional significance. Only a detailed analysis of 
ascidian physiology will answer these questions. Such a study is currently in 
progress in this laboratory.
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Stimulation of Gastric Enzyme Secretion by Porcine 
Cholecystokinin in the Asciidian Styela clava^
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The effects o f  porcine cholecystokinin  (CCK) and secretin on gastric enzym e secretion in 
Styela  clava  w ere measured using a perfusion technique. Secretin was found not to be 
active, whereas CCK and CCK-octapeptide were both found to stimulate gastric release o f  
acid phosphatase and proteins. Varying doses o f CCK, between 0.1 and 1.0 mg, produced an 
approximately linear dose/response. It is suggested that these results are evidence o f  a 
paracrine system  involving a prosecgastrin-like m olecule, produced in the gastric epithe­
lium.
Protochordates are the most primitive 
chordate group and occupy a unique posi­
tion in vertebrate phylogeny. They possess 
some highly specialized adaptations while 
retaining a number of primitive features 
which makes their study important when 
considering the evolutionary development 
of vertebrate gastrointestinal peptide hor­
mones. Two protochordate groups have so 
far been examined for peptide hormones 
using histochemical and cytochemical 
techniques, the cephalochordates (Bran- 
chiostomatidae) (Van Noorden and Pearse,
1976), and the more primitive urochordates 
(Ascidiacea) (Bevis and Thorndyke, 1978; 
1979; Thorndyke and Bevis, 1978; Fritsch 
and Sprang, 1977; Fritsch et al., 1978). 
Both groups possess cells which are im- 
munologically similar to vertebrate peptide 
hormone-producing cells (Pearse, 1969). 
The cells, which extend to the gut lumen 
contain basal, electron-dense granules.
Using immunofluorescence techniques, 
glucagon-, gastrin-, and insulin-like pep­
tides have been observed in the gut of am­
phioxus, Branchiostoma lanceolatiim (Van 
Noorden and Pearse, 1976), and insulin-,
' A preliminary report on part o f  this work was given  
at the Third International Sym posium  on Gut Hor­
m ones in Cambridge, U .K ., Septem ber 1 4 -1 8 , 1980 
(Thorndyke and B evis, 1980).
* To whom reprint requests should be addressed.
gastrin-, secretin-, and somatostatin-like 
immunoreactivity has been observed in the 
guts of the ascidians Styela clava and Ciona 
intestinalis (Bevis and Thorndyke, 1978; 
1979; Fritsch and Sprang, 1977; Fritsch et 
ai, 1978).
These findings indicate that the gut 
epithelia of these protochordate groups 
contain cells which produce peptides im- 
munologically similar to some vertebrate 
gut hormones. However, there are not suf­
ficient grounds at the present time for refer­
ring to a protochordate gut endocrine sys­
tem, since there is no evidence that these 
peptides are biologically active in these 
animals.
If a protochordate gut endocrine system 
were to exist, then it would require meth­
ods other than immunofluorescence to 
demonstrate it. The present study ap­
proaches this question using a gastric per­
fusion technique.
M A TER IA LS AND M ETH O D S
Materials
I) A nim als. Specim ens o f  S tyela  clava  were co l­
lected in the Portsmouth area and transported to Lon­
don in aerated seawater. Animals were subsequently  
maintained in a fasting condition in a circulating sea­
water aquarium at 10°. M ost animals adapted well to 
th e se  c o n d it io n s , and the sm all p ercen ta g e  o f  
moribund animals w ere readily identified by their
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flacidity, and closed siphons. Only healthy, turgid, ac­
tively siphoning animals were used in experim ents.
2) H orm ones. Synthetic, nonsulphated cholecysto- 
kinin-octapeptide and porcine secretin were purchased 
from Peninsula Laboratories, Inc., California. T ech­
nical grade CCK was purchased from Sigma (London).
Perfusion Technique
/ )  A natom y. S tyela  clava  is a sessile filter feeder 
and has a simple gut conveniently divided into four 
distinct regions: the pharynx, oesophagus, stom ach, 
and intestine. H ow ever, it should be pointed out that 
these terms are used largely as a matter o f  convenience  
and should not be compared directly with their verte­
brate counterparts. The short oesophagus draws food  
particles from the pharynx into the stom ach, where 
both intracellular and extracellu lar digestion  take 
place. The gastric epithelium is folded into a series o f  
ridges, the ap ices o f  which form distinct " c a p s ,”  
w h ich  c o n s is t  o f  m u co u s-p r o d u c in g  c e l l s ,  and  
endocrine-like cells (Fig. I). The side walls contain  
absorptive cells, and enzym e-secreting zym ogen cells. 
Underlying these ridges is a com plex network o f blood 
spaces, which connect to vessels lying on the outer 
surface o f  the stomach and leading to the general cir­
culatory system . T hese gastric vessels all radiate from 
the cardiostom aic vessel (CSV) which connects di­
rectly to the simple heart.
Prelim inary experim ents using a resin-corrosion  
technique have shown that material infused via the 
CSV reaches the gastric blood spaces. As this is also
"sti  m u l u s "
a b s o rp t iv e
I  b l o o d  a n d  P 
I n t e r c e l l u l a r  ( 
/ s p a c e  ).
s e c r e to r y  
c e t  Is
F i g. 1. Schem atic representation o f a transverse 
section o f  one o f  the gastric ridges. The cap regions 
project into the gastric lumen and consist o f  m ucous 
cells as w ell as endocrine cells which are w ell situated 
to respond to material passing through the stom ach. It 
is suggested that such a stimulus may cause the release 
o f  a hormonal factor into the underlying blood spaces. 
This could  then stim ulate basal receptors on the 
“ zym ogen” cells, causing them to release digestive 
enzym es into the gastric lumen.
the largest vessel in the animal, except for the very 
delicate heart, the CSV w as used as the infusion site.
2 ) Surgical procedure (F ig. 2). A left ventral inci­
sion was made, extending the length o f  the body cav­
ity, passing through all the layers o f  the body wall, and 
exposing the gut, without damaging the pharynx. A 
polyethylene tube (Portex 100) was inserted into the 
proximal end o f  the stomach through a small incision  
in the distal end o f  the oesophagus and secured with a 
suture. A large tube (Portex 300) was then inserted 
through a shallow incision on the outer side o f  the 
intestinal loop , passing into the distal end o f  the 
stom ach, and secured by a ligature at the proximal end 
o f the intestine. It was found that this tube could be­
com e occluded by the gastric epithelium , and to pre­
vent this from occurring, a hole was cut in the side wall 
about 5 mm from the proximal end.
The animal w as then transferred to a small Perspex 
dish through which was passed aerated seawater at 
12°. U sing the cannulae, the stom ach was flushed with 
5 ml o f  artificial seawater to rem ove any solid gastric 
contents, and then using a binocular m icroscope the 
CSV was located and loosely ligated. A small incision  
w as m ade, and a short polyethylene tube (Portex 100), 
which had been drawn slightly to reduce the outside 
diameter at one end to 0 .2 - 0 .3 mm, was filled with 
tunicate Ringer and inserted with the aid o f  a micro-
oesophagi
a r t i f i c i a
water
i n f u s i o n
CSV .
s t o m a c h
i n t e s t i n etunic,  
(c ut)
p e r f u s a t e
h o l d f a s t
F i g . 2 . S ch em atic  rep resen ta tio n  o f  ca n n u lae  
placem ent for gastric perfusion in S tyela . Cannulation 
o f  esophagus and intestine provides gastric input and 
drainage, respectively, while cannulation o f CSV af­
fords a site for reproducible infusion o f  test material, 
at.s .. Atrial siphon; o r .s ., oral siphon; C SV , cardio­
stom aic vessel.
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manipulator. The ligature w as then firmly tightened 
around the cannula.
With practice this procedure took about 10 min, oc­
casional failures being caused by rupture o f the vein  
during cannula insertion, or puncture o f  the gastric 
epithelium by the cannula tip.
Experimental Procedure
The stomach w as perfused with artificial seawater 
(Synthetical, through the oesophageal cannula, using a 
W atson—Marlow pump (M HRK-1), at a flow rate o f 28 
/il/m in. The perfusate was collected  in the wells o f a 
microtitre plate, the cannula being transferred to a 
fresh well at 1 0 -min intervals.
After six samples had been collected, 200 fil o f  the 
tunicate Ringer, containing the test material, was in­
fused through the CSV cannula over a 15-sec period. A 
short infusion period was chosen to make certain that 
adequate pressure was developed to ensure that hor­
m ones would com e in contact with the basal edge o f  
the gut epithelial cells.
Control animals were either cannulated but given no 
infusion, or infused with 200 p,l o f  tunicate Ringer.
Samples were taken over a 2-hr period, the infusion 
being given after 1 hr. At the end o f this period protein 
and acid phosphatase levels in each sam ple were de­
termined.
Protein and ac id  ph osph a tase  determ ination . Perfu­
sate protein levels were taken as an index o f  enzym e  
output, and were measured using 0 . 2  ml o f  the seaw a­
ter perfusate, by the Low ry method (Lowry e t a i ,  
1951). H ow ever, it w as found that addition o f  the 
F olin—Ciocalteu reagent (Sigma, London) caused a 
salt precipitate to form, which interfered with the ab­
sorbance m easurem ents. Spinning the tubes in a bench  
centrifuge for the 30-min developm ent period, how ­
ever, caused the precipitate to be com pacted, and a 
reliable absorbance value o f  the suupernatant could  
then be determined. This method gave a very repro­
ducible standard curve, with values slightly low er than 
those obtained from protein solutions in water.
Acid phosphatase levels were determined using a 
colorimetric method (Boehringer Mannheim GmbH, 
W. Germany). All absorbances were measured on a 
Pye Unicam SP8-100 spectrophotom eter.
A dm inistration  o f  horm ones. The weights o f  indi­
vidual animals are fairly variable w hen repeatedly  
weighed, as a significant quantity o f seawater is re­
tained in their pharynxes. A  high percentage o f the 
weight o f  these animals com prises seawater and the 
keratinous tunic, which is often covered with com mon  
fouling organisms. The w et weight o f  these animals 
was therefore felt to be an unreliable index for cal­
cu lating the d ose for each  anim al. A nim als w ere  
therefore chosen  which were o f  approximately equal 
size. The dry weights o f  these animals (less tunic) were  
found to lie within the range 0 .5 1 -1 .2 2  g.
H orm ones (0 .1 -1 .0  mg) were d issolved immediately 
before use in filtered tunicate Ringer (NaCl, 25.9 g/
liter; KCl, 0.75 g/liter; Ca CI2 , 1.05 g/liter; MgClg, 5.295 
g/liter; Na^SO^, 1.63 g/liter; N aH  CO3, 0.06 g/liter; and 
glucose, 1. 0  g/liter).
S ta tis tic a l an a lysis . D ifferen ces betw een  means 
were considered to be significant if, using Student’s t 
test, F <  0.05.
RESULTS
Effect of Seawater Perfusion on Protein 
and Acid Phosphatase Levels
Figure 3 show s the effect o f perfusion 
w ith artific ia l seaw a te r  on th e  levels of 
protein  and acid phosphatase  in the perfu­
sate. During the first 60-min, protein  levels 
fall from  10 ±  1.5 mg/dl to  3.7 ± 1 .8  mg/dl. 
In the absence o f an infusion, protein out­
put rem ains below  this level throughout the 
following 60 min.
Acid phosphatase levels show  a similar 
response , ou tp u t in the perfusa te  falling 
from  2.0 ±  0.5 to 0.3 ±  0.1 units/liter after 
60 m in. O utpu t then  rem ains below  this 
level over the next 60 min.
Infusion o f tunicate R inger w ithout CCK 
(Fig. 4) caused no increase in e ither protein 
or acid phosphatase levels during the sub­
sequent 60 min.
_ 1 0  -
2
15)
< 0
9 0 12030 6 0
F i g . 3. Effect o f  seaw ater perfusion on protein and 
acid phosphatase levels in the perfusate over a (2 0 -min 
period). Mean ±  SE , n =  5. Stom achs are preflushed 
with 5 ml o f  seawater, and then perfused at 28 ^1/min. 
Both protein and acid phosphatase levels show a de­
crease in perfusate levels over the follow ing 1 2 0  min.
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F i g. 4. Effect o f  Sigma CCK (infused at 0 min) on 
protein and acid phosphatase levels in the perfusate 
over the subsequent 60 min. Mean ±  SE . Infusions o f  
0.1 m g ( 0 ,n  =  4), 0.2 mg ( A , n  =  5), 0.4 mg ( □ ,«  =  4), 
and 1.0 mg (■ , n =  5) CCK all produced levels o f  
protein and acid phosphatase during the subsequent 60 
min which w ere significantly higher than control infu­
sions ( • ,  /J =  6 ) .  Infusion o f control Ringer did not 
produce protein or acid phosphatase levels signifi­
cantly different from controls where no infusion was 
given (Fig. 3).
Effect of Hormones on Protein and Acid
Phosphatase Levels
Infusion of Sigma CCK , at all doses, pro­
duced a significant elevation o f perfusate 
protein and acid phosphatase, with m axi­
mal levels occurring 1 0 - 2 0  min postinfu­
sion (Fig. 4), R ecovery  occurred within 60 
min with doses o f 0.1, 0.2, and 0.4 mg, but 
1 . 0  mg produced elevated  levels over the 
entire 60-min sam pling period.
Figure 5 show s an approxim ately linear 
relationship betw een both acid phosphatase 
and protein ou tpu t, and the doses o f Sigma 
CCK infused. Total gastric output was es­
tim ated by calculating the am ounts of pro­
tein or acid phosphatase presen t in all the 
sam ples of perfusate collected during the 
60-min postinfusion period.
C holecystokinin-octapeptide (Peninsula) 
(0 . 1  mg) produced a considerably larger re ­
E 3
® 2
O  4 -
100 02 0 4 0 6 0 8
C C K ,  mg
Fig. 5. Effect o f  gastric production o f  protein and 
acid phosphatase o f  infusion o f  Sigma CCK ( 0 . 1 - 1.0 
mg). R esponse to each dose is estim ated by calculating  
the total amount o f  protein and acid phosphatase pro­
duced during the 60-min postinfusion period. Mean ±  
SE (number o f  animals in parentheses). In both in­
stances an approximately linear relationship betw een  
dose and response exists.
spouse than did the Sigma CCK at the sam e 
dose (Fig. 6 ). The maximal protein level oc­
curred after 20 min (25 ± 3 .7  mg/dl) with a 
recovery to 6.0 ±  1.2 mg/dl after 60 min. The 
maximal acid phosphatase level occurred  
after 10 min. (7.0 ±  1.4 units/liter) with a 
recovery  to 0.4 ±  0.4 units/liter. Figure 6  
also show s that infusion o f 0 . 1  mg o f syn­
thetic porcine secretin  produced levels o f 
protein and acid phosphatase over the sub­
sequent 60 min which w ere not significantly 
different from control values.
D ISC U SSIO N
The results show that porcine CCK and 
C C K - 8  s tim ula te  gastric  re lease  o f acid 
phosphatase and probably o ther enzym es 
m easured as Low ry protein (Figs. 4, 6 ). In 
m am m als, two o f the m ajor physiological
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Fig. 6. Effect o f  0.1 mg CCK -8  (O) and 0.1 mg se­
cretin ( • )  on gastric protein and acid phosphatase  
levels over the 60-min postinfusion period. Mean ±  SE  
(number o f  animals in parentheses). CCK -8  produced 
a significant elevation o f  protein levels above control 
values (Fig. 3) over the 60-min postinfusion period, 
maximal levels occurring after 10 min (25 ±  3.7 mg/dl). 
CCK 8  also produced a significant elevation o f acid 
phosphatase levels, maximal levels occurring after 1 0  
min (7.02 ±  1.4 U/liter). Secretin caused no significant 
elevation o f  either protein or acid phosphatase levels 
over the 60-min postinfusion period.
actions of CCK are the stimulation of pan­
creatic enzyme secretion and initiation of 
gall bladder contraction: the ecbolic or pan­
creozymin effect and the cholecystokinetic 
effect, respectively. In Styela, CCK stimu­
lates only enzyme secretion, since these 
animals do not possess a gall bladder 
homologue, or any other gut-associated 
smooth muscle. Vigna and Gorbman (1979) 
have similarly found that CCK may act in a 
“pancreozymin” fashion on enzyme secre­
tion in the hagfish Eptatretus stouti, and 
have demonstrated that porcine CCK-33 
induces intestinal lipase secretion, but not 
gall bladder contraction. However, acid- 
alcohol extracts of the intestine of the hag- 
fish Myxine glutinosa can cause guinea 
pig gall bladder contraction (Nilsson, 1973), 
and intestinal extracts of the lampreys 
Lampetra fluviatilis and Fetromyzon
marinus have a CCK-like effect on mam­
malian gall bladder and pancreas (Bar­
rington, 1971; Barrington and Dockray, 
1970). Dockray (1977), has suggested that 
regulation of gall bladder contraction may 
have evolved before the control of intesti­
nal enzyme secretion in the Agnatha. How­
ever, our results and those of Vigna and 
Gorbman (1979) both appear to support the 
opposite contention.
The present results indicate that se­
cretory cells in the gastric epithelium of 
Styela, probably the zymogen cells (Thorn­
dyke, 1977), have, located on their basal 
plasma membranes, a class of receptors 
Sensitive to porcine CCK. Furthermore it 
seems likely that the receptors are part of a 
cytoplasmic system controlling the release 
of secretory products.
However, immunofluorescence studies 
(Bevis and Thorndyke, 1979; Thorndyke 
and Bevis, 1980) have failed to show the 
presence of a CCK-like peptide in the gas­
tric endocrine cells of Styela. Immunofluo­
rescence studies with CCK/gastrin C- 
terminal tetrapeptide as well as antisera to 
human gastrin have proved negative (Bevis 
and Thorndyke, 1979; Thorndyke and 
Bevis, 1980), whereas similar tests with an­
tisera prepared against secretin have 
proved positive (Bevis and Thorndyke,
1979). We have so far been unable to obtain 
antisera to CCK-33 or CCK-8.
Thus the present results suggest the con­
trol of gastric secretory activity by a CCK- 
like factor rather than the secretin-like fac­
tor indicated by the immunocytochemical 
results. Despite this apparent contradic­
tion, we suggest that the cap endocrine cells 
release a peptide which may act on neigh­
bouring zymogen cells in a paracrine fashion 
(Fig. 1).
Weinstein (1972) has suggested, on 
theoretical grounds, that both the secretin/ 
glucagon/VIP family and the gastrin/CCK 
family arose from a single parent molecule 
which he termed prosecgastrin. Holmquist 
et al. (1979) have suggested that in lam­
preys small CCK/gastrin- and glucagon/
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secretin-like peptides may already be pro­
duced separately , while Van N oorden and 
Pearse (1974, 1976) have dem onstrated  that 
a single cell type, found in the gut o f lam ­
prey  and the m ore prim itive B ranch ios­
tom a, has the ability to react w ith both 
anti-glucagon and anti-gastrin sera. They 
suggest that this double im m unoreactivity 
is due to the presence o f a prosecgastrin  
type o f paren t horm one. We su g gest'tha t 
this may be the condition o f Styela, w here 
cap endocrine cells contain a prosecgastrin  
m olecule. It may be that in such a large 
molecule, only the secretin-like region is 
accessible for im m unostaining, o r equally, 
that the C C K -tetrapeptide antiserum  that 
we have used is effective only against ver­
tebrate  CCK  and not the Styela  prosecgas­
trin m olecule. This is consistent with ob­
se rv a tio n s th a t p en tag astrin  (Peptav lon) 
does not induce gastric secretion in Styela  
(T h orndyke  and  B ev is, 1980), and it is 
clearly o f im portance to test w hether or not 
o ther CCK  and C CK -related peptide anti­
sera produce positive im m unofluorescence.
The large doses of CCK which w ere re­
quired  to  produce a significant response  
suggest that although CCK-like, the peptide 
involved is not identical to porcine CCK. 
The possibility that C C K -related peptides 
such as caerulein and phyllocaerulein are 
biologically active is certainly relevant, and 
will require testing.
F u rther im m unocytochem ical and physi­
ological w ork in this field would be o f con­
siderable value both in determ ining the na­
ture o f the suggested Styela  prosecgastrin , 
and the nature o f the CCK -initiated enzym e 
re lease. Such a study is cu rren tly  being 
undertaken in this laboratory .
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Endocrine Cells in the Gut of the Ascidian Sty'cla clava
M.C. Thorndyke* and P.J.R. Bevis*
Department o f Zoology, Bedford College, London. England
Summary. U ltrastructural studies have shown the presence of two types of 
granulated endocrine cell in the gut o f Styela clava. Type I. which occurs in the 
stomach and intestine contains small irregular granules, each with a distinct 
halo. Type II. found only in the oesophagus contains larger rounded granules, 
often with little or no halo. The characteristics o f these two cell types are 
com pared with those o f endocrine cells found in the digestive tracts o f other 
protochordates and discussed with special reference to the evolution o f 
gastrointestinal endocrine cells in vertebrates.
Keywords: Endocrine cells-A scidian (5 nc/r/c/r7vrU- Gut epithelium -  Electron 
microscopy.
Introduction
The gastrointestinal mucosa in higher vertebrates is characterised by the presence 
o f a wide range o f endocrine cell types (.Andrew 1976a. b; Capella et ah. 1969; 
Forssm ann, 1970: Polak et ah. 1976: Solcia et ah. 1975) and ulirastructurally they 
have been classified according to their granule type and size (Andrew. 1976: Solcia 
et ah, 1975; Polak et ah, 1976). A num ber of other cytochemical and 
immunocytochemical characteristics are shared by these cells which produce 
polypeptide horm ones and or biogenic amines and have been used by Pearse in the 
development o f the so called A PU D  concept (Pearse. 196S. 1969). These features 
are thought to be connected with the common origin of the cells in neuroectoderm al 
tissue (Pearse, 1969; Pearse et ah, 1973). Observations on the digestive epithelia of
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lower vertebrates have indicated the presence of cells with similar characteristics 
(Ostberg et ah, 1976; Van N oorden and Pearse. 1974; Van N oorden et ah. 1972).
Limited studies on invertebrates have suggested that the gut in these animals 
mav also have an endocrine capacity (Boquist et ah. 1971; Davidson et ah. 1971; 
Falkm er and Ostberg. 1976).
In the protochordates there are a few reports available on the occurrence of 
amines and chromaffin cells (Erspamer. 1946; Erspam er and Asero. 1952; Gerzeli. 
1961. 1963; Welsh and Loveland. 1968). M ore recent u ltrastructural and 
histochemical work has shown the presence of granulated endocrine-like cells in the 
gut o f several Ascidian species (Burighel and Milanesi. 1975; Fritsch and Sprang, 
1977; Thorndyke, 1977). while other workers. (Van N oorden and Pearse. 1976) 
have described a num ber of granulated cell types in the gastrointestinal epithelium 
of amphioxus (Branchiostoma lanceolatum). The present report describes the 
occurrence o f similar granulated endocrine-like cells in the gut o f Styela clava.
Materials and Methods
Specimens o f Styela clava collected in the Portsmouth area w ere transported to London in aerated sea 
water and transferred to circulating sea water aquaria at 10' C. The oesophagus, stomach and intestine 
were rapidly excised into cold (4 0 3  °oglutaraidehyde. buffered with 0.1 M sodium cacodyla te (pH 7.2) 
in sea water. Following dissection, small fragments o f each tissued  mm-') were transferred to aliquots o f  
the same fixative for a total o f  2h. Post fixation was for 1 h in 1 °o OsO^ in the same buffer followed by 
dehydration in graded ethanols and embedding in TA.AB epoxy resin. Thin sections (pale gold-silver) 
were cut on a Cambridge Huxley Automatic microtome, counterstained with uranyl acetate and lead 
citrate and examined in an AEl EM 6 B or Corinth 275 microscope.
Results
G ranulated, endocrine-like cells may be found at all levels in the post pharyngeal 
digestive epithelium of Styela, although they are m ost commonly seen in the 
stomach and oesophagus ( Fig. 1 a -d ). The gastric epithelium in Styela  comprises a 
series of ridges, the side walls o f which are populated by both absorptive and 
protein secreting cells, while the cap o f each ridge is composed of mucous cells 
(Thorndyke, 1977). It is only in this latter region that the gastric endocrine cells are 
found (Fig. 1 a. b). The oesophagus and intestine do not show this type of regional 
specialization and endocrine cells are evenly distributed am ongst the epithelial 
mucous cells (Fig. Ic, d).
Throughout the gut the endocrine cells usually occupy a basal position (Fig. 1 a, 
d). although there are indications that this may be due to the plane of section, since 
on occasions in both stomach and oesophagus the cells take on a m ore slender, 
colum nar, appearance (Fig. 2a. b).
The granules in the gastric and intestinal endocrine cells (Type I) are small, 
electron dense and rather irregular in profile, with a distinct halo separating 
granules from m em brane (Figs. lb . 3a). They are scattered throughout the 
cytoplasm and range from 50-155 nm in diam eter (90 nm average). The rem ainder 
of the cytoplasm is filled with a largely vesicular sm ooth endoplasmic reticulum, 
interspersed with free ribosomes and m itochondna (Figs. 1 b. 3a). The granules in
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Fig. 1. a and b Gastric endocrine cells showing l\p ical position on ba.sement membrane, a x 4000. 
b X 18.000. c and d Oesophageal endocrine cells sited basall> between columnar mucous cells, 
c X 13.000. d X 4000
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Fig. 2a and b. Electron micrographs o f the more elongated columnar endocrine cells occasionally found 
in the stomach (a) and oesophagus (b). a x 6300. b x 5400
the oesophageal endocrine cells (Type II) on the o ther hand are m ore regular in 
shape with a very narrow, or at times, non-existent halo and vary between 100- 
175nm in diameter (average 130nm) (Figs. Ic , 3b).
Discussion
This present report shows that the gastrointestinal epithelium of Styela, like other 
protochordates (Burighel and Milanesi. 1975; K ataoka and Fuji ta, 1974; Fritsch 
and Sprang, 1977; Van N oorden and Pearse. 1974), carries a population of 
granulated endocrine-like cells which possess some o f the features exhibited by the 
polypeptide horm one producing members of the .A.PUD series in vertebrates 
(Ostberg ct al.. 1976; Pearse. 1968.1969.1974; Solcia et ah. 1975; Van N oorden and 
Pearse. 1974). Reports on Ascidians (Burighel and M ilanesi. 1975; Fritsch and
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Fig. 3. a Details o f gastric endocrine cell showing granules with irregular, electron-dense core, 
surrounded hy a distinct halo, x 20.000. b Oesophageal endocrine cells, the granule cores have a more 
regular outline and the halo is narrow and indistinct, x 24.500
Sprang, 1977) cannot, on ultrastructural evidence, distinguish différent types of 
endocrine cell; although the observations of Fritsch (1976) suggest that more than 
one type may occur in Ciona. Similarly recent work on cyclostomes describes only a 
single gut endocrine cell type (Ostberg et al., 1976; Van Noorden and Pearse, 1974).
In sharp contrast to this, observations on the digestive epithelium of 
Branchio.stonia{K‘àVdok'd and Fuji ta, 1974; Van Noorden and Pearse. 1976) find at 
least two cell types, perhaps even three or four, classified according to their 
ultrastructural appearance. Thus in Branchio.stoma. type I cells have dense, 
irregular granules with an obvious halo and an average diameter of 140 nm. Type 
III are similar but with eccentric cores and an average diameter of only 60 nm ( Van 
Noorden and Pearse, 1976). The type II cell granules in this species are more 
rounded with a narrow or non-existent halo and a mean diameter of 170 nm (Van 
Noorden and Pearse, 1976). Our observations indicate similarities between Siycla 
and Branchio.stoma, each with more than one cell type classified by the size and 
appearance of granules (Figs. 1 b, c, 3 a. b). The type I cells found in the stomach and 
intestine Styela fall somewhere between the types I and III of Branchio.stoma, 
while the Styela type II seem comparable to Branchio.stoma type II. Clearly there are 
some differences in granule size range between these two species, as there is between 
Styela and Cm/;u (Fritsch and Sprang. 1977) where the single endocrine cell type 
approaches Styela type I. However, this only serves to emphasize the problems
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associated with this work, where the ultrastructural appearance of granules is so 
markedly affected by the method of fixation employed (Mortensen and Morris,
1977). The most that can be said for Siycla, where the same fixation routine was 
used throughout, is that there are two types of granulated cell, types I and II. which 
bear some resemblance, albeit superficial, to the type I HI and type II respectively in 
Branchiosioma.
The final outcome of this preliminary classification depends on a number of 
other, cytochemical and immunocytochemical. tests (Pearse. 1968, 1969: Van 
Noorden et al.. 1972). Following such tests, Branchiostoma type I cells have been 
equated to argyrophilic, glucagon gastrin immunoreactive cells and type III to 
biogenic amine producing cells (Van Noorden and Pearse, 1976). Initial 
observations on Styela type I cells (Bevis and Thorndyke, unpublished obser­
vations) indicate the production of biogenic amines. This agrees with the 
histological findings of Gerzeli (1963) and Fritsch (1976) in Ciona and with other 
biochemical investigations (Erspamer and Asero. 1952: Welsh and Loveland, 
1968). The localization of a polypeptide hormone-like factor awaits final 
confirmation. An exploratory analysis of Styela type II cells suggests they are 
aldehyde fuchsin positive and possibly produce an insulin-like factor (Bevis and 
Thorndyke. 1978). These features are in agreement with the characteristics of the 
similar type II cell in Branchiostoma (Van Noorden and Pearse, 1976).
Thus, in e/A there appears to beat least two' distinct endocrine cell types in the 
gastrointestinal epithelium. It may also be that each cell type in turn produces more 
than one factor, as suggested for the endocrine cells in C/Vw/(Fritsch and Sprang,
1977) and Branchiostoma (Van Noorden and Pearse. 1976). The nature of the 
product or products, awaits further investigation, although on present evidence it 
seems probable that it is a polypeptide hormone and or biogenic amine.
Furthemiore it is still far from clear as to whether these substances are released as 
hormones into the blood system, as postulated for Branchiostoma (Kataoka and 
Fuji ta. 1974). Similarly it is not known whether they have any normal physiological 
role in the life of the animal.
Whatever the answers to these questions are. there can be no serious doubt that 
the present situation in Ascidians with regard to gut endocrine cells is of crucial 
significance to our understanding of the evolution of gastrointestinal endocrine 
cells in vertebrates.
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